SVM-light Version V5.01-TK-1.5
5 # kernel type
3 # kernel parameter -d 
1 # kernel parameter -g 
1 # kernel parameter -s 
1 # kernel parameter -r 
empty# kernel parameter -u 
0.4 # kernel parameter -L 
1 # kernel parameter -T 
S # kernel parameter -C 
1 # kernel parameter -F 
0 # kernel parameter -S 
0.400000 # kernel parameter -M 
3 # kernel parameter -N 
S # kernel parameter -V 
S # kernel parameter -W 
0 # kernel parameter -U 
4330 # highest feature index 
509 # number of training documents 
318 # number of support vectors plus 1 
1.0240474 # threshold b, each following line is a SV (starting with alpha*y)
-4.5068990627598779497020586859435  |BT| (S (PRP$ (Our))(VP (VBP (result))(ADVP (RB (clearly)))(VP (VBP (indicate))(SBAR (S (NP (JJ (sulfated))(NN (polysaccharide))(NNP (U.))(NN (lactuca)))(VP (VBD (exert))(NP (JJ (marked))(NN (chemoprevention))(JJ (DENA-initiated))(NN (hepatocarcinogenesis))(NN (inhibition))(JJ (abnormal))(NN (cell))(NN (proliferation))(NN (induction))(NN (apoptosis))))))))) |ET|  |BS| 39:G04.299.139.160 43:F01.145.544 183:G04.299.233.750 253:E02.319.162 554:D02.654.442.200 803:D01.248.497.158.845 804:D09.698  |ES| 19:1 89:1 94:1 101:1 103:1 299:1 658:1 736:1 870:1 900:1 1229:1 1479:1 2802:1 2838:1 2839:1 2840:1 2841:1 2842:1 2843:1 2844:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NN (BACKGROUND))(: (:)))(NP (NP (NNP (Magnolol))(, (,))(NN (plant))(NN (lignan)))(NP (VBN (isolated))(NN (bark))(NN (seed))(NN (cone))(NN (Magnolia))(NN (officinalis)))(, (,))(VP (VBN (shown))(NP (JJ (chemopreventive))(NN (effect))(JJ (chemically-induced))(NN (skin))(NN (cancer))(NN (development)))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 328:B01.650 619:D02.455.426.559.847.117.159.205 620:B01.650.940.800.575.100.680.500 621:D02.455.426.559.389.140.450 622:A08.675.650.850.625.670.100 623:A08.186.211.730.885.287.500 624:D27.505.696.706.018 625:A06.407.071.140 626:A05.810.453.324 627:A18.024.500.750  |ES| 2:1 18:1 19:1 35:1 75:1 104:1 237:1 1046:1 1098:1 1653:1 1946:1 2233:1 2312:1 2313:1 2314:1 2315:1 2316:1 2317:1 2318:1 2319:1  |EV| 
-4.259579715249174114433117210865  |BT| (NP (NP (NN (PURPOSE)))(: (:))(S (NP (JJ (Recent))(NN (study)))(VP (VBD (revealed))(S (NP (NP (JJ (branched-chain))(NN (amino))(NN (acid)))(PRN (-LRB- (-LRB-))(NP (NN (BCAA)))(-RRB- (-RRB-))))(VP (VB (reduce))(NP (NP (NP (NN (development))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(NN (patient))(NN (obesity))(NN (hepatitis))(NN (C))(NN (virus))(NN (infection))(S (VP (VBG (improving))(NP (NP (NN (insulin))(NN (resistance)))(PRN (-LRB- (-LRB-))(NP (NN (IR)))(-RRB- (-RRB-)))))))))))) |ET|  |BS| 50:M01.643 104:C04.557.470.200.025.255 550:B04.450.410 564:C18.654.726.500 637:D06.472.699.587.200.500.625 638:C02.440.440 639:D12.125.070  |ES| 10:1 14:1 19:1 35:1 104:1 120:1 131:1 275:1 303:1 304:1 441:1 687:1 1094:1 1275:1 1422:1 1955:1 2010:1 2048:1 2189:1 2358:1 2359:1 2360:1 2361:1 2362:1 2363:1 2364:1 2365:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NNS (RESULTS))(: (:)))(NP (NN (Silibinin))(NN (feeding)))(VP (VBD (showed))(NP (NP (ADJP (NP (JJ (dose-dependent))(NN (decrease))(JJ (azoxymethane-induced))(NN (colon))(NN (tumorigenesis)))(JJR (stronger)))(NN (efficacy))(NN (pretreatment)))(CC (versus))(NP (NN (posttreatment))(NNS (regimen)))))) |ET|  |BS| 32:C04.697.098.500 33:C04.697.098 46:A03.556.124.526.356 132:D02.172.080 532:E02.183  |ES| 19:1 78:1 104:1 113:1 132:1 295:1 710:1 1881:1 1983:1 2304:1 2531:1 2533:1 2824:1 2942:1 2943:1 2944:1 2945:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NN (BACKGROUND))(: (:)))(NP (NP (NNP (Drug))(NN (combination))(NN (therapy)))(VP (VBG (using))(NP (NP (NN (cisplatin))(JJ (natural))(NN (product)))(JJ (common))(NN (practice))(NN (treatment))(JJ (human))(NN (lung))(NN (cancer)))))) |ET|  |BS| 52:E02 55:B01.050.150.900.649.801.400.112.400.400 498:D01.210.375 793:D20.215 939:E02.319.310  |ES| 18:1 19:1 36:1 104:1 130:1 328:1 350:1 530:1 546:1 655:1 675:1 1046:1 1761:1 2333:1 2345:1 3296:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NN (BACKGROUND/AIMS)))(: (:))(NP (NP (JJ (Several))(NN (study)))(VP (VBD (reported))(NP (NP (NP (NP (NP (NN (efficacy))(NN (combination))(NN (therapy))(NN (interferon)))(PRN (-LRB- (-LRB-))(NP (NN (IFN)))(-RRB- (-RRB-))))(NN (alpha))(NN (5-fluorouracil)))(PRN (-LRB- (-LRB-))(NP (NN (5-FU)))(-RRB- (-RRB-))))(NP (NP (JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-)))))))) |ET|  |BS| 104:C04.557.470.200.025.255 560:D03.383.742.698.875.404 617:D12.644.276.374.440 618:E02.186  |ES| 10:1 14:1 19:1 104:1 130:1 131:1 303:1 304:1 441:1 530:1 993:1 1836:1 2302:1 2303:1 2304:1 2305:1 2306:1 2307:1 2308:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NN (AIM))(: (:)))(S (S (VP (TO (To))(VP (VB (elucidate))(S (NP (JJ (anticancer))(NN (mechanism))(NNP (Huqi))(NNP (San)))(VP (VBG (assessing))(NP (NN (expression))(NN (G-6-Pase))))))))(, (,))(NP (NP (NN (SDH)))(, (,))(NP (NN (ATPase))(NN (AFP))(JJ (N-nitrosodiethylamine-mediated))(NN (hepatocarcinogenesis))(NN (rat)))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 554:D02.654.442.200 893:D08.811.277.040.025 894:D08.811.277.040.025  |ES| 2:1 19:1 104:1 115:1 162:1 828:1 849:1 900:1 959:1 1196:1 1697:1 1880:1 2762:1 2765:1 2766:1 3630:1 3632:1 3634:1 3957:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (AIM))(: (:)))(S (VP (TO (To))(VP (VB (investigate))(NP (NP (NP (JJ (therapeutic))(NN (effect))(JJ (potential))(NN (mechanism))(JJ (natural))(NN (flavonoid))(NN (quercetin-3-O-beta-D-glucuronide)))(PRN (-LRB- (-LRB-))(NP (NN (Q3GA)))(-RRB- (-RRB-))))(VP (NN (lipid))(NP (NP (NN (metabolism))(NN (disorder))(JJ (free))(JJ (fatty))(NN (acid)))(PRN (-LRB- (-LRB-))(NP (NN (FFA)))(-RRB- (-RRB-)))))))))(: (-))(VP (VBN (induced))(NP (NN (fatty))(NN (liver)))(ADVP (FW (vivo))(FW (vitro))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 242:A03.620 533:D03.383.663.283.266.450.284.777 534:D03.383.663.283.266.450 1132:C18.452.584 1133:D10.251.310  |ES| 10:1 14:1 19:1 75:1 104:1 162:1 216:1 378:1 409:1 459:1 541:1 827:1 828:1 836:1 959:1 1275:1 1886:1 2007:1 2070:1 2333:1 2401:1 3163:1 3958:1 3959:1 3960:1 3961:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NN (Alcohol))(JJ (well-established))(NN (risk))(NN (factor))(JJ (hepatocellular))(NN (carcinoma)))(, (,))(NP (NN (mechanism))(NN (alcohol))(NN (liver))(NN (cancer))(NN (complex)))) |ET|  |BS| 104:C04.557.470.200.025.255 409:E05.318.740.600.800.725 751:D02.033.375 822:D02.033  |ES| 2:1 18:1 19:1 162:1 171:1 185:1 303:1 304:1 695:1 836:1 1770:1 3710:1 3962:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NP (JJ (Altered))(NN (gene))(NN (expression))(NN (DNA))(NN (repair)))(: (-))(NP (NP (NN (cell))(JJ (proliferation-associated))(NNS (proteins/enzymes)))(VP (VBN (examined))(NP (NN (process))(JJ (tamoxifen-induced))(NN (hepatocarcinogenesis))(JJ (female))(JJ (Sprague-Dawley))(NN (rat))))))) |ET|  |BS| 155:G05.355.310 640:D02.455.426.559.389.150.700.900 642:M01.975 730:D08.811 769:B01.050.150.900.649.865.635.505.700.750 1134:G02.111.087.219 1135:D12.776.543  |ES| 9:1 19:1 94:1 115:1 324:1 638:1 666:1 849:1 900:1 971:1 1404:1 2707:1 3963:1 3964:1 3965:1 3966:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NNP (Thymidylate))(NN (synthase)))(, (,))(NP (NN (thymidine))(NN (phosphorylase)))(, (,))(NP (NN (dihydropyrimidine))(NN (dehydrogenase))(NN (expression)))(, (,))(NP (JJ (histological))(NN (tumour))(NN (regression))(JJ (5-FU-based))(JJ (neo-adjuvant))(JJ (chemoradiotherapy))(JJ (rectal))(NN (cancer)))) |ET|  |BS| 8:C04 333:D01.045 560:D03.383.742.698.875.404 561:E02.186.079.500 713:D08.811.913.555.500.862 846:F01.393.784 869:D08.811.913.400.725.850.500 870:D08.811.682.660.350  |ES| 2:1 18:1 19:1 66:1 115:1 1011:1 1986:1 1987:1 1988:1 1989:1 3002:1 3081:1 3082:1 3083:1 3084:1 3085:1 3086:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (AIRmax)))(ADVP (RB (also)))(NP (JJ (susceptible))(NN (AIRmin))(NN (colon))(NN (cancer)))(VP (VP (VBD (induced))(NP (NP (QP (CD (2))(CD (7)))(JJ (weekly))(NNS (dos)))(ADJP (ADJP (JJ (1,2-dimethylhydrazine)))(PRN (-LRB- (-LRB-))(NP (NN (DMH)))(-RRB- (-RRB-)))))(, (,))(S (VP (VBG (showing))(NP (NP (ADJP (RB (significantly))(JJR (higher)))(NN (number))(JJ (colonic))(JJ (aberrant))(NN (crypt))(NN (focus)))(PRN (-LRB- (-LRB-))(NP (NN (ACF)))(-RRB- (-RRB-))))(NP (CD (150))(NN (day))(NN (DMH))(NN (treatment))))))(PRN (-LRB- (-LRB-))(S (NP (NN (P)))(VP (JJ (=))(NP (CD (0.01)))))(-RRB- (-RRB-))))(NP (ADJP (RB (significantly))(JJR (higher)))(NN (number))(NN (tumor))(VBG (affecting))(NP (NP (JJR (larger))(JJ (intestinal))(NN (area)))(CD (300-475))(NN (day))))) |ET|  |BS| 8:C04 46:A03.556.124.526.356 52:E02 292:Z01 433:F01.470.047 824:C04.834.020 1177:A03.556.124.526  |ES| 2:1 5:1 7:1 10:1 14:1 18:1 19:1 109:1 113:1 124:1 148:1 170:1 311:1 315:1 412:1 546:1 581:1 646:1 677:1 899:1 988:1 1431:1 1725:1 2201:1 2530:1 2642:1 2643:1 2653:1 2913:1 2914:1 4074:1 4075:1 4076:1 4077:1 4078:1 4079:1 4080:1 4081:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (JJ (Preclinical))(JJ (clinical))(NN (investigation)))(VP (VBP (demonstrate))(SBAR (S (NP (NN (aspirin)))(VP (VBP (inhibit))(NP (NP (JJ (several))(NN (type))(NN (cancer))(JJ (colorectal))(NN (adenoma))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))))))) |ET|  |BS| 17:C04.557.470.035 104:C04.557.470.200.025.255 122:C14.280.383 225:E05.337 670:D02.455.426.559.389.657.410.595.176  |ES| 10:1 14:1 17:1 18:1 19:1 42:1 84:1 262:1 303:1 304:1 441:1 502:1 543:1 1370:1 1497:1 2487:1 2893:1  |EV| 
4.5068990627598779497020586859435  |BT| (FRAG (PP (IN (In))(ADJP (JJ (present))(SBAR (S (NP (NP (NN (paper)))(, (,))(NP (NP (JJ (ethanol-induced))(JJ (acute))(JJ (chronic))(NN (liver))(NN (damage))(NN (rat))(NN (model)))(VP (VBN (used))))(, (,)))(VP (VBP (result))(VP (VBD (showed))(SBAR (S (NP (NN (dioscin)))(ADVP (RB (significantly)))(VP (VBD (alleviated))(SBAR (S (NP (NP (NN (liver))(NN (steatosis)))(, (,))(NP (VBN (reduced))(NN (level))(NN (alanine))(NN (aminotransferase)))(, (,))(NP (NN (aspartate))(NN (aminotransferase)))(, (,))(NP (NP (JJ (total))(NN (triglyceride)))(PRN (-LRB- (-LRB-))(NP (NN (TG)))(-RRB- (-RRB-))))(, (,))(NP (JJ (total))(NN (cholesterol))(NN (malondialdehyde)))(, (,)))(VP (VBD (increased))(NP (NP (NN (level))(JJ (high-density))(NN (lipoprotein)))(, (,))(NP (NN (superoxide))(NN (dismutase)))(, (,))(NP (NN (glutathione))(NN (glutathione))(NN (peroxidase))))))))))))))))) |ET|  |BS| 58:D08.811.682.881 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 508:C06.552.241 646:D08.811.913.477.700.100 647:D08.811.913.477.700.347 655:D04.808.247.222.284 751:D02.033.375 753:C06.552.241 991:D08.811.682.732.500 1207:D08.811.913.477.700.225 1208:D12.644.456.448 1209:D10.532.432 1210:D02.047.700 1211:J01.637.650 1212:D10.351.801  |ES| 2:1 10:1 14:1 19:1 47:1 72:1 90:1 101:1 124:1 132:1 146:1 147:1 244:1 249:1 452:1 476:1 836:1 849:1 1307:1 1790:1 1848:1 2392:1 2393:1 2403:1 2672:1 2674:1 2678:1 2744:1 3132:1 3485:1 4234:1 4235:1 4236:1 4237:1 4238:1 4239:1 4240:1 4241:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NP (NN (BACKGROUND)))(CC (&))(NP (NNS (AIMS))))(: (:))(S (NP (JJ (Chronic))(NN (alcohol))(NN (drinking)))(VP (VBZ (accelerates))(NP (NP (NN (liver))(NN (fibrosis))(NN (patient)))(JJ (viral))(NN (hepatitis)))(VP (ADVP (RB (fully)))(VBD (explained))(NP (JJ (ethanol-enhanced))(NN (liver))(NN (damage))))))) |ET|  |BS| 50:M01.643 242:A03.620 676:C06.552.630 751:D02.033.375 904:F01.145.317.269 1136:B04.450  |ES| 19:1 104:1 120:1 529:1 836:1 889:1 949:1 1046:1 1777:1 1778:1 1848:1 2048:1 3710:1 3967:1 3968:1 3969:1 3970:1 3971:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NN (BACKGROUND))(: (:)))(S (NP (NN (Alcohol))(NN (consumption)))(VP (VBZ (promotes))(NP (NP (JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))))) |ET|  |BS| 104:C04.557.470.200.025.255 904:F01.145.317.269  |ES| 10:1 14:1 19:1 104:1 298:1 303:1 304:1 441:1 1046:1 2387:1 3962:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (NN (order))))(VB (clarify))(SBAR (IN (whether))(S (NP (NP (JJ (peroxisomal))(NN (hydrogen))(NN (peroxide)))(PRN (-LRB- (-LRB-))(NP (NN (H2O2)))(-RRB- (-RRB-))))(VP (VBP (play))(NP (JJ (important))(NN (role))(NN (peroxisome))(JJ (proliferator-induced))(NN (hepatocarcinogenesis))))))(, (,))(NP (VBN (examined))(NN (change))(NN (metabolism))(JJ (peroxisomal))(NN (H2O2)))(ADVP (FW (vivo))(FW (vitro)))(VP (VBG (using))(NP (NP (JJ (male))(NN (Fischer-344))(NN (rat))(NN (fed))(NN (clofibrate)))(, (,))(NP (NP (JJ (bezafibrate))(FW (di)))(PRN (-LRB- (-LRB-))(NP (NN (2-ethylhexyl)))(-RRB- (-RRB-))))(NP (NP (NN (phthalate)))(PRN (-LRB- (-LRB-))(NP (NN (DEHP)))(-RRB- (-RRB-)))))(NP (CD (78))(NN (week))))) |ET|  |BS| 12:Z01.542.049 15:F01.829.316.616 30:Z01.058.290.190.800 31:D08.811.520.224.800 79:I03.450.642.693 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 479:G08.686.157.500 590:B01.050.050.199.520.760.200 663:C16.320.565.398.500.330.500 898:G03.495 907:D01.248.497.158.685.750.424 908:A11.284.430.214.190.500.585.600 909:D02.065.277.067 910:D02.241.081.114.968.500.500.195 911:D02.241.223.805.250 912:D27.888.569.100.675  |ES| 2:1 10:1 14:1 19:1 31:1 200:1 216:1 221:1 238:1 244:1 324:1 350:1 378:1 783:1 849:1 900:1 902:1 1402:1 1887:1 2426:1 3163:1 3192:1 3193:1 3194:1 3195:1 3196:1 3197:1 3198:1 3199:1 3200:1 3201:1 3202:1 3203:1 3204:1 3205:1 3206:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NP (NNP (Celecoxib)))(, (,))(NP (NP (JJ (selective))(NN (cyclooxygenase-2)))(PRN (-LRB- (-LRB-))(NP (NN (COX-2)))(-RRB- (-RRB-))))(NP (NN (inhibitor)))(, (,)))(NP (JJ (effective))(JJ (chemopreventive))(NN (colon))(NN (cancer))(JJ (nonsteoroidal))(JJ (antiinflammatory))(NN (drug)))(VP (VBD (approved))(NP (NP (NNP (FDA))(JJ (adjuvant))(NN (therapy))(NN (patient)))(JJ (familial))(JJ (adenomatous))(NN (polyposis))))) |ET|  |BS| 3:C04.557.470.035.215.100 50:M01.643 52:E02 349:D27.505.519.389.310.500 633:I01.409.418.750.600.650.760 683:D27.505.519.389.310 684:D02.065.884.247 685:D27.505.696.477.067 686:D27.505.954.158 687:D26.650.064  |ES| 2:1 10:1 14:1 18:1 19:1 57:1 58:1 61:1 76:1 113:1 120:1 130:1 191:1 380:1 854:1 1639:1 1749:1 1946:1 2343:1 2475:1 2476:1 2477:1 2478:1 2479:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (ADVP (RB (However)))(, (,))(NP (NNP (Sorafenib))(NN (treatment)))(ADVP (RB (transiently)))(VP (VBD (inhibited))(SBAR (S (NP (NN (cell))(NN (cycle))(NN (progression)))(VP (VBD (resulted))(SBAR (S (NP (JJ (mitotic))(NN (catastrophe)))(VP (VBD (enhanced))(NP (JJ (non-apoptotic))(NN (liver))(NN (injury))(NN (regeneration))))))))))) |ET|  |BS| 16:C23.550.291.656 39:G04.299.139.160 52:E02 122:C14.280.383 353:G04.299.134 925:G10.261.326.520  |ES| 2:1 19:1 48:1 94:1 365:1 385:1 433:1 546:1 594:1 601:1 720:1 836:1 2416:1 2833:1 3210:1 3260:1 3614:1 4213:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (JJ (Critical))(NN (function))(NN (ADAM9))(NN (mouse))(NN (prostate))(NN (cancer)))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500  |ES| 18:1 19:1 33:1 52:1 77:1 3211:1 3415:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (NN (conclusion))))(, (,))(NP (NP (NP (NN (dioscin))(NN (show))(JJ (excellent))(JJ (protective))(NN (effect)))(JJ (ethanol-induced))(NN (liver))(NN (injury)))(S (VP (VBG (ameliorating))(NP (NP (JJ (ethanol-induced))(JJ (oxidative))(NN (stress)))(, (,))(NP (JJ (mitochondrial))(NN (function)))(, (,)))(NP (NP (JJ (inflammatory))(NP (NN (cytokine)))(NN (production)))(, (,))(NP (NN (apoptosis))(NN (liver))(NN (steatosis)))(, (,))))))(VP (VBD (developed))(NP (JJ (new))(NN (drug))(NN (treatment))(JJ (ethanol-induced))(NN (liver))(NN (injury))(NN (future))))) |ET|  |BS| 39:G04.299.139.160 52:E02 67:D26 242:A03.620 354:I01.320 508:C06.552.241 565:A11.284.430.214.190.875.564 567:G05.360.340.024.340.365 716:G03.495.710 751:D02.033.375 752:D12.644.276.374 753:C06.552.241  |ES| 2:1 19:1 33:1 75:1 89:1 191:1 244:1 429:1 493:1 546:1 712:1 836:1 1165:1 1190:1 1284:1 2004:1 2416:1 2430:1 2522:1 2583:1 2672:1 2673:1 2674:1 2675:1 2676:1 2677:1 2678:1  |EV| 
4.5068990627598779497020586859435  |BT| (SINV (NP (NP (JJ (Hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(NP (CD (one))(JJ (common))(NN (cancer)))(ADVP (RB (worldwide)))(, (,))(VP (VBD (caused)))(NP (NP (NP (NNP (Hepatitis))(NNP (C))(NN (virus)))(PRN (-LRB- (-LRB-))(NP (NN (HCV)))(-RRB- (-RRB-))))(NN (hepatotoxin)))) |ET|  |BS| 104:C04.557.470.200.025.255 550:B04.450.410  |ES| 2:1 10:1 14:1 18:1 19:1 304:1 441:1 655:1 1010:1 1422:1 1938:1 1954:1 1955:1 2151:1 2506:1 3987:1 3988:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (ADVP (RB (Conversely)))(, (,))(NP (NP (JJ (partial))(NN (loss))(NN (A20)))(, (,))(NP (NN (A20))(NN (heterozygote))(NN (mouse)))(, (,)))(ADVP (RB (significantly)))(VP (VBZ (impairs))(NP (NP (NN (liver))(NN (regeneration))(NN (damage)))(, (,))(NP (VP (VBZ (confers))(NP (JJ (high))(NN (lethality)))(S (VP (ADVP (RB (otherwise)))(NP (JJ (safe))(NN (procedure))))))(NP (FW (i.e.))(, (,))(CD (2/3))(JJ (partial))(NN (hepatectomy))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 157:G05.380.383 375:Z01.639.100 925:G10.261.326.520 928:E04.210.556 967:D01.248.497.158.490  |ES| 2:1 19:1 32:1 52:1 124:1 178:1 836:1 1508:1 1826:1 1848:1 2729:1 2737:1 3260:1 3272:1 3273:1 3404:1 3405:1 3406:1 3407:1 3408:1 3409:1 3410:1  |EV| 
-0.034894999737659304628323297947645  |BT| (S (NP (JJ (Anthocyanin-containing))(JJ (purple-fleshed))(NN (potato)))(VP (VBP (suppress))(NP (NP (NN (colon))(NN (tumorigenesis)))(PP (IN (via))(NP (NN (elimination))(NN (colon))(NN (cancer))(NN (stem))(NN (cell))))))) |ET|  |BS| 32:C04.697.098.500 33:C04.697.098 308:A11.872 667:B01.650.940.800.575.100.905.725.777 668:B01.650.940.800.575.100.905.725.777 669:D03.383.663.283.266.450.087  |ES| 18:1 19:1 78:1 94:1 113:1 156:1 596:1 1106:1 2438:1 2439:1 2440:1 2441:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (NP (JJ (Carcinogenic))(NN (risk))(JJ (molecular))(NN (mechanism)))(VP (VBG (underlying))(NP (NP (NN (liver))(JJ (tumor-promoting))(NN (activity)))(NN (copper))(NN (gluconate)))))(, (,))(NP (JJ (additive))(JJ (functional))(NN (food)))(, (,)))(VP (VBN (investigated))(S (VP (VBG (using))(NP (NP (NP (NN (rat))(JJ (medium-term))(NN (liver))(NN (carcinogenicity))(NN (bioassay))(NN (protocol)))(PRN (-LRB- (-LRB-))(NP (NN (Ito))(NN (test)))(-RRB- (-RRB-))))(ADJP (ADJP (JJ (2-week)))(ADJP (JJ (short-term))))(NN (administration))(NN (experiment))))))) |ET|  |BS| 12:Z01.542.049 61:E05.318.740.600.800 106:E05.091 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 279:D27.888.569.100 515:C04.588.274.623 849:G08.686.785.760.769.490.500 914:L01.178 1145:D02.241.081.844.322 1146:D27.720.368 1147:C17.800.621  |ES| 2:1 10:1 14:1 19:1 161:1 162:1 171:1 350:1 399:1 403:1 415:1 435:1 836:1 849:1 1418:1 2470:1 2575:1 2632:1 2931:1 3022:1 3215:1 3216:1 3266:1 3583:1 3776:1 3801:1 3978:1 3979:1 3980:1 3981:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Loss))(NN (hepatocyte))(NN (growth))(NN (factor/c-Met))(NN (signaling))(NN (pathway)))(VP (VBZ (accelerates))(SBAR (S (NP (JJ (early))(NN (stage))(NN (N-nitrosodiethylamine)))(VP (VBD (induced))(NP (NN (hepatocarcinogenesis)))))))) |ET|  |BS| 45:G07.700.320.249 69:G02.111.087.800 126:G02.111.087.800 262:A11.436.348 554:D02.654.442.200  |ES| 19:1 102:1 195:1 383:1 412:1 529:1 900:1 1128:1 1129:1 1788:1 1909:1 2602:1 4289:1  |EV| 
-1.7878676945520055596716701984406  |BT| (S (NP (DT (The))(NN (cyclooxygenase-2))(-LRB- (-LRB-))(NN (COX-2))(-RRB- (-RRB-))(NN (inhibitor))(NN (celecoxib)))(VP (VBN (approved))(NP (NP (NN (drug))(NN (clinic))(NN (colon))(NN (cancer))(NN (chemoprevention)))(VP (VBN (tested))(NP (NP (JJ (chemopreventive))(JJ (therapeutic))(NN (efficacy)))(JJ (various))(JJ (clinical))(NN (trial))))))) |ET|  |BS| 12:Z01.542.049 52:E02 67:D26 253:E02.319.162 349:D27.505.519.389.310.500 683:D27.505.519.389.310 684:D02.065.884.247 840:E01.789.800 841:E05.318.760.250.500 842:N02.278.035  |ES| 10:1 14:1 18:1 19:1 61:1 76:1 84:1 113:1 191:1 380:1 541:1 691:1 870:1 1096:1 1946:1 2304:1 2343:1 2807:1 2987:1 2988:1 2989:1  |EV| 
4.5068990627598779497020586859435  |BT| (SINV (PP (IN (In))(NP (NN (order))))(VP (VBP (prepare)))(NP (NP (JJ (human))(NN (trial))(NN (inhibition))(NN (colon))(NN (carcinogenesis)))(, (,))(NP (NP (VBN (conducted))(NN (study))(JJ (green))(NN (tea))(NNS (polyphenols)))(VP (JJ (preventive))(VP (NN (agent))(NP (NN (azoxymethane))(S (-LRB- (-LRB-))(NP (NN (AOM))(-RRB- (-RRB-))(: (-)))(VP (VBN (induced))(NP (NN (rat))(NN (colon))(NN (cancer))(NN (model)))(S (VP (VBG (using))(NP (NP (NP (JJ (aberrant))(NN (crypt))(NN (focus)))(PRN (-LRB- (-LRB-))(NP (NN (ACF)))(-RRB- (-RRB-))))(NN (end))(NN (point))))))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 33:C04.697.098 43:F01.145.544 46:A03.556.124.526.356 55:B01.050.150.900.649.801.400.112.400.400 56:D02.455.426.559.389.657.715 132:D02.172.080 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 375:Z01.639.100 824:C04.834.020 841:E05.318.760.250.500 876:F01.145  |ES| 2:1 10:1 14:1 18:1 19:1 36:1 72:1 103:1 113:1 131:1 154:1 207:1 244:1 350:1 409:1 728:1 849:1 1431:1 1725:1 1883:1 1993:1 1994:1 2121:1 2379:1 2834:1 2913:1 2914:1 2989:1 3100:1 3192:1 4228:1 4229:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (PRP$ (Our))(S (VP (VBP (result))(S (VP (VBP (provide))(NP (NP (ADJP (NN (clue))(JJ (molecular)))(NN (event)))(VP (VBN (involved))(NP (NN (mechanism))(NN (action))(JJ (HCB-induced))(NN (hepatocarcinogenesis))))))))))) |ET|  |BS| 742:G03.787 1232:D02.455.426.559.389.261.400  |ES| 19:1 101:1 161:1 162:1 205:1 658:1 711:1 774:1 900:1 1142:1 2013:1 4320:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Hepatocarcinogenesis)))(VP (VBD (induced))(NP (NN (diethylnitrosamine))(JJ (hepatic))(NN (deletion))(NN (PTEN))))) |ET|  |BS| 306:G05.355.600.800 554:D02.654.442.200  |ES| 19:1 412:1 838:1 1059:1 1936:1 1952:1 1959:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NP (NP (NN (Expression))(NN (cyclooxygenase)))(PRN (-LRB- (-LRB-))(NP (NN (COX)))(-RRB- (-RRB-))))(CD (-2))(NN (protein))(NN (rat))(NN (hepatocarcinogenesis)))(VP (VBN (associated))(NP (NP (JJ (fatty))(NN (change)))(, (,))(NP (NN (fibrosis)))(, (,)))(NP (NP (NN (cirrhosis))(JJ (oxidative))(NN (DNA))(NN (damage)))(, (,))(VP (VBD (caused))(SBAR (S (NP (ADJP (ADJP (JJ (choline-deficient)))(, (,))(ADJP (ADJP (NN (L-amino))(JJ (acid-defined)))(PRN (-LRB- (-LRB-))(ADJP (JJ (CDAA)))(-RRB- (-RRB-)))))(NN (diet)))(VP (VBD (investigated))(NP (NP (NN (F344))(JJ (male))(NN (rat)))(, (,))(PP (IN (along))(NP (NP (JJ (chemopreventive))(NN (efficacy))(JJ (specific))(NN (COX-2))(NN (inhibitor)))(, (,))(NP (NP (NN (nimesulide)))(PRN (-LRB- (-LRB-))(NP (NN (NIM)))(-RRB- (-RRB-)))))))))))))) |ET|  |BS| 7:D12.776 24:D08.811.600.720.750 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 349:D27.505.519.389.310.500 357:C06.552.630 526:G05.355.180 590:B01.050.050.199.520.760.200 594:D02.033.100.291.211 595:G07.203.650.240 596:E02.642.249 597:D12.125 662:C23.550.355 691:C23.550.355  |ES| 2:1 4:1 10:1 14:1 19:1 76:1 169:1 200:1 316:1 380:1 403:1 540:1 666:1 849:1 900:1 949:1 1199:1 1402:1 1848:1 1946:1 2070:1 2188:1 2190:1 2191:1 2304:1 2506:1 2583:1 2666:1 3180:1 3181:1 3182:1 3183:1 3184:1 3185:1 3186:1 3187:1  |EV| 
-2.2758268477314231859054416418076  |BT| (S (VP (NP (NNP (Digital)))(VBG (karyotyping))(VP (VBZ (identifies))(NP (NN (thymidylate))(NN (synthase))(NN (amplification))(NN (mechanism))(NN (resistance))(NN (5-fluorouracil))(JJ (metastatic))(JJ (colorectal))(NN (cancer))(NN (patient)))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 30:Z01.058.290.190.800 31:D08.811.520.224.800 50:M01.643 560:D03.383.742.698.875.404 712:E01.370.225.500.385.315 713:D08.811.913.555.500.862 714:A01.378.800.667.430  |ES| 17:1 18:1 19:1 66:1 120:1 162:1 337:1 921:1 1094:1 1610:1 2307:1 2576:1 2577:1 2578:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (NP (DT (The))(NN (process))(NN (hepatocarcinogenesis))(NN (diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(JJ (initiation/phenobarbital))(-LRB- (-LRB-))(NN (PB))(-RRB- (-RRB-))(NN (promotion))(NN (mouse))(NN (model)))(VP (VBZ (involves))(NP (NP (JJ (selective))(JJ (clonal))(NN (outgrowth))(NN (cell))(NN (harboring))(NN (oncogene))(NN (mutation))(NN (Ctnnb1)))(, (,))(S (NP (JJ (spontaneous))(JJ (DEN-only-induced))(NN (tumor)))(ADVP (RB (often)))(NP (NP (NN (Ha-ras)))(: (-))(NP (JJ (B-raf-mutated)))))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 8:C04 9:G05.360.340.024.340.375.500 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 23:D12.776.091.249 41:A11 216:Z01.107.084.900.425 278:D08.811.913.696.620.682.700.559.842.374 301:A11.251.353 554:D02.654.442.200 756:D03.383.742.698.253.650  |ES| 2:1 7:1 10:1 14:1 19:1 24:1 34:1 52:1 72:1 94:1 283:1 632:1 638:1 691:1 900:1 1069:1 1304:1 1673:1 1749:1 1875:1 1952:1 2337:1 3496:1 4030:1 4031:1 4032:1 4033:1 4034:1 4035:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NN (CONCLUSION)))(: (:))(NP (NP (NNP (Metformin)))(, (,))(VP (ADVP (RB (generally)))(VBN (considered))(S (ADJP (JJ (nontoxic))(SBAR (S (ADJP (RB (remarkably))(JJ (inexpensive)))(, (,))(VP (MD (might))(NP (VBN (used))(NN (combination))(NNS (TKIs))(NN (patient))(JJ (non-small))(NN (cell))(NN (lung))(NN (cancer)))(, (,))(S (VP (VBG (harboring))(S (NP (NN (EGFR))(NN (mutation)))(VP (VBP (overcome))(S (NP (NN (TKI))(NN (resistance)))(VP (VB (prolong))(NP (NN (survival))))))))))))))))) |ET|  |BS| 18:G05.365.590 30:Z01.058.290.190.800 31:D08.811.520.224.800 50:M01.643 96:I03.784 110:C04.588.894.797.520.109.220.249 784:D02.078.370.141.450  |ES| 2:1 18:1 19:1 34:1 94:1 104:1 120:1 187:1 274:1 328:1 476:1 530:1 694:1 798:1 1061:1 1094:1 1304:1 1882:1 2746:1 2998:1 3364:1 3365:1 3366:1 3367:1 3368:1 3369:1 3370:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (S (VP (TO (To))(ADVP (RBR (better)))(VP (VB (understand))(NP (NP (JJ (anticancer))(NN (activity))(NNP (Levamisole)))(PRN (-LRB- (-LRB-))(NP (NNP (LMS)))(-RRB- (-RRB-)))))))(, (,))(NP (NP (NN (serf))(JJ (adjuvant))(NN (colon))(NN (cancer))(NN (therapy))(NN (combination))(NN (5-Fluorouracil)))(, (,))(NP (NP (NN (study))(NN (analysis))(NNP (LMS))(POS (')))(NN (ability)))(S (VP (VBP (induce))(NP (NP (NN (apoptosis))(NN (growth))(NN (arrest)))(NP (VBN (cultured))(JJ (human))(JJ (micro))(: (-))(NP (JJ (macrovascular))(JJ (endothelial))(NN (cell))(PRN (-LRB- (-LRB-))(NP (NNS (ECs)))(-RRB- (-RRB-)))(NN (fibroblast)))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 39:G04.299.139.160 45:G07.700.320.249 55:B01.050.150.900.649.801.400.112.400.400 239:F02.463.188.357 385:F02.784.629.131 560:D03.383.742.698.875.404 618:E02.186 685:D27.505.696.477.067 687:D26.650.064 871:D02.886.675.346 872:A11.329.228 873:A11.436.275  |ES| 2:1 10:1 14:1 18:1 19:1 36:1 89:1 94:1 102:1 113:1 130:1 131:1 243:1 399:1 530:1 602:1 661:1 828:1 829:1 882:1 904:1 1232:1 1300:1 1489:1 1880:1 2213:1 2404:1 2479:1 3088:1 3089:1 3090:1 3091:1 3092:1 3093:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (DT (These))(VBG (finding))(S (VP (VBP (confirm))(NP (NN (hypothesis))(NN (ODC))(NN (polymorphism))(JJ (genetic))(NN (marker))(NN (colon))(NN (cancer))(NN (risk))))(, (,))(NP (NP (NP (NN (support))(NN (use))(NN (ODC))(NN (inhibitor))(NN (aspirin)))(, (,))(NP (NP (JJ (nonsteroidal))(JJ (antiinflammatory))(NN (drug)))(PRN (-LRB- (-LRB-))(NP (NNS (NSAIDs)))(-RRB- (-RRB-))))(, (,)))(NN (combination))(NN (strategy))(NN (colon))(NN (cancer))(NN (prevention))))) |ET|  |BS| 61:E05.318.740.600.800 149:G05.360.340.024.340.364.875.890 158:D23.101 307:G05.365.795 670:D02.455.426.559.389.657.410.595.176 796:D27.505.696.663.850.014.040.500  |ES| 2:1 10:1 14:1 18:1 19:1 113:1 171:1 191:1 380:1 530:1 534:1 792:1 864:1 927:1 1060:1 1114:1 1364:1 1474:1 1659:1 2477:1 2487:1 2697:1 2966:1 3044:1 3045:1 3046:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NNS (METHODS))(: (:)))(S (NP (DT (A))(JJ (Solt-Farber))(JJ (two-step))(NN (test))(NN (model))(NN (hepatocarcino))(NN (genesis)))(VP (VBD (established))(S (NP (NP (NP (NP (NP (NN (diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(NN (2-acetylaminofluorene)))(PRN (-LRB- (-LRB-))(NP (NN (AAF)))(-RRB- (-RRB-))))(NN (rat)))(VP (VBP (investigate))(S (VP (VBG (modifying))(NP (NP (NP (NN (effect))(NN (expression))(NN (6-glucosephosphatase)))(PRN (-LRB- (-LRB-))(NP (NN (G-6-Pase)))(-RRB- (-RRB-))))(, (,))(NP (NN (succinodehydrogenase))(-LRB- (-LRB-))(NN (SDH))(-RRB- (-RRB-)))(, (,))(NP (NP (NP (NN (adenosine))(NN (triphosphatase)))(PRN (-LRB- (-LRB-))(NP (NN (ATPase)))(-RRB- (-RRB-))))(JJ (N-nitrosodiethylamine-mediated))(NN (hepatocarcinogenesis))))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 168:E05.581 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 506:F01.829.263.315 554:D02.654.442.200 767:D02.065.064.150 893:D08.811.277.040.025 894:D08.811.277.040.025 1040:D08.811.277.352.650.225 1041:E01.370.370.380.250  |ES| 2:1 10:1 14:1 19:1 69:1 72:1 75:1 104:1 115:1 459:1 565:1 849:1 900:1 1418:1 1875:1 1952:1 2660:1 2762:1 3158:1 3221:1 3271:1 3624:1 3625:1 3626:1 3627:1 3628:1 3629:1 3630:1 3631:1 3632:1 3633:1 3634:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NP (NN (Involvement))(NN (Mouse))(JJ (Constitutive))(NN (Androstane))(NN (Receptor))(JJ (Acifluorfen-Induced))(NN (Liver)))(NP (NNP (Injury))(JJ (Subsequent))(NN (Tumor))(NN (Development))))) |ET|  |BS| 8:C04 242:A03.620  |ES| 19:1 1218:1 2059:1 2127:1 2721:1 3399:1 4264:1 4265:1 4266:1 4267:1 4268:1 4269:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (NNP (Farnesyltransferase))(NN (inhibitor)))(, (,))(NP (NN (ABT-100)))(, (,))(NP (JJ (potent))(NN (liver))(NN (cancer))(JJ (chemopreventive))(NN (agent))))) |ET|  |BS| 988:D08.811.913.225.431 989:D08.811.913.225.437  |ES| 2:1 18:1 19:1 22:1 380:1 728:1 836:1 1946:1 2538:1 3487:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (JJ (medium-term))(NN (carcinogenesis))(NN (test))(NN (rat))))(, (,))(NP (NP (ADJP (CD (2.0))(NN (%)))(NN (KA)))(VP (ADVP (RB (orally)))(VBN (given))(NP (NN (F344/DuCrj))(NN (rat))(CD (4))(NN (week))(NN (initiation))(NN (period))))(, (,)))(VP (VBD (followed))(NP (NP (NN (combination))(JJ (partial))(NN (hepatectomy))(NN (treatment))(NN (hepatocarcinogenesis))(NN (promoter)))(, (,))(NP (NP (NN (phenobarbital)))(PRN (-LRB- (-LRB-))(NP (NN (PB)))(-RRB- (-RRB-))))))) |ET|  |BS| 52:E02 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 590:B01.050.050.199.520.760.200 756:D03.383.742.698.253.650 776:G01.910.645 849:G08.686.785.760.769.490.500 914:L01.178 928:E04.210.556 1205:E05.940.150  |ES| 2:1 10:1 14:1 19:1 29:1 83:1 207:1 244:1 319:1 369:1 530:1 546:1 637:1 783:1 849:1 900:1 1418:1 2685:1 2725:1 3130:1 3215:1 3272:1 3273:1 3496:1 4224:1 4225:1 4226:1 4227:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (DT (The))(NNS (data)))(VP (VBP (provide))(NP (JJ (additional))(NN (evidence))(JJ (potential))(NN (use))(NN (roxithromycin))(NN (treatment))(JJ (hepatocellular))(NN (carcinoma))(NN (prevention))))) |ET|  |BS| 52:E02 104:C04.557.470.200.025.255 843:D02.540.576.500.992.630  |ES| 19:1 38:1 303:1 304:1 546:1 691:1 711:1 793:1 827:1 980:1 1474:1 1659:1 2990:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NNP (Administration))(NN (HMGB1))(NN (release))(NN (inhibitor))(NN (ethyl))(NN (pyruvate)))(, (,))(VP (VBP (affect))(NP (NP (JJ (p53-mediated))(JJ (hepatic))(NN (apoptosis)))(, (,))(VP (ADVP (RB (substantially)))(VBD (prevented))(NP (JJ (carcinogen-induced))(NN (cirrhosis))(NN (tumorigenesis))(NN (rat))(NN (liver))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 32:C04.697.098.500 33:C04.697.098 39:G04.299.139.160 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 279:D27.888.569.100 357:C06.552.630 433:F01.470.047 585:D12.644.276.087.371 589:E02.204.125 662:C23.550.355  |ES| 2:1 19:1 78:1 89:1 380:1 836:1 838:1 849:1 1199:1 1486:1 1944:1 2164:1 2165:1 2346:1 2417:1 2418:1 2419:1 2420:1 2421:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NP (JJ (Dietary))(NN (intake))(NN (pterostilbene)))(, (,))(NP (NN (constituent))(NN (blueberry)))(, (,)))(VP (VBZ (inhibits))(NP (NN (beta-catenin/p65))(JJ (downstream))(NN (signaling))(NN (pathway))(NN (colon))(NN (carcinogenesis))(NN (rat))))) |ET|  |BS| 23:D12.776.091.249 33:C04.697.098 46:A03.556.124.526.356 69:G02.111.087.800 122:C14.280.383 126:G02.111.087.800 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 595:G07.203.650.240 710:B01.650.940.800.575.100.343.774.249  |ES| 2:1 19:1 113:1 195:1 207:1 383:1 560:1 615:1 849:1 2428:1 2457:1 2562:1 2563:1 2564:1 2565:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (S (VP (TO (To))(VP (VB (clarify))(S (VP (VBG (modifying))(NP (NP (NN (effect))(NN (N-Acetyl-L-Cysteine)))(PRN (-LRB- (-LRB-))(NP (NN (NAC)))(-RRB- (-RRB-)))))))))(, (,))(NP (NP (JJ (antioxidative))(NN (ability)))(, (,))(NP (NN (hepatocarcinogenesis)))(VP (VBD (promoted))(SBAR (S (NP (NP (NP (NP (NN (fenofibrate)))(PRN (-LRB- (-LRB-))(NP (NN (FF)))(-RRB- (-RRB-))))(, (,))(NP (NP (NP (NN (peroxisome))(JJ (proliferator-activated))(NN (receptor)))(PRN (-LRB- (-LRB-))(NP (NN (PPAR)))(-RRB- (-RRB-))))(NN (alpha)))(NP (NN (agonist))))(, (,))(NP (NP (JJ (male))(NN (F344/N))(NN (rat)))(VP (VBN (administered))(NP (NP (NP (ADJP (JJ (single))(JJ (intraperitoneal)))(NN (injection))(NN (N-diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(NN (initiator))))))(VP (VBD (followed))(NP (NN (administration))(NN (diet))(VBG (containing))(CD (3,000))(NN (ppm))(NN (FF))(CD (16))(NN (week)))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 385:F02.784.629.131 536:D12.776.826.239.500 554:D02.654.442.200 590:B01.050.050.199.520.760.200 596:E02.642.249 791:D02.886.030.230.259 805:F01.829.263.315.500.725 806:F01.829.263.315.500.725 916:D02.241.081.114.968.500.625 917:E02.319.267.530.490  |ES| 2:1 10:1 14:1 19:1 75:1 186:1 286:1 783:1 785:1 828:1 849:1 900:1 1300:1 1402:1 1801:1 1836:1 1875:1 1887:1 1912:1 2191:1 2336:1 2575:1 2644:1 2846:1 3130:1 3193:1 3221:1 3222:1 3223:1 3224:1 3225:1 3226:1 3227:1 3228:1 3229:1 3230:1 3231:1 3232:1 3233:1 3234:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (VP (VBG (Combining))(NP (NN (kallistatin))(NN (gene))(NN (therapy))(NN (meloxicam))(NN (treat))(JJ (hepatocellular))(NN (carcinoma))(NN (mouse))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 52:E02 104:C04.557.470.200.025.255  |ES| 9:1 19:1 52:1 130:1 303:1 304:1 1087:1 1088:1 1089:1 1090:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (EX (There)))(NP (JJ (abundant))(JJ (epidemiological))(NN (evidence))(JJ (heavy))(NN (alcohol))(NN (intake)))(VP (VBZ (contributes))(NP (NP (NP (JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(NN (development))))) |ET|  |BS| 104:C04.557.470.200.025.255 651:H02.403.720.500 904:F01.145.317.269  |ES| 10:1 14:1 19:1 35:1 38:1 303:1 304:1 441:1 767:1 845:1 1798:1 2563:1 3217:1 3710:1 4039:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (JJ (present))(NN (study))))(, (,))(S (VP (VBG (using))(NP (FW (vivo))(NN (model))(NN (rat))(NN (hepatocarcinogenesis)))))(VP (VP (VBD (induced))(NP (NN (2-acetylaminofluorene))))(, (,))(VP (VBD (found))(NP (JJ (extensive))(NN (alteration))(JJ (cellular))(NN (iron))(NN (metabolism))(JJ (preneoplastic))(NN (stage))(NN (liver))(NN (carcinogenesis)))))) |ET|  |BS| 12:Z01.542.049 33:C04.697.098 41:A11 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 881:D02.065.064.150 895:D01.490.600 896:D01.268.556.412 898:G03.495  |ES| 2:1 19:1 37:1 72:1 131:1 207:1 244:1 350:1 378:1 412:1 836:1 849:1 900:1 951:1 1129:1 1307:1 1438:1 3074:1 3162:1 3163:1 3271:1 4242:1  |EV| 
-4.4668487773322738121350994333625  |BT| (S (NP (JJ (Epidemiological))(NN (evidence)))(VP (VBZ (suggests))(S (NP (NN (vitamin))(NN (D)))(VP (MD (may))(VP (VB (play))(NP (NP (NN (role)))(VP (VBG (inhibiting))(NP (NN (development))(NN (colon))(NN (prostate))(NN (cancer)))))))))) |ET|  |BS| 15:F01.829.316.616 46:A03.556.124.526.356 79:I03.450.642.693 122:C14.280.383 651:H02.403.720.500 720:D04.808.247.222.474 721:D04.808.812.768  |ES| 18:1 19:1 31:1 35:1 38:1 77:1 113:1 238:1 331:1 491:1 880:1 2384:1 2591:1 2592:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (5-aza-dC))(NN (treatment)))(ADVP (RB (markedly)))(VP (VBD (decreased))(NP (NP (NN (atherosclerosis))(NN (development))(NN (Ldlr)))(-LRB- (-LRB-))(PRN (: (-))(: (/))(: (-)))(-RRB- (-RRB-))(NN (mouse)))(NP (PP (IN (without))(NP (NN (change))(NN (body))(NN (weight))))(, (,))(NP (NN (plasma))(NN (lipid))(NN (profile)))(, (,))(NP (NN (macrophage))(NN (cholesterol))(NN (level))(NN (plaque))(NN (lipid))(NN (content)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 52:E02 511:C14.907.137.126.307 513:C14.907.137.126 558:C23.300.821 653:C23.888.144 654:D02.145.150 655:D04.808.247.222.284 656:C07.793.208.377 657:A12.207.152.693 658:A11.329.372 659:D10  |ES| 2:1 10:1 14:1 19:1 35:1 45:1 52:1 200:1 202:1 249:1 546:1 1195:1 1711:1 1794:1 1804:1 1981:1 2395:1 2396:1 2397:1 2398:1 2399:1 2400:1 2401:1 2402:1 2403:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Hepatocarcinogenesis)))(VP (VBD (induced))(ADJP (JJ (diethylnitrosamine/phenobarbital))(PRN (-LRB- (-LRB-))(NP (NN (DEN/PB)))(-RRB- (-RRB-)))))) |ET|  |BS| 554:D02.654.442.200 756:D03.383.742.698.253.650  |ES| 10:1 14:1 19:1 412:1 1959:1 4182:1 4183:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (JJ (Considerable))(NN (attention)))(VP (VBD (focused))(NP (NP (JJ (peroxisome))(JJ (proliferator-induced))(JJ (hepatocellular))(NN (carcinoma)))(, (,))(SBAR (S (NP (NN (phenomenon)))(VP (VBD (noted))(NP (NN (man)))))))(, (,))(SBAR (IN (whereas))(S (NP (JJ (limited))(NN (study)))(VP (VBP (examine))(VP (VBZ (fibrates))(SBAR (S (NP (JJ (therapeutic))(NN (drug)))(VP (VBP (induce))(NP (NP (NN (cholestasis)))(, (,))(NP (JJ (common))(NN (finding))(JJ (human))))))))))))) |ET|  |BS| 52:E02 55:B01.050.150.900.649.801.400.112.400.400 67:D26 104:C04.557.470.200.025.255 275:C23.888 879:C06.130.120.135 905:F02.830.104.214 912:D27.888.569.100.675 1188:D02.241.081.114.968.500 1189:M01.390  |ES| 2:1 19:1 36:1 131:1 191:1 243:1 303:1 304:1 372:1 541:1 655:1 927:1 960:1 1887:1 2131:1 2310:1 3198:1 4125:1 4126:1 4127:1 4128:1 4129:1 4130:1 4131:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (PRP (We)))(ADVP (RB (also)))(VP (VBN (shown))(SBAR (S (NP (NP (JJ (ursodeoxycholic))(NN (acid)))(PRN (-LRB- (-LRB-))(NP (NN (UDCA)))(-RRB- (-RRB-))))(VP (VBD (prevented))(SBAR (S (NP (JJ (AOM-induced))(NN (colon))(NN (cancer)))(VP (VBD (suppressed))(NP (NN (Cox-2))(NN (induction))))))))))) |ET|  |BS| 132:D02.172.080 737:D04.808.105.225.272.962  |ES| 5:1 10:1 14:1 18:1 19:1 62:1 113:1 237:1 307:1 736:1 843:1 1275:1 1944:1 2630:1 2631:1 3135:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (S (VP (TO (To))(VP (VB (clarify))(S (VP (VBG (modifying))(NP (NP (NN (effect))(NN (N-Acetyl-L-Cysteine)))(PRN (-LRB- (-LRB-))(NP (NN (NAC)))(-RRB- (-RRB-)))))))))(, (,))(NP (NP (JJ (antioxidative))(NN (ability)))(, (,))(NP (NN (hepatocarcinogenesis)))(VP (VBD (promoted))(SBAR (S (NP (NP (NP (NP (NN (fenofibrate)))(PRN (-LRB- (-LRB-))(NP (NN (FF)))(-RRB- (-RRB-))))(, (,))(NP (NP (NP (NN (peroxisome))(JJ (proliferator-activated))(NN (receptor)))(PRN (-LRB- (-LRB-))(NP (NN (PPAR)))(-RRB- (-RRB-))))(NN (alpha)))(NP (NN (agonist))))(, (,))(NP (NP (JJ (male))(NN (F344/N))(NN (rat)))(VP (VBN (administered))(NP (NP (NP (ADJP (JJ (single))(JJ (intraperitoneal)))(NN (injection))(NN (N-diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(NN (initiator))))))(VP (VBD (followed))(NP (NN (administration))(NN (diet))(VBG (containing))(CD (3,000))(NN (ppm))(NN (FF))(CD (16))(NN (week)))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 385:F02.784.629.131 536:D12.776.826.239.500 554:D02.654.442.200 590:B01.050.050.199.520.760.200 596:E02.642.249 791:D02.886.030.230.259 805:F01.829.263.315.500.725 806:F01.829.263.315.500.725 916:D02.241.081.114.968.500.625 917:E02.319.267.530.490  |ES| 2:1 10:1 14:1 19:1 75:1 186:1 286:1 783:1 785:1 828:1 849:1 900:1 1300:1 1402:1 1801:1 1836:1 1875:1 1887:1 1912:1 2191:1 2336:1 2575:1 2644:1 2846:1 3130:1 3193:1 3221:1 3222:1 3223:1 3224:1 3225:1 3226:1 3227:1 3228:1 3229:1 3230:1 3231:1 3232:1 3233:1 3234:1  |EV| 
4.5068990627598779497020586859435  |BT| (FRAG (ADVP (RB (However)))(, (,))(NP (NP (NN (action))(NN (compound))(JJ (ethanol-induced))(NN (liver))(NN (injury)))(ADJP (RB (still))(JJ (unknown))))) |ET|  |BS| 242:A03.620 751:D02.033.375  |ES| 2:1 19:1 433:1 776:1 836:1 2013:1 2182:1 2416:1 2433:1 2674:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (JJ (Garlic))(NN (oil)))(VP (VBD (attenuated))(NP (NP (JJ (nitrosodiethylamine-induced))(NN (hepatocarcinogenesis)))(VP (VBG (modulating))(NP (JJ (metabolic))(NN (activation))(NN (detoxification))(NN (enzyme))))))) |ET|  |BS| 554:D02.654.442.200 728:G03.495.244.224 729:G03.495.244.450 730:D08.811  |ES| 19:1 225:1 808:1 900:1 2006:1 2388:1 2435:1 2613:1 2614:1 2615:1 2616:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (PRP$ (Our))(VBP (result)))(VP (VBP (indicate))(SBAR (S (NP (NP (NN (administration))(NN (resveratrol)))(UCP (CC (either))(NP (JJ (early))(JJ (advanced))(NN (stage))(NN (hepatocarcinogenesis)))(ADJP (RB (equally))(JJ (effective)))))(VP (VBZ (involves))(NP (NP (NN (activation)))(NP (JJ (apoptotic))(NN (pathway))(NN (male))(NNP (Wistar))(NN (rat))))))))) |ET|  |BS| 39:G04.299.139.160 723:B01.050.150.900.649.865.635.505.700.900  |ES| 19:1 39:1 101:1 225:1 383:1 658:1 849:1 900:1 997:1 1128:1 1129:1 1402:1 1479:1 1639:1 1673:1 1712:1 2223:1 2575:1 2603:1 2854:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (JJ (azoxymethane-treated))(NN (rat))(NN (model))(JJ (experimental))(NN (colon))(NN (carcinogenesis))))(, (,))(NP (NN (sulindac))(NN (treatment)))(ADVP (RB (markedly)))(VP (VBD (induced))(NP (NP (NNP (Csk))(JJ (corresponding))(NN (increase))(JJ (inhibitory))(NN (phosphorylation))(NN (Src)))(PRN (-LRB- (-LRB-))(NP (NN (Tyr))(PRN (-LRB- (-LRB-))(CD (527))(-RRB- (-RRB-)))(-RRB- (-RRB-))))))) |ET|  |BS| 33:C04.697.098 46:A03.556.124.526.356 52:E02 95:E05.599 132:D02.172.080 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 251:D02.455.426.559.847.486.875 634:D12.125.072.050.875 972:G02.111.087.677 1206:D08.811.682.690.708.125.500  |ES| 2:1 10:1 14:1 19:1 40:1 72:1 113:1 207:1 244:1 263:1 412:1 546:1 849:1 869:1 2396:1 2429:1 2793:1 3426:1 3674:1 4230:1 4231:1 4232:1 4233:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (JJ (High-saturate-fat))(NN (diet))(NN (delay))(NN (initiation))(JJ (diethylnitrosamine-induced))(JJ (hepatocellular))(NN (carcinoma)))) |ET|  |BS| 104:C04.557.470.200.025.255 554:D02.654.442.200 694:G07.203.650.240.267  |ES| 19:1 136:1 303:1 304:1 637:1 2191:1 2732:1 4211:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (PRP$ (Our))(VP (VBP (result))(NP (NP (NN (show))(NNS (HCCs)))(VP (VBG (developing))(FRAG (X (SYM (AOX)))(: (-))(NP (NP (: (/))(: (-))(NN (mouse))(NN (share))(NN (number)))(VP (VBN (deregulated))(FRAG (-LRB- (-LRB-))(NP (RP (up))(: (-))(VBN (down-regulated))(-RRB- (-RRB-))(NN (gene))(JJ (ciprofibrate-induced))(NN (liver))(NN (tumor))))))))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 104:C04.557.470.200.025.255 142:I01.880.604 351:A17.360 515:C04.588.274.623  |ES| 7:1 9:1 10:1 14:1 19:1 52:1 101:1 429:1 590:1 646:1 658:1 836:1 1132:1 1283:1 1965:1 4321:1 4322:1 4323:1 4324:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (NN (Tamoxifen))(JJ (non-steroidal))(JJ (anti-estrogenic))(NN (drug)))(NP (ADJP (RB (widely))(JJ (used)))(NN (treatment))(NN (prevention))(NN (breast))(NN (cancer))(NN (woman))))(: (;))(FRAG (ADVP (RB (however)))(, (,))(NP (NP (NN (evidence))(NN (tamoxifen))(JJ (hepatocarcinogenic))(NN (rat)))(, (,))(NP (NN (mouse)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 52:E02 67:D26 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 640:D02.455.426.559.389.150.700.900 641:D27.505.696.399.472.277.540 642:M01.975  |ES| 2:1 18:1 19:1 23:1 38:1 52:1 191:1 217:1 476:1 546:1 849:1 1387:1 1474:1 2366:1 2367:1 2368:1 2369:1 2370:1 2371:1 2372:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (JJ (Arsenic))(VP (VBN (induced))(NP (NP (NP (JJ (dose-related))(NN (increase))(NN (lung))(NN (adenocarcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (sex)))(-RRB- (-RRB-))))(, (,))(NP (NP (JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (sex)))(-RRB- (-RRB-))))(, (,))(NP (NP (NN (gallbladder))(NN (tumor)))(PRN (-LRB- (-LRB-))(NP (NN (male)))(-RRB- (-RRB-))))(, (,))(NP (JJ (uterine))(NN (carcinoma)))))) |ET|  |BS| 104:C04.557.470.200.025.255 265:C04.557.470.200 1158:D01.268.513.249 1178:F01.145.802.188 1179:F01.393.446.250 1180:F01.145.802 1181:G08.686.810 1182:C04.588.274.120.401 1183:A05.360.319.679  |ES| 2:1 7:1 10:1 14:1 19:1 40:1 255:1 303:1 304:1 328:1 412:1 1402:1 4086:1 4087:1 4088:1 4089:1 4090:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (S (NP (JJ (Chronic))(JJ (inorganic))(JJ (arsenic))(NN (exposure)))(VP (VBZ (induces))(NP (JJ (hepatic))(JJ (global))(JJ (individual))(NN (gene))(NN (hypomethylation)))))(: (:))(NP (NN (implication))(JJ (arsenic))(NN (hepatocarcinogenesis)))) |ET|  |BS| 6:G05.360.340.024.340 197:A01.456.505.420 493:M01 1158:D01.268.513.249  |ES| 9:1 19:1 85:1 104:1 214:1 660:1 838:1 900:1 1953:1 2512:1 3174:1 3967:1 4106:1 4107:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (DT (The))(NN (purpose))(NN (investigation)))(VP (VBP (investigate))(FRAG (NP (NP (JJ (chemopreventive))(NN (action))(JJ (possible))(NN (mechanism))(NN (saffron))(NN (diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(: (-))(NP (VBN (induced))(NN (liver))(NN (cancer))(NN (rat)))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 225:E05.337 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 554:D02.654.442.200 701:B01.650.940.800.575.100.549.500  |ES| 10:1 14:1 18:1 19:1 162:1 409:1 459:1 691:1 836:1 849:1 1359:1 1497:1 1875:1 1946:1 1952:1 2013:1 2523:1 3011:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (VBG (Following))(NP (NP (JJ (initial))(CD (14))(NN (day)))(JJ (dietary))(NN (dose))(NN (range-finding))(NN (study))(JJ (male))(NN (mouse))))(, (,))(ADJP (NP (NP (JJ (mechanistic))(NN (study)))(PRN (-LRB- (-LRB-))(NP (NP (CD (0))(, (,))(CD (3))(, (,))(CD (32))(, (,))(CD (320))(NN (ppm))(NN (toxaphene))(NN (diet))(CD (7)))(, (,))(NP (CD (14)))(, (,))(NP (ADJP (CD (28))(NN (day)))(NN (treatment))))(-RRB- (-RRB-))))(VBN (performed)))(VP (VBP (examine))(SBAR (S (NP (JJ (potential))(NN (mechanism))(NN (toxaphene)))(VP (VBD (induced))(NP (NN (mouse))(NN (liver))(NN (tumor)))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 52:E02 275:C23.888 515:C04.588.274.623 595:G07.203.650.240 596:E02.642.249 1149:D02.455.526.439.913  |ES| 2:1 7:1 10:1 14:1 19:1 52:1 131:1 162:1 412:1 458:1 546:1 827:1 836:1 862:1 960:1 988:1 1401:1 1402:1 1440:1 1890:1 2191:1 2301:1 2546:1 2594:1 3233:1 3985:1 4078:1 4160:1 4161:1 4162:1 4163:1 4164:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NN (indica)))(NP (NP (-RRB- (-RRB-))(NN (extract))(-LRB- (-LRB-))(NN (FIE))(-RRB- (-RRB-))(NN (N-nitrosodiethylamine))(NN (CCl)))(FRAG (-LRB- (-LRB-))(NP (NP (CD (4))(-RRB- (-RRB-))(: (-)))(VBN (induced))(NN (hepatocarcinogenesis))(NNP (Wistar))(NN (rat)))))) |ET|  |BS| 554:D02.654.442.200 723:B01.050.150.900.649.865.635.505.700.900 1217:A02.513.514.100  |ES| 10:1 14:1 19:1 319:1 409:1 849:1 900:1 2496:1 2601:1 2602:1 2603:1 4260:1 4261:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Pterostilbene)))(VP (VBZ (inhibits))(NP (NP (NP (JJ (colorectal))(JJ (aberrant))(NN (crypt))(NN (focus)))(PRN (-LRB- (-LRB-))(NP (NN (ACF)))(-RRB- (-RRB-))))(NP (NP (NN (colon))(NN (carcinogenesis)))(PP (IN (via))(NP (NN (suppression))(JJ (multiple))(NN (signal))(NN (transduction))(NN (pathway))(JJ (azoxymethane-treated))(NN (mouse)))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 33:C04.697.098 46:A03.556.124.526.356 52:E02 122:C14.280.383 126:G02.111.087.800 132:D02.172.080 824:C04.834.020  |ES| 10:1 14:1 17:1 19:1 52:1 113:1 207:1 383:1 596:1 615:1 649:1 859:1 1431:1 1725:1 2453:1 2793:1 2912:1 2913:1 2914:1 2915:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (ADJP (RB (Orally))(VBN (administered)))(NN (lycopene)))(VP (VBZ (attenuates))(NP (NP (JJ (diethylnitrosamine-induced))(NN (hepatocarcinogenesis))(NN (rat)))(VP (VBG (modulating))(NP (NP (NN (Nrf-2)))(: (/))(NP (NN (HO-1))(NN (Akt/mTOR))(NN (pathway)))))))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 378:D08.811.913.696.620.682.700.755 554:D02.654.442.200 799:D12.776.260.615.249 800:Z01.107.169.534  |ES| 19:1 383:1 849:1 900:1 2336:1 2423:1 2435:1 2566:1 2732:1 2817:1 2818:1 2819:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NN (BACKGROUND))(: (:)))(NP (JJ (Chronic))(NP (NP (NN (ethanol))(NN (consumption))(NN (increase))(NN (risk))(JJ (hepatic))(NN (cirrhosis))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-)))))) |ET|  |BS| 61:E05.318.740.600.800 104:C04.557.470.200.025.255 357:C06.552.630 904:F01.145.317.269  |ES| 10:1 14:1 19:1 40:1 104:1 171:1 303:1 304:1 441:1 838:1 1046:1 1199:1 2387:1 3440:1 3967:1  |EV| 
4.5068990627598779497020586859435  |BT| (SINV (ADVP (RB (Here)))(, (,))(VP (VBN (examined))(NP (NP (NP (JJ (chemopreventive))(JJ (potential))(NN (Acteoside)))(PRN (-LRB- (-LRB-))(NP (NN (ACT)))(-RRB- (-RRB-))))(, (,))(NP (NP (NN (plant)))(VP (VBN (derived))(NP (NP (JJ (phenylethanoid))(NN (glycoside))(JJ (environmental))(JJ (dietary))(NN (carcinogen)))(, (,))(NP (NP (NN (diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(S (: (-))(VP (VBN (induced))(NP (NN (rat))(NN (hepatocarcinogenesis))))))))))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 279:D27.888.569.100 328:B01.650 554:D02.654.442.200 595:G07.203.650.240 1199:D04.808.155.580 1200:G16.500.275 1201:D09.408  |ES| 2:1 10:1 14:1 19:1 324:1 400:1 409:1 827:1 849:1 900:1 1098:1 1721:1 1875:1 1946:1 1952:1 2125:1 2594:1 3446:1 4195:1 4196:1 4197:1 4198:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (JJ (present))(NN (study))))(, (,))(VP (VBP (demonstrate))(NP (NP (JJ (altered))(NN (gene))(NN (expression))(JJ (various))(NNS (proteins/enzymes)))(VP (VBN (involved))(NP (NP (NN (DNA))(NN (repair)))(, (,))(NP (NP (NN (cell))(NN (growth))(NN (cell))(NN (cycle))(NN (process)))(JJ (tamoxifen-induced))(NN (hepatocarcinogenesis)))))))) |ET|  |BS| 41:A11 45:G07.700.320.249 353:G04.299.134 640:D02.455.426.559.389.150.700.900 730:D08.811 1134:G02.111.087.219 1213:D12.776  |ES| 2:1 9:1 19:1 94:1 102:1 115:1 131:1 244:1 502:1 513:1 601:1 638:1 666:1 693:1 774:1 900:1 1096:1 1307:1 3965:1 3966:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NN (Vanadium))(JJ (chemopreventive))(JJ (early))(NN (stage))(JJ (2-AAF-induced))(NN (hepatocarcinogenesis))(NN (rat)))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 837:D01.268.556.920 881:D02.065.064.150  |ES| 19:1 849:1 900:1 1128:1 1129:1 1946:1 3124:1 3125:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (JJ (present))(NN (study))))(, (,))(VP (VBD (demonstrated))(NP (NP (NN (alantolactone)))(, (,))(NP (NN (sesquiterpene))(NN (lactone)))(, (,))(NP (NP (JJ (potential))(NN (activity))(JJ (triple-negative))(NN (breast))(NN (cancer))(NN (MDA-MB-231))(NN (cell))(JJ (suppressing))(NN (signal))(NN (transducer))(NN (activator))(NN (transcription))(CD (3)))(PRN (-LRB- (-LRB-))(NP (NN (STAT3)))(-RRB- (-RRB-))))(NP (NN (signaling))(NN (pathway)))))) |ET|  |BS| 41:A11 69:G02.111.087.800 160:C04.588.180.788 209:G02.111.087.847 250:E07.305.812 759:D02.092.471.683.152.660 760:Z01.107.084.900.600 761:G02.111.087.800 762:D02.455.849.765 763:Z01.542.248.540 764:D02.540  |ES| 2:1 10:1 14:1 18:1 19:1 23:1 26:1 94:1 131:1 195:1 244:1 251:1 383:1 399:1 487:1 827:1 859:1 860:1 861:1 862:1 1175:1 1307:1 2250:1 2686:1 2687:1 2688:1 2689:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NP (JJ (Male))(NN (Malat1)))(: (-))(: (/))(: (-)))(NP (S (NP (NN (mouse))(JJ (wild-type))(-LRB- (-LRB-))(JJ (WT))(-RRB- (-RRB-))(NNS (littermates)))(VP (VBD (studied))(NP (NP (CD (one))(NN (year)))(NP (NP (NN (treatment))(JJ (genotoxic))(NN (agent))(NN (diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-)))))))(, (,))(NP (JJ (potent))(NN (inducer))(NN (liver))(NN (cancer))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 554:D02.654.442.200 775:E02.760.058  |ES| 2:1 8:1 10:1 14:1 18:1 19:1 22:1 52:1 401:1 546:1 728:1 836:1 1010:1 1355:1 1452:1 1875:1 1952:1 1995:1 3329:1 3635:1 3791:1 4296:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Curcumin)))(VP (VBZ (sensitizes))(NP (NP (JJ (human))(JJ (colorectal))(NN (cancer))(NN (xenograft))(JJ (nude))(NN (mouse))(NN (gamma-radiation)))(VP (VBG (targeting))(NP (JJ (nuclear))(JJ (factor-kappaB-regulated))(NN (gene))(NN (product))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 30:Z01.058.290.190.800 31:D08.811.520.224.800 55:B01.050.150.900.649.801.400.112.400.400 88:B01.050.150.900.649.865.635.505.500.550.500 92:E04.936.764 93:A01.941.875 142:I01.880.604 210:D12.776.260.600 692:D02.455.326.146.485.222.222 816:G01.358.500.505.300 973:E05.393.335  |ES| 9:1 17:1 18:1 19:1 36:1 52:1 265:1 266:1 616:1 675:1 1256:1 2062:1 3429:1 3430:1 3431:1  |EV| 
-4.0333834854075121256755664944649  |BT| (FRAG (NP (NNS (RESULTS)))(: (:))(NP (NP (NN (Liver))(NN (tumor))(NN (mass)))(NP (NP (NP (JJR (lower))(NN (pravastatin))(NN (group)))(PRN (-LRB- (-LRB-))(NP (NN (PG)))(-RRB- (-RRB-))))(NP (NP (NP (NN (control))(NN (group)))(PRN (-LRB- (-LRB-))(NP (NN (CG)))(-RRB- (-RRB-))))(, (,))(NP (NP (VBN (estimated))(NN (number))(NN (liver))(NN (tumor)))(PRN (-LRB- (-LRB-))(NP (NP (NN (p)))(ADJP (JJR (<))(NP (CD (0.004)))))(-RRB- (-RRB-))))(NP (NP (NN (liver))(NN (weight/body))(NN (weight))(NN (ratio)))(PRN (-LRB- (-LRB-))(S (NP (NN (p)))(NP (QP (JJR (<))(CD (0.04)))))(-RRB- (-RRB-)))))))) |ET|  |BS| 242:A03.620 515:C04.588.274.623 616:E05.318.780.074 653:C23.888.144 817:D02.455.426.559.847.638.930 829:M01.686  |ES| 2:1 7:1 10:1 14:1 19:1 104:1 117:1 289:1 312:1 646:1 710:1 836:1 2300:1 2399:1 2721:1 2804:1 2933:1 2934:1 2935:1 2936:1 2937:1 2938:1 2939:1 2940:1 2941:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Liver))(NN (tumor)))(VP (VBD (induced))(NP (NP (JJ (male))(NNP (Fischer))(NN (F344))(NN (rat))(NN (diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-)))))) |ET|  |BS| 515:C04.588.274.623 554:D02.654.442.200 590:B01.050.050.199.520.760.200  |ES| 7:1 10:1 14:1 19:1 412:1 849:1 1402:1 1875:1 1952:1 2721:1 3185:1 4288:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (NP (NP (NP (NN (PPARgamma)))(PRN (-LRB- (-LRB-))(CC (+))(: (/))(: (-))))(-RRB- (-RRB-))(NN (mouse))(JJ (susceptible))(JJ (DMH-induced))(NN (colon))(NN (carcinogenesis))(NN (PPARgamma)))(PRN (-LRB- (-LRB-))(CC (+))(: (/))(CC (+))(-RRB- (-RRB-))))(NP (NN (mouse))))(, (,))(S (NP (NN (embelin)))(ADVP (RB (significantly)))(VP (VBD (reduced))(NP (NP (NP (NN (incidence))(NN (colon))(NN (cancer))(NN (PPARgamma)))(PRN (-LRB- (-LRB-))(NP (NP (CC (+))(: (/))(CC (+))(-RRB- (-RRB-))(NN (mouse))(NN (PPARgamma)))(PRN (-LRB- (-LRB-))(CC (+))(: (/))(: (-))))(-RRB- (-RRB-))))(NN (mouse)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 33:C04.697.098 46:A03.556.124.526.356 434:E05.318.308.985.525.375 719:D12.776.826.239.588  |ES| 2:1 10:1 14:1 18:1 19:1 44:1 51:1 52:1 113:1 124:1 207:1 452:1 899:1 1511:1 2588:1 2888:1 2889:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NP (NP (JJ (Aldo-keto))(NN (reductase))(NN (family))(CD (1))(NN (B10)))(PRN (-LRB- (-LRB-))(NP (NN (AKR1B10)))(-RRB- (-RRB-))))(, (,))(NP (NN (member))(JJ (aldo-keto))(NN (reductase))(NN (superfamily)))(, (,)))(VP (VP (VBN (overexpressed))(NP (JJ (human))(JJ (hepatocellular))(NN (carcinoma))))(, (,))(NP (NN (lung))(JJ (squamous))(NN (cell))(NN (carcinoma))(NN (lung))(NN (adenocarcinoma))))) |ET|  |BS| 44:F01.829.263 55:B01.050.150.900.649.801.400.112.400.400 104:C04.557.470.200.025.255 182:A04.411 929:C04.557.470.200.400  |ES| 2:1 10:1 14:1 19:1 25:1 36:1 94:1 95:1 96:1 97:1 98:1 99:1 255:1 303:1 304:1 328:1 769:1 1067:1 3275:1 3276:1 3277:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (ADVP (RB (Notably)))(, (,))(NP (NN (colon))(NN (tumor))(NN (prevention))(NN (activity))(NN (sulindac)))(VP (VP (VBN (accompanied))(NP (NP (JJ (marked))(NN (induction))(JJ (lymphoid))(NN (aggregate)))(NP (JJ (proximal))(JJ (colonic))(JJ (inflammatory))(NN (mass))(NN (lesion)))))(, (,))(VP (S (NP (JJ (side))(NN (effect)))(VP (VBN (seen))(NP (JJR (lesser))(NN (degree))(NN (celecoxib)))))(, (,))(NP (NN (aspirin)))))) |ET|  |BS| 51:C04.588.274.476.411.307.180 213:F02.830.816.964 251:D02.455.426.559.847.486.875 670:D02.455.426.559.389.657.410.595.176 684:D02.065.884.247 797:A10.549.600  |ES| 2:1 7:1 19:1 75:1 113:1 399:1 677:1 724:1 736:1 869:1 871:1 1070:1 1131:1 1474:1 1967:1 2430:1 2487:1 2798:1 2801:1 2802:1 2803:1 2804:1 2805:1 2806:1 2807:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (NP (NN (BACKGROUND)))(CC (&))(NP (NNS (AIMS))))(: (:))(NP (NP (NP (NN (Chromodomain))(NN (helicase/adenosine))(NN (triphosphatase))(NN (DNA))(NN (binding))(NN (protein)))(NP (ADJP (JJ (1-like))(-LRB- (-LRB-))(NN (CHD1L))(-RRB- (-RRB-))(JJ (SNF2-like)))(NN (transcription))(NN (factor))))(VP (VBN (involved))(S (VP (NN (development))(NP (NP (JJ (human))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-)))))))))) |ET|  |BS| 14:F01.525 104:C04.557.470.200.025.255 166:D12.776.930 893:D08.811.277.040.025 894:D08.811.277.040.025  |ES| 4:1 10:1 14:1 19:1 35:1 36:1 104:1 185:1 303:1 304:1 441:1 487:1 666:1 774:1 1046:1 1487:1 1777:1 1778:1 3156:1 3157:1 3158:1 3159:1 3160:1 3161:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (S (NP (NP (JJ (Low))(JJ (dietary))(NN (folate))(NN (intake)))(VP (VBN (associated))))(VP (VBD (increased))(NP (NN (risk))(NN (colon))(NN (cancer))))(: (;)))(S (ADVP (RB (however)))(, (,))(NP (JJ (relevant))(JJ (genetic))(NN (animal))(NN (model)))(VP (VBG (lacking))))) |ET|  |BS| 19:B01.050 61:E05.318.740.600.800 224:D03.438.733.631.400 285:E05.598 595:G07.203.650.240 1109:E05.599.395.397  |ES| 2:1 18:1 19:1 46:1 47:1 72:1 113:1 169:1 171:1 217:1 376:1 778:1 864:1 865:1 1387:1 2563:1 2594:1 3615:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (JJ (wild-type))(NN (mouse))))(, (,))(NP (CD (200))(NN (ppm))(NN (cyproconazole)))(VP (VBD (caused))(NP (NP (NP (NP (NN (liver))(NN (hypertrophy)))(, (,))(NP (VBD (increased))(NN (liver))(NN (weight))(NN (cell))(NN (proliferation)))(, (,)))(JJ (single-cell))(NN (necrosis))(JJ (fat))(NN (vacuolation)))(, (,))(NP (NP (NP (NN (effect)))(ADJP (RB (generally))(JJ (similar))))(VP (VBN (caused))(NP (CD (850))(NN (ppm))(NN (phenobarbital)))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 183:G04.299.233.750 242:A03.620 756:D03.383.742.698.253.650 805:F01.829.263.315.500.725 806:F01.829.263.315.500.725 1151:C06.552.416 1215:C23.888.144.243.926 1216:C23.550.717  |ES| 2:1 8:1 19:1 47:1 52:1 75:1 94:1 244:1 299:1 332:1 836:1 2399:1 2425:1 2506:1 2685:1 3233:1 3364:1 3992:1 4254:1 4255:1 4256:1 4257:1 4258:1 4259:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NNP (Pravastatin)))(VP (VBZ (reduces))(NP (NN (lung))(NN (metastasis))(NN (rat))(JJ (hepatocellular))(NN (carcinoma)))(PP (IN (via))(NP (VBN (coordinated))(NN (decrease))(NN (MMP))(NN (expression))(NN (activity)))))) |ET|  |BS| 104:C04.557.470.200.025.255 113:C04.697.650 182:A04.411 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 817:D02.455.426.559.847.638.930 818:D08.811.277.656.300.480.525  |ES| 19:1 115:1 142:1 295:1 303:1 304:1 328:1 399:1 596:1 806:1 849:1 2890:1 2891:1 2892:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (S (NP (JJ (Diethylnitrosamine-induced))(NN (hepatocarcinogenesis)))(VP (VBD (suppressed))(NP (NN (lecithin)))))(: (:))(S (NP (NN (retinol))(JJ (acyltransferase-deficient))(NN (mouse)))(ADVP (RB (primarily)))(NP (NP (JJ (retinoid))(NN (action)))(NP (ADVP (RB (immediately)))(NP (NN (carcinogen))(NN (administration))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 279:D27.888.569.100 554:D02.654.442.200 711:D02.455.326.271.665.202.495  |ES| 19:1 52:1 104:1 307:1 900:1 1970:1 2013:1 2125:1 2569:1 2570:1 2571:1 2572:1 2573:1 2574:1 2575:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (JJ (present))(NN (study))))(, (,))(NP (VBN (shown))(NN (diosmin)))(VP (VBZ (attenuates))(SBAR (S (NP (NP (NN (2-AAF)))(VP (VBD (induced))(NP (NP (NP (JJ (hepatic))(NN (toxicity))(JJ (early))(NN (tumor))(NN (promotion))(NN (marker)))(PRN (-LRB- (-LRB-))(NP (NP (NN (ODC)))(, (,))(NP (NN (PCNA))(NN (Ki67))))(-RRB- (-RRB-))))(, (,))(NP (JJ (chemopreventive))(NN (efficacy))(NN (DEN))))))(VP (VBD (initiated))(NP (JJ (2-AAF))(VBN (promoted))(NN (hyper-proliferation))(NN (hepatocarcinogenesis))(NNP (Wistar))(NN (rat)))))))) |ET|  |BS| 376:D23.101.140 715:D03.383.663.283.266.450.260.222 723:B01.050.150.900.649.865.635.505.700.900 745:C10.597.350.350 767:D02.065.064.150 768:D12.776.660.740  |ES| 2:1 7:1 10:1 14:1 19:1 131:1 237:1 244:1 412:1 534:1 838:1 849:1 900:1 1128:1 1307:1 1875:1 1900:1 1912:1 1946:1 2304:1 2337:1 2406:1 2423:1 2603:1 2695:1 2696:1 2697:1 2698:1 2699:1 2700:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (JJ (Male))(NN (F344))(NN (rat)))(VP (VBN (treated))(S (NP (NP (CD (one))(JJ (powerful))(NNP (Valerian))(NN (specie)))(PRN (-LRB- (-LRB-))(NP (NN (Valeriana))(NN (sitchensis)))(-RRB- (-RRB-))))(VP (VBZ (dos))(NP (CD (0))(, (,))(CD (50))(, (,))(NP (NP (CD (500))(CD (5000))(NN (ppm))(NN (drinking))(NN (water))(NN (initiation))(NN (hepatocarcinogenesis))(NN (diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))))))) |ET|  |BS| 52:E02 554:D02.654.442.200 590:B01.050.050.199.520.760.200 857:B01.650.940.800.575.100.955.888 858:B01.650.940.800.575.100.955.888 1060:D01.045.250.875.300 1224:E05.318.740.872 1225:F01.658.780  |ES| 2:1 10:1 14:1 19:1 368:1 637:1 849:1 900:1 1010:1 1099:1 1875:1 1952:1 2355:1 2653:1 3057:1 3185:1 3233:1 3635:1 3968:1 4163:1 4290:1 4291:1 4292:1 4293:1 4294:1 4295:1  |EV| 
4.5068990627598779497020586859435  |BT| (FRAG (NP (NNS (METHODS))(: (:)))(NP (NN (Liver))(NN (fibrosis)))(VBD (induced))(NP (NN (mouse)))(VBG (receiving))(NP (NP (NN (bile))(NN (duct))(NN (ligation)))(PRN (-LRB- (-LRB-))(NP (NN (BDL)))(-RRB- (-RRB-))))(NP (NN (carbon))(NN (tetrachloride)))(-LRB- (-LRB-))(NP (NP (NN (CCl))(PRN (-LRB- (-LRB-))(CD (4))(-RRB- (-RRB-))(-RRB- (-RRB-)))(NN (administration))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 168:E05.581 676:C06.552.630 1217:A02.513.514.100 1220:D02.455.526.439.150 1222:A03.159.183 1223:E04.426  |ES| 10:1 14:1 19:1 52:1 104:1 319:1 412:1 548:1 565:1 949:1 1621:1 1622:1 2575:1 2721:1 4261:1 4278:1 4279:1 4282:1 4309:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (JJ (Chronic))(JJ (excessive))(NN (alcohol))(NN (consumption))(NN (lead))(NN (development)))(NP (NP (JJ (alcoholic))(NN (liver))(NN (disease)))(PRN (-LRB- (-LRB-))(NP (NN (ALD)))(-RRB- (-RRB-))))(S (VP (ADVP (RB (greatly)))(VB (increase))(NP (NN (risk))(NN (liver))(NN (cancer)))))) |ET|  |BS| 61:E05.318.740.600.800 86:D01.268.556.435 650:C06.552 904:F01.145.317.269 1148:M01.066  |ES| 10:1 14:1 18:1 19:1 35:1 40:1 171:1 254:1 836:1 998:1 2387:1 2880:1 3710:1 3967:1 3982:1 3983:1 3984:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (JJ (Chronic))(NN (exposure))(NN (toxaphene)))(VP (VBD (resulted))(NP (NN (increase))(NN (liver))(NN (tumor))(NN (B6C3F1))(NN (mouse))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 515:C04.588.274.623 1149:D02.455.526.439.913  |ES| 7:1 19:1 40:1 52:1 594:1 836:1 1953:1 3967:1 3985:1 3986:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (ADVP (RB (Here)))(, (,))(VP (VBN (conducted))(S (NP (NP (NP (CD (two))(NN (stage))(NN (hepatocarcinogenesis))(NN (study))(NN (rat)))(VP (VBN (exposed))(S (VP (VBG (initiating))(NP (NP (NN (agent))(NN (nitrosodiethylamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))))))(, (,))(NP (NP (JJ (hepatotoxic))(NN (compound))(NN (thioacetamide)))(PRN (-LRB- (-LRB-))(NP (NN (TAA)))(-RRB- (-RRB-))))(, (,)))(NP (NP (NN (methapyrilene)))(PRN (-LRB- (-LRB-))(NP (NN (MP)))(-RRB- (-RRB-))))(VP (NN (acetaminophen))(S (-LRB- (-LRB-))(NP (NN (APAP))(-RRB- (-RRB-))(CD (1-2))(NP (NN (week))))(VP (VBD (followed))(NP (NP (NN (liver))(NN (tumor))(NN (promoter))(NN (phenobarbital)))(PRN (-LRB- (-LRB-))(NP (NN (PB)))(-RRB- (-RRB-)))))))))) |ET|  |BS| 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 296:D02.065.064.786 554:D02.654.442.200 600:D27.888.569.100 661:D02.065.199.092.040 756:D03.383.742.698.253.650 876:F01.145 1198:D02.092.782.258.368.500  |ES| 2:1 7:1 10:1 14:1 19:1 83:1 131:1 400:1 728:1 783:1 836:1 849:1 900:1 933:1 1035:1 1129:1 1875:1 2019:1 2412:1 2433:1 2685:1 2862:1 3100:1 3102:1 3130:1 3496:1 4189:1 4190:1 4191:1 4192:1 4193:1 4194:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (NN (Expression))(NP (JJ (ets-related))(JJ (transcriptional))(NN (factor)))(NN (E1AF))(VBN (associated))(NN (tumor))(NN (progression))(NN (over-expression))(NN (matrilysin)))(NP (JJ (human))(JJ (gastric))(NN (cancer))))) |ET|  |BS| 8:C04 16:C23.550.291.656 55:B01.050.150.900.649.801.400.112.400.400 166:D12.776.930 937:D08.811.277.656.300.480.525.700.250  |ES| 7:1 18:1 19:1 36:1 48:1 86:1 169:1 185:1 316:1 559:1 1013:1 3289:1 3483:1 3484:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (DT (The))(JJ (objective))(NN (study)))(VP (VBD (determine))(SBAR (S (NP (NP (NP (NP (JJ (chemopreventive))(NN (activity))(JJ (Korean))(JJ (red))(NN (ginseng))(NN (extract)))(PRN (-LRB- (-LRB-))(NP (NN (KRG)))(-RRB- (-RRB-))))(NN (diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(VP (VBD (induced))(NP (NN (hepatocarcinogenesis))(NN (rat)))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 415:F01.658.500 554:D02.654.442.200 1162:B01.650.940.800.575.100.087.500  |ES| 10:1 14:1 19:1 74:1 131:1 399:1 412:1 691:1 849:1 900:1 1634:1 1875:1 1946:1 1952:1 2496:1 2916:1 4014:1 4015:1 4016:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NN (Amelioration))(JJ (free))(NN (fatty))(JJ (acid-induced))(NN (fatty))(NN (liver))(NN (quercetin-3-O-beta-D-glucuronide))(NN (modulation))(NN (peroxisome))(JJ (proliferator-activated))(JJ (receptor-alpha/sterol))(JJ (regulatory))(JJ (element-binding))(JJ (protein-1c))(NN (signaling)))) |ET|  |BS| 69:G02.111.087.800 242:A03.620 533:D03.383.663.283.266.450.284.777 536:D12.776.826.239.500 576:D12.776.260.103.500.750.500 1133:D10.251.310  |ES| 19:1 195:1 836:1 1801:1 1817:1 1887:1 1945:1 2070:1 2599:1 3958:1 3960:1 4082:1 4083:1 4084:1 4085:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (PP (IN (After))(NP (JJ (2-week))(NN (treatment))))(, (,))(NP (NN (animal)))(VP (VBN (subjected))(SBAR (`` (``))(S (NP (NP (JJ (resistant))(NN (hepatocyte))('' (''))(NN (model))(NN (hepatocarcinogenesis)))(PRN (-LRB- (-LRB-))(NP (NP (NN (initiation))(NN (diethylnitrosamine)))(, (,))(NP (NN (selection/promotion))(JJ (2-acetylaminofluorene))(JJ (partial))(NN (hepatectomy))))(-RRB- (-RRB-))))(VP (VBD (euthanized))(NP (ADJP (CD (8))(NN (week)))(NN (treatment)))))))) |ET|  |BS| 19:B01.050 52:E02 262:A11.436.348 554:D02.654.442.200 812:G05.355.800 881:D02.065.064.150 927:E02.760.905.850 928:E04.210.556  |ES| 2:1 10:1 14:1 19:1 46:1 72:1 427:1 546:1 637:1 781:1 783:1 900:1 1909:1 1952:1 3265:1 3266:1 3267:1 3268:1 3269:1 3270:1 3271:1 3272:1 3273:1 3274:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NNS (Effects)))(VP (VBP (magnolol))(NP (NP (JJ (UVB-induced))(NN (skin))(NN (cancer))(NN (development))(NN (mouse)))(JJ (possible))(NN (mechanism))(NN (action))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 742:G03.787  |ES| 18:1 19:1 35:1 52:1 162:1 1359:1 2013:1 2319:1 2526:1 2752:1 3461:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (DT (This))(NN (study)))(VP (VBZ (validates))(NP (NP (NP (NN (utility))(NN (Gum))(JJ (Arabic-conjugated))(NN (gold))(NNS (nanoparticles)))(PRN (-LRB- (-LRB-))(NP (NNS (GA-AuNPs)))(-RRB- (-RRB-))))(SBAR (S (NP (NN (laser)))(VP (VBP (induce))(NP (JJ (photothermal))(NN (inhibition))(NN (hepatocarcinogenesis)))))))(, (,))(PP (IN (via))(S (VP (VBG (employing))(NP (NP (NN (diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-)))))))(FRAG (: (-))(NP (VBN (mediated))(JJ (hepatocellular))(NN (carcinoma))(NN (model)))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 43:F01.145.544 104:C04.557.470.200.025.255 554:D02.654.442.200 1166:Z01.058.290.190.300 1167:D05.750.078.739.500 1168:J01.637.512.600 1169:D01.268.556.322 1170:E07.632.490  |ES| 2:1 10:1 14:1 19:1 72:1 103:1 131:1 243:1 303:1 304:1 596:1 807:1 900:1 1875:1 1952:1 2194:1 4011:1 4040:1 4041:1 4042:1 4043:1 4044:1 4045:1 4046:1 4047:1 4048:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Liver))(NN (tumor)))(VP (VBG (promoting))(NP (NN (effect))(NN (etofenprox))(NN (rat))(JJ (possible))(NN (mechanism))(NN (action))))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 515:C04.588.274.623 742:G03.787  |ES| 7:1 19:1 75:1 162:1 849:1 881:1 1359:1 2013:1 2721:1 4287:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (GT-094))(JJ (first))(NN (nitrate)))(VP (VBD (reported))(VP (VB (reduce))(NP (NP (NP (JJ (aberrant))(NN (crypt))(NN (focus)))(PRN (-LRB- (-LRB-))(NP (CD (45))(NN (%)))(-RRB- (-RRB-))))(NP (VBN (administered))(NN (carcinogen))(NN (standard))(NN (azoxymethane))(NN (rat))(NN (model))(JJ (colorectal))(NN (cancer))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 30:Z01.058.290.190.800 31:D08.811.520.224.800 132:D02.172.080 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 279:D27.888.569.100 824:C04.834.020 1195:D01.248.497.158.606  |ES| 10:1 14:1 17:1 18:1 19:1 72:1 369:1 816:1 849:1 993:1 1431:1 1725:1 1993:1 2125:1 2336:1 2361:1 2913:1 4175:1 4176:1 4177:1 4178:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NP (NNP (Myrtenal)))(, (,))(NP (JJ (natural))(NN (monoterpene)))(, (,)))(VP (VBZ (down-regulates))(SBAR (S (NP (NN (TNF-alpha))(NN (expression)))(VP (VBZ (suppresses))(NP (JJ (carcinogen-induced))(JJ (hepatocellular))(NN (carcinoma))(NN (rat)))))))) |ET|  |BS| 104:C04.557.470.200.025.255 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 279:D27.888.569.100 351:A17.360 758:D02.455.849.575 789:D12.644.276.374.500.800 790:D12.644.276.374.750  |ES| 2:1 19:1 115:1 303:1 304:1 686:1 849:1 2333:1 2421:1 2683:1 2773:1 2774:1 2775:1  |EV| 
4.5068990627598779497020586859435  |BT| (FRAG (PP (IN (In))(NP (NP (NP (NN (azoxymethane)))(PRN (-LRB- (-LRB-))(NP (NN (AOM)))(-RRB- (-RRB-))))(NN (model))(NN (colon))(NN (cancer))))(, (,))(NP (NP (NN (addition))(NN (K-ras))(NN (mutation)))(, (,))(VP (VBN (shown))(S (NP (ADJP (ADJP (JJ (wild-type)))(PRN (-LRB- (-LRB-))(ADJP (JJ (WT)))(-RRB- (-RRB-))))(NN (Ras)))(VP (VBD (activated))(NP (NP (JJ (upstream))(NN (pathway)))(, (,))(S (VBG (including))(, (,))(PP (FW (e.g.)))(, (,))(VP (VBG (signaling))(NP (NN (ErbB))(NN (receptor))))))))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 18:G05.365.590 69:G02.111.087.800 132:D02.172.080 563:D08.811.913.696.620.682.725.400.009  |ES| 2:1 8:1 10:1 14:1 18:1 19:1 34:1 72:1 113:1 163:1 186:1 195:1 237:1 244:1 383:1 468:1 561:1 1121:1 1775:1 1993:1 1994:1 1995:1 1996:1 1997:1 1998:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (PRP$ (Our))(NNS (data)))(VP (VBD (indicated))(NP (NP (NN (silymarin))(JJ (therapeutic))(NN (effect)))(NP (JJ (early))(NN (stage))(NN (liver))(NN (damage))))(, (,))(S (VP (VBG (reversing))(NP (NP (JJ (fatty))(NN (change)))(VP (VBG (recovering))(NP (NN (liver))(NN (histopathology))(JJ (dose-dependent))(NN (manner))))))))) |ET|  |BS| 242:A03.620 801:D03.383.663.283.266.450.268.777  |ES| 2:1 19:1 75:1 200:1 541:1 658:1 793:1 836:1 1128:1 1129:1 1541:1 1668:1 1848:1 2070:1 2740:1 2821:1 2822:1 2823:1 2824:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (DT (The))(JJ (key))(NN (event))(JJ (responsible))(NN (mouse))(NN (liver))(NN (tumor)))(VP (VBD (induced))(NP (NP (NN (pesticide)))(PRN (-LRB- (-LRB-))(NP (NP (NN (viz.)))(, (,))(NP (NN (pronamide))))(-RRB- (-RRB-))))))(VP (VBD (investigated))(NP (S (NP (NN (series))(NN (study)))(VP (VBG (employing))(ADJP (ADJP (JJ (molecular)))(, (,))(ADJP (JJ (biochemical)))(, (,))(ADJP (JJ (cellular))))))(, (,))(NP (JJ (apical))(NN (endpoint)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 41:A11 515:C04.588.274.623 913:D27.720.031.700  |ES| 2:1 7:1 10:1 14:1 19:1 52:1 131:1 159:1 161:1 205:1 403:1 412:1 691:1 836:1 1689:1 1807:1 2132:1 3074:1 3214:1 3323:1 4010:1 4011:1 4012:1 4013:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NN (Inhibition))(NP (NN (c-Jun))(JJ (NH2-terminal))(NN (kinase))(NN (switch)))(NN (Smad3))(NN (signaling))(NN (oncogenesis))(NN (tumor)))(: (-))(NP (NN (suppression))(NN (rat))(JJ (hepatocellular))(NN (carcinoma)))) |ET|  |BS| 8:C04 30:Z01.058.290.190.800 31:D08.811.520.224.800 32:C04.697.098.500 33:C04.697.098 43:F01.145.544 69:G02.111.087.800 104:C04.557.470.200.025.255 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 771:D08.811.913.696.620.682.700.567.374  |ES| 19:1 195:1 303:1 304:1 470:1 849:1 1686:1 2453:1 2703:1 2708:1 2709:1 2710:1 2711:1 2712:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Melatonin)))(VP (VBZ (prevents))(NP (NN (deregulation))(NN (sphingosine))(NN (kinase/sphingosine))(NN (1-phosphate))(NN (signaling))(NN (pathway))(NN (mouse))(NN (model))(JJ (diethylnitrosamine-induced))(JJ (hepatocellular))(NN (carcinoma))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 69:G02.111.087.800 104:C04.557.470.200.025.255 126:G02.111.087.800 469:D08.811.913.696 554:D02.654.442.200 707:D03.438.473.914.481 1227:D01.029.260.700.675.374 1228:D02.705.400  |ES| 19:1 52:1 72:1 195:1 303:1 304:1 383:1 402:1 2718:1 2732:1 2738:1 4306:1 4307:1 4308:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (ADVP (RB (However)))(, (,))(NP (NN (investigation))(JJ (protective))(NN (effect))(NN (betaine))(NN (hepatocarcinogenesis))))) |ET|  |BS| 225:E05.337 743:D02.092.877.883.077  |ES| 2:1 19:1 75:1 433:1 493:1 900:1 1497:1 2636:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (DT (These))(NN (observation))(NN (show)))(, (,))(NP (JJ (first))(NN (time)))(, (,))(S (NP (NP (NN (CP-31398))(NN (posse))(JJ (significant))(JJ (dose-dependent))(JJ (chemopreventive))(NN (activity)))(JJ (well-established))(NN (colon))(NN (cancer))(NN (model))(NN (combination))(JJ (low-dose))(NN (CP-31398))(NN (celecoxib)))(ADVP (RB (significantly)))(VP (VBD (enhanced))(NP (NN (colon))(NN (cancer))(JJ (chemopreventive))(NN (efficacy)))))) |ET|  |BS| 322:G01.910 429:N04.761.559.590.900 430:E05.581.249 684:D02.065.884.247  |ES| 2:1 18:1 19:1 72:1 113:1 124:1 135:1 385:1 399:1 429:1 530:1 792:1 816:1 1081:1 1477:1 1770:1 1946:1 2304:1 2807:1 2824:1 3047:1 3048:1 3049:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (NNS (Mice)))(VP (VBG (developing))(NP (NP (JJ (diethylnitrosamine-induced))(JJ (hepatocellular))(NN (carcinoma)))(VP (VBN (subjected))(NP (JJ (hydrodynamic))(NN (gene))(NN (delivery)))))))(VP (VBP (overexpress))(NP (NN (Gas1))(NN (liver))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 104:C04.557.470.200.025.255 242:A03.620 554:D02.654.442.200 1229:E04.520.252 1230:G01.342  |ES| 9:1 19:1 303:1 304:1 583:1 590:1 836:1 2513:1 2732:1 3267:1 4311:1 4312:1 4313:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (JJ (Antagonistic))(NN (effect))(NN (selenium))(NN (lipid))(NN (peroxide)))(NN (growth))(NN (control))(JJ (early))(JJ (hepatocellular))(NN (carcinoma)))) |ET|  |BS| 45:G07.700.320.249 104:C04.557.470.200.025.255 934:D01.248.497.158.685.750.637 935:D01.268.185.850  |ES| 19:1 75:1 102:1 289:1 303:1 304:1 1128:1 2401:1 3196:1 3283:1 3284:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (ADVP (RB (Herein)))(VP (VBP (show))(SBAR (S (NP (JJ (global))(NN (loss))(NN (ERRalpha)))(VP (VBZ (accelerates))(NP (NP (NN (development))(NN (diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-)))))))(: (-))(S (VP (VBN (induced))(NP (JJ (hepatocellular))(NN (carcinoma))))))) |ET|  |BS| 104:C04.557.470.200.025.255 197:A01.456.505.420 554:D02.654.442.200  |ES| 10:1 14:1 19:1 32:1 35:1 303:1 304:1 409:1 428:1 429:1 529:1 660:1 1875:1 1952:1 4209:1  |EV| 
-1.9383128784746759265544824302197  |BT| (S (S (S (NP (PRP (We)))(VP (VBD (found))(S (VP (VBG (impairing))(NP (JJ (autophagy))(NNS (hepatocytes)))))))(VP (MD (would))(VP (VB (induce))(NP (JJ (oxidative))(NN (stress))(NN (DNA))(NN (damage))))))(, (,))(NP (VBD (followed))(NN (initiation))(NN (hepatocarcinogenesis)))(, (,))(VP (MD (could))(VP (VBD (suppressed))(NP (NN (antioxidant))(NN (N-acetylcysteine)))))) |ET|  |BS| 262:A11.436.348 390:G04.299.139.399 526:G05.355.180 700:D27.505.519.217 716:G03.495.710 791:D02.886.030.230.259  |ES| 2:1 19:1 37:1 243:1 307:1 637:1 666:1 775:1 843:1 866:1 894:1 900:1 908:1 1317:1 1848:1 2521:1 2522:1 2583:1 3130:1 3131:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (JJ (present))(NN (study))))(, (,))(VP (VBN (shown))(NP (NP (JJ (myrtenal))(, (,))(JJ (natural))(NN (monoterpene)))(, (,))(NP (VP (VBP (act))(SBAR (S (NP (JJ (antineoplastic))(NN (agent))(NN (diethylnitrosamine)))(VP (VBD (induced))(NP (JJ (phenobarbital))(VBN (promoted))(NP (JJ (experimental))(JJ (hepatocellular))(NN (carcinoma)))))))))))) |ET|  |BS| 81:E02.095.465.425.400.330.050.400 554:D02.654.442.200 660:D27.505.954.248 756:D03.383.742.698.253.650 757:C04.588.274.623.460 758:D02.455.849.575  |ES| 2:1 19:1 131:1 237:1 244:1 246:1 263:1 303:1 304:1 412:1 728:1 1307:1 1912:1 1952:1 2333:1 2682:1 2683:1 2684:1 2685:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NN (BACKGROUND))(: (:)))(S (NP (NP (JJ (Hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(ADVP (RB (rapidly)))(VP (VBG (increasing))(NP (NP (NN (cancer)))(WHNP (WHNP (WP$ (whose))(JJ (known))(NN (risk))(NN (factor)))(NP (JJ (chronic))(NN (ethanol))(NN (abuse))))(, (,))(NP (JJ (viral))(NN (hepatitis))(NN (infection)))(, (,))(NP (NN (aflatoxin))(NN (exposure))))))) |ET|  |BS| 104:C04.557.470.200.025.255 409:E05.318.740.600.800.725 1137:D03.383.663.283.119 1138:C02.440.420 1139:C25.775.100.250 1140:C06.552.380 1141:C02  |ES| 2:1 10:1 14:1 18:1 19:1 104:1 171:1 185:1 304:1 441:1 556:1 715:1 919:1 1046:1 1790:1 1953:1 2048:1 2151:1 2214:1 2362:1 3424:1 3440:1 3969:1 3974:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (IN (For))(NP (FW (vivo))(NN (study))))(, (,))(NP (JJ (1,2-dimethylhydrazine))(NN (dihydrochloride))(-LRB- (-LRB-))(NN (DMH))(-RRB- (-RRB-))(NN (s.c.)))(VP (VBD (injected))(VP (VBP (induce))(NP (NP (NP (NN (colon))(NN (cancer))(NN (PPARgamma)))(PRN (-LRB- (-LRB-))(CC (+))(: (/))(CC (+))(-RRB- (-RRB-))))(NN (PPARgamma))(PRN (-LRB- (-LRB-))(CC (+))(: (/))(: (-)))))(-RRB- (-RRB-))(NP (NN (mouse))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 719:D12.776.826.239.588  |ES| 2:1 10:1 14:1 18:1 19:1 44:1 51:1 52:1 113:1 131:1 243:1 378:1 2588:1 2642:1 2643:1 3489:1 3586:1 4165:1 4166:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NN (BACKGROUND))(: (:)))(S (NP (DT (The))(NP (NN (ErbB2/Her2/Neu))(NN (receptor))(NN (tyrosine))(NN (kinase))))(VP (VBD (amplified))(NP (ADJP (QP (RB (approximately))(CD (30)))(NN (%)))(JJ (human))(NN (breast))(NN (cancer)))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 63:G05.360.340.024.340.375.500.791.295.305 65:D08.811.913.696.620.682.725.400.009.400  |ES| 18:1 19:1 23:1 36:1 104:1 186:1 369:1 470:1 691:1 1046:1 1520:1 1843:1 2208:1 2341:1 3165:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (PP (IN (In))(NP (NN (study))))(, (,))(NP (NP (NP (NN (report))(NN (effect))(NN (resveratrol))(JJ (early))(JJ (advanced))(NN (stage))(NN (hepatocarcinogenesis))(NN (model))(NN (N-nitrosodiethylamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(: (-))(VBN (induced))(NP (NP (JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(JJ (male))(NNP (Wistar))(NN (rat))))) |ET|  |BS| 104:C04.557.470.200.025.255 554:D02.654.442.200 723:B01.050.150.900.649.865.635.505.700.900  |ES| 2:1 10:1 14:1 19:1 72:1 75:1 131:1 244:1 303:1 304:1 409:1 417:1 441:1 849:1 900:1 997:1 1128:1 1129:1 1402:1 1712:1 1875:1 2602:1 2603:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (PRP$ (Our))(JJ (prior))(NN (work)))(VP (VBD (showed))(NP (NP (NP (JJ (brief))(NN (exposure))(JJ (pregnant))(NN (C3H))(NN (mouse))(JJ (inorganic))(JJ (arsenic-induced))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(NP (NN (formation))(JJ (adult))(JJ (male))(NN (offspring)))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 104:C04.557.470.200.025.255 445:I03.946 1154:B01.050.050.199.520.520.388 1155:G08.686.340 1156:F01.829.263.065 1157:E05.916.039 1158:D01.268.513.249  |ES| 10:1 14:1 19:1 43:1 52:1 132:1 303:1 304:1 355:1 441:1 658:1 1402:1 1546:1 1953:1 3174:1 3998:1 3999:1 4000:1 4001:1 4002:1 4003:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (CD (2012))(NN (case))(NN (report))))(, (,))(VP (VBN (described))(NP (NP (NN (breakthrough)))(VP (VBG (finding))(NP (NP (CD (two))(JJ (advanced))(NNP (HCC))(NN (patient)))(, (,))(NP (S (NP (CD (one)))(VP (VBD (achieved))(SBAR (S (NP (JJ (complete))(NN (remission))(NN (liver))(NN (tumor)))(VP (VBD (normalized))(NP (NP (NN (alpha-fetoprotein))(NN (level)))(, (,))(PP (IN (along))(NP (JJ (complete))(NN (remission))(NN (lung))(NN (metastasis))))))))))(, (,))(NP (JJ (concomitant))(NN (use))(NN (thalidomide))(NN (cyproheptadine))))))))) |ET|  |BS| 50:M01.643 104:C04.557.470.200.025.255 113:C04.697.650 182:A04.411 275:C23.888 405:V03.100 406:V03.100 515:C04.588.274.623 747:D02.455.426.559.847.181.384.340 748:D12.776.124.790.106.092 749:D02.241.223.805.810.800  |ES| 2:1 7:1 19:1 120:1 172:1 244:1 249:1 328:1 417:1 441:1 634:1 806:1 836:1 927:1 933:1 934:1 997:1 1010:1 1659:1 1681:1 2491:1 2661:1 2662:1 2663:1 2664:1 2665:1 2666:1 2667:1 2668:1  |EV| 
4.5068990627598779497020586859435  |BT| (FRAG (PP (IN (In))(NP (NN (contrast))))(, (,))(NP (NP (CD (three))(CD (18))(NN (vinyl))(JJ (carbamate-induced))(NN (liver))(NN (tumor)))(, (,))(NP (CD (one))(CD (18))(JJ (TCDD-induced))(NN (liver))(NN (tumor)))(, (,))(NP (CD (two))(CD (22))(JJ (spontaneous))(NN (liver))(NN (neoplasm))(NN (mutation))(NN (beta-catenin))))) |ET|  |BS| 18:G05.365.590 23:D12.776.091.249 491:D27.505.259.500 515:C04.588.274.623 1096:D03.383.231.900  |ES| 2:1 7:1 19:1 34:1 60:1 244:1 283:1 482:1 836:1 933:1 1010:1 1193:1 1392:1 1523:1 3714:1 4221:1 4222:1 4223:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (PRP$ (Our))(JJ (previous))(NN (study)))(VP (VBD (demonstrated))(SBAR (S (NP (NP (JJ (garlic))(NN (oil)))(PRN (-LRB- (-LRB-))(NP (NN (GO)))(-RRB- (-RRB-))))(VP (MD (could))(VP (VB (prevent))(NP (JJ (NDEA-induced))(NN (hepatocarcinogenesis))(NN (rat)))(, (,))(NP (NP (VBG (underlying))(NN (mechanism)))(VP (ADVP (RB (fully)))(VBN (understood)))))))))) |ET|  |BS| 239:F02.463.188.357 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 554:D02.654.442.200  |ES| 2:1 10:1 14:1 19:1 131:1 162:1 435:1 658:1 733:1 849:1 889:1 900:1 908:1 979:1 1175:1 1819:1 2614:1 2835:1 2836:1 2837:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NNP (Coffee)))(VP (VBZ (reduces))(NP (NP (NN (liver))(NN (damage))(NN (rat))(NN (model))(NN (steatohepatitis)))(: (:))(NP (VBG (underlying))(NN (mechanism))(NN (role))(NNS (polyphenols))(NNS (melanoidins)))))) |ET|  |BS| 15:F01.829.316.616 56:D02.455.426.559.389.657.715 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 508:C06.552.241 652:D20.215.784.249  |ES| 19:1 31:1 72:1 104:1 142:1 154:1 162:1 435:1 836:1 849:1 1791:1 1848:1 2480:1 2481:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Liver))(NN (tumor))(NN (formation))(JJ (female))(NN (rat)))(VP (VBD (induced))(NP (NN (fluopyram))(JJ (mediated))(NN (CAR/PXR))(JJ (nuclear))(NN (receptor))(NN (activation))))) |ET|  |BS| 20:G03.495 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 515:C04.588.274.623 642:M01.975  |ES| 7:1 19:1 43:1 186:1 225:1 412:1 437:1 849:1 1256:1 1404:1 2721:1 4285:1 4286:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NP (NN (BACKGROUND)))(: (:))(NP (NP (JJ (Prolonged))(JJ (high))(NN (intake))(JJ (dietary))(NN (selenium)))(VP (VBN (shown))(VP (VBP (induce))(NP (JJ (gestational))(NN (diabetes))(NN (rat))(NN (hyperinsulinemia))(NN (pig)))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 595:G07.203.650.240 935:D01.268.185.850 1053:C18.452.394.968 1142:B01.050.150.900.649.077.880.399 1143:B01.050.150.900.649.077.880 1144:C13.703.170  |ES| 19:1 104:1 178:1 237:1 243:1 849:1 1046:1 2009:1 2563:1 2594:1 3284:1 3670:1 3975:1 3976:1 3977:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (JJ (present))(NN (study))))(, (,))(VP (VBN (investigated))(S (NP (NP (NN (role))(NN (IDO))(NN (diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(: (-))(VP (VBN (induced))(NP (NN (hepatocarcinogenesis)))(S (VP (VBG (using))(NP (NP (NP (NN (IDO-knockout)))(PRN (-LRB- (-LRB-))(NP (NN (KO)))(-RRB- (-RRB-))))(NN (mouse))))))))) |ET|  |BS| 15:F01.829.316.616 29:B01.050.050.136.500.500 554:D02.654.442.200  |ES| 2:1 10:1 14:1 19:1 31:1 52:1 131:1 244:1 350:1 403:1 409:1 900:1 1307:1 1875:1 1952:1 2849:1 4243:1 4244:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NNP (Coffee)))(VP (VBZ (reduces))(NP (NP (NN (liver))(NN (damage))(NN (rat))(NN (model))(NN (steatohepatitis)))(: (:))(NP (VBG (underlying))(NN (mechanism))(NN (role))(NNS (polyphenols))(NNS (melanoidins)))))) |ET|  |BS| 15:F01.829.316.616 56:D02.455.426.559.389.657.715 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 508:C06.552.241 652:D20.215.784.249  |ES| 19:1 31:1 72:1 104:1 142:1 154:1 162:1 435:1 836:1 849:1 1791:1 1848:1 2480:1 2481:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (N-acetyl-L-cysteine)))(VP (VBD (blocked))(SBAR (S (NP (NN (EGFR))(NN (activation)))(VP (VBD (reduced))(NP (JJ (N-nitrosodiethylamine-initiated))(NN (hepatocarcinogenesis))(NN (level))(NNP (Cre-Ctrl))(NN (mouse)))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 122:C14.280.383 554:D02.654.442.200 791:D02.886.030.230.259  |ES| 19:1 52:1 187:1 225:1 249:1 452:1 900:1 2776:1 2777:1 2778:1 2779:1  |EV| 
4.5068990627598779497020586859435  |BT| (SINV (PP (IN (In))(NP (NN (study))))(, (,))(VBD (evaluated))(FRAG (NP (NN (susceptibility))(NNP (Vparp)))(: (-))(: (/))(: (-))(NP (NN (Tep1))(: (-))(: (/))(: (-))(NN (mouse))(JJ (dimethylhydrazine-induced))(NN (colon))(NN (tumorigenesis))(JJ (urethane-induced))(NN (lung))(NN (tumorigenesis))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 32:C04.697.098.500 33:C04.697.098 46:A03.556.124.526.356 182:A04.411 225:E05.337 401:C23.550.291.687 1214:D02.241.081.251.944  |ES| 2:1 19:1 52:1 78:1 113:1 131:1 244:1 328:1 780:1 1353:1 4250:1 4251:1 4252:1 4253:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (HTHQ)))(ADVP (RB (also)))(VP (VBD (inhibited))(NP (NP (NP (JJ (2-amino-1-methyl-6-phenylimidazo))(-LRB- (-LSB-))(JJ (4,5-b))(-RRB- (-RSB-))(NN (pyridine)))(PRN (-LRB- (-LRB-))(NP (NN (PhIP)))(-RRB- (-RRB-))))(: (-))(NP (VBN (induced))(NN (colon))(NN (carcinogenesis))(CD (two))(NN (stage))(NN (colon))(NN (carcinogenesis))(NN (model)))(S (VP (VBG (using))(NP (NP (NP (NN (1,2-dimethylhydrazine)))(PRN (-LRB- (-LRB-))(NP (NN (DMH)))(-RRB- (-RRB-))))(NN (initiator)))))))) |ET|  |BS| 33:C04.697.098 46:A03.556.124.526.356 122:C14.280.383 744:D03.383.725  |ES| 5:1 10:1 14:1 19:1 72:1 113:1 207:1 350:1 365:1 409:1 933:1 1129:1 1373:1 1378:1 2637:1 2638:1 2639:1 2640:1 2641:1 2642:1 2643:1 2644:1  |EV| 
-4.5068990627598779497020586859435  |BT| (SINV (ADVP (RB (Here)))(VP (VBN (aimed)))(VP (VBP (determine))(NP (NP (NN (mechanism))(NN (action))(NN (DHEA)))(, (,))(NP (NP (NN (comparison))(NN (vitamin))(NN (E)))(, (,))(NP (JJ (chemically-induced))(JJ (hepatocellular))(NN (carcinoma))(NN (model))(NN (rat))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 104:C04.557.470.200.025.255 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 740:D04.808.054.079.429.625 741:D03.383.663.283.909 742:G03.787  |ES| 2:1 19:1 72:1 74:1 162:1 303:1 304:1 400:1 844:1 849:1 2013:1 2085:1 2233:1 2591:1 2633:1 2634:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (PRP (We)))(VP (VBD (studied))(NP (NP (NN (mechanism))(VBG (underlying))(NN (inhibition))(NN (diethylnitrosamine))(-LRB- (-LRB-))(NN (DEN))(-RRB- (-RRB-))(: (-)))(VBN (induced))(NN (hepatocarcinogenesis))(NN (lycopene))(NN (rat))))) |ET|  |BS| 38:Z01.058.290.120.180 40:Z01.542.248.700 43:F01.145.544 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 554:D02.654.442.200  |ES| 10:1 14:1 19:1 103:1 162:1 401:1 409:1 435:1 843:1 849:1 900:1 1875:1 1952:1 2566:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (NP (JJ (Dimethylarsinic))(NN (acid)))(PRN (-LRB- (-LRB-))(NP (NN (DMA)))(-RRB- (-RRB-))))(JJ (major))(NN (metabolite))(JJ (inorganic))(JJ (arsenical)))(, (,))(NP (ADJP (RB (epidemiologically))(JJ (significant)))(NN (chemical))(NN (relation))(NN (liver))(NN (cancer))(NN (mammal)))) |ET|  |BS| 901:B01.050.150.900.649 902:D02.691.088.100 903:D01.075  |ES| 2:1 10:1 14:1 18:1 19:1 135:1 462:1 836:1 1275:1 1678:1 2124:1 3171:1 3172:1 3173:1 3174:1 3175:1 3176:1 3177:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (ADVP (RB (Moreover)))(, (,))(NP (NP (NN (mouse))(NN (model))(JJ (azoxymethane-induced))(NN (colon))(NN (carcinogenesis)))(, (,))(S (NP (NN (rimonabant)))(ADVP (RB (significantly)))(VP (VBD (decreased))(NP (NP (NP (JJ (aberrant))(NN (crypt))(NN (focus)))(PRN (-LRB- (-LRB-))(NP (NN (ACF)))(-RRB- (-RRB-))))(NN (formation)))))(, (,)))(VP (VBZ (precedes))(NP (JJ (colorectal))(NN (cancer))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 11:B01.050.150.900.649.865.635.505.500 20:G03.495 33:C04.697.098 46:A03.556.124.526.356 132:D02.172.080 824:C04.834.020  |ES| 2:1 10:1 14:1 17:1 18:1 19:1 43:1 52:1 72:1 113:1 124:1 202:1 207:1 622:1 1431:1 1725:1 2533:1 2831:1 2913:1 2914:1 4318:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (S (NP (NNP (Lycopene)))(VP (VBZ (modulates))(SBAR (S (NP (NN (initiation))(NN (N-nitrosodiethylamine)))(VP (VBD (induced))(NP (NN (hepatocarcinogenesis))))))))(: (:))(S (NP (NP (NN (study))(JJ (chromosomal))(NN (abnormality)))(, (,))(NP (NN (membrane))(NN (fluidity))(JJ (antioxidant))(NN (defense))(NN (system)))))) |ET|  |BS| 554:D02.654.442.200 700:D27.505.519.217 1037:C23.550.210 1038:G01.154.500 1039:C16.131.260  |ES| 2:1 19:1 104:1 131:1 412:1 593:1 606:1 637:1 900:1 1002:1 1027:1 1104:1 2521:1 2602:1 2733:1 3622:1 3623:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (JJ (2-Amino-1-methyl-6-phenylimidazo))(PRN (-LRB- (-LSB-))(ADJP (JJ (4,5-b)))(-RRB- (-RSB-)))(NN (pyridine))(NN (increase))(NN (number))(NN (tumor)))(, (,))(NP (JJ (cystic))(NN (crypt))(JJ (aberrant))(NN (crypt))(NN (focus))(JJ (multiple))(JJ (intestinal))(NN (neoplasia))(NN (mouse)))) |ET|  |BS| 8:C04 11:B01.050.150.900.649.865.635.505.500 102:C04.588.274.476.411 555:C04.182 744:D03.383.725 824:C04.834.020  |ES| 2:1 7:1 19:1 40:1 52:1 109:1 640:1 646:1 649:1 1373:1 1378:1 1431:1 1725:1 2639:1 2640:1 2913:1 4060:1 4061:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NN (Modulation))(NN (energy))(JJ (metabolic))(NN (enzyme))(NN (expression))(JJ (N-nitrosodiethylamine-mediated))(NN (hepatocarcinogenesis))(JJ (Chinese))(NN (herb)))(, (,))(NP (NNP (Huqi))(NNP (San)))) |ET|  |BS| 554:D02.654.442.200 730:D08.811 788:H01.158.273.118.598.500  |ES| 2:1 19:1 115:1 900:1 2006:1 2388:1 2760:1 2761:1 2762:1 2763:1 2764:1 2765:1 2766:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (NP (NN (Aspirin)))(PRN (-LRB- (-LSB-))(NP (NP (JJ (acetylsalicylic))(NN (acid)))(PRN (-LRB- (-LRB-))(NP (NN (ASA)))(-RRB- (-RRB-))))(-RRB- (-RSB-))))(VP (VBN (shown))(VP (VBP (prevent))(NP (NN (CRC))))))(: (;))(S (ADVP (RB (however)))(, (,))(NP (JJ (epigenetic))(NN (mechanism))(NN (action)))(VP (VBP (remain))(ADJP (JJ (unknown)))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 30:Z01.058.290.190.800 31:D08.811.520.224.800 670:D02.455.426.559.389.657.410.595.176 671:G05.355.315.203  |ES| 2:1 10:1 14:1 19:1 162:1 217:1 237:1 245:1 733:1 1275:1 1373:1 1378:1 1387:1 1603:1 2013:1 2181:1 2182:1 2449:1 2450:1 2451:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Liver))(NN (fibrosis)))(VP (VBD (induced))(NP (NP (NN (carbon))(NN (tetrachloride)))(, (,))(NP (NN (bile))(NN (duct))(NN (ligation)))(, (,))(NP (NP (NN (disruption))(JJ (multidrug-resistance))(NN (transporter))(CD (2))(NN (gene)))(PRN (-LRB- (-LRB-))(NP (NN (Mdr2)))(-RRB- (-RRB-))))))) |ET|  |BS| 227:D12.776.157.530 676:C06.552.630 1220:D02.455.526.439.150 1221:G05.360.340.024.340.361 1222:A03.159.183 1223:E04.426  |ES| 2:1 9:1 10:1 14:1 19:1 148:1 412:1 779:1 949:1 1602:1 1621:1 1622:1 2721:1 4278:1 4279:1 4282:1 4283:1 4284:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NP (JJ (Pre-operative))(NN (5-fluorouracil)))(PRN (-LRB- (-LRB-))(NP (NN (5-FU)))(-RRB- (-RRB-))))(: (-))(NP (VBN (based))(NN (chemoradiotherapy)))(ADVP (RB (locally)))(VP (VBD (advanced))(SBAR (S (NP (NP (JJ (rectal))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (UICC-II/III)))(-RRB- (-RRB-))))(VP (MD (may))(ADVP (RB (significantly)))(VP (VB (reduce))(NP (JJ (local))(NN (tumour))(NN (mass))))))))) |ET|  |BS| 8:C04 59:E02.186.079 333:D01.045 560:D03.383.742.698.875.404  |ES| 10:1 14:1 18:1 19:1 124:1 491:1 997:1 1011:1 1985:1 1986:1 1989:1 2307:1 2308:1 2361:1 2804:1 2894:1 2895:1 2896:1 2897:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (AZD6244))(NN (doxorubicin)))(VP (VBP (induce))(NP (NN (growth))(NN (suppression))(NN (apoptosis))(NN (mouse))(NN (model))(JJ (hepatocellular))(NN (carcinoma))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 39:G04.299.139.160 45:G07.700.320.249 104:C04.557.470.200.025.255 136:D02.455.426.559.847.562.050.200.175  |ES| 19:1 52:1 72:1 89:1 102:1 243:1 303:1 304:1 599:1 2452:1 2453:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (PRP (We)))(VP (VBP (find))(SBAR (S (JJ (enzastaurin))(ADVP (RB (potently)))(VP (VBZ (reduces))(NP (NP (JJ (azoxymethane-induced))(NN (colon))(NN (tumor))(NN (initiation))(NN (progression)))(VP (VBG (inhibiting))(NP (JJ (PKCbetaII-mediated))(NN (tumor))(NN (cell))(NN (proliferation))(NN (beta-catenin))(NN (accumulation)))))))))) |ET|  |BS| 8:C04 16:C23.550.291.656 23:D12.776.091.249 51:C04.588.274.476.411.307.180 122:C14.280.383 132:D02.172.080 183:G04.299.233.750 866:D08.811.913.696.620.682.700.725.049  |ES| 7:1 19:1 48:1 60:1 94:1 113:1 142:1 299:1 637:1 843:1 880:1 2120:1 2533:1 2855:1 3127:1 3128:1 3129:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (JJ (Chemopreventive))(NN (evaluation))(NN (Tephrosia))(NN (purpurea))(JJ (N-nitrosodiethylamine-induced))(NN (hepatocarcinogenesis))(NNP (Wistar))(NN (rat)))) |ET|  |BS| 225:E05.337 554:D02.654.442.200 723:B01.050.150.900.649.865.635.505.700.900 1153:B01.650.940.800.575.100.401.890  |ES| 19:1 849:1 900:1 2503:1 2603:1 2948:1 3972:1 3994:1 3995:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Inhibition))(JJ (retinoic))(NN (acid))(NN (hepatocarcinogenesis)))(VP (VBD (induced))(NP (NN (N-nitrosomorpholine))(NN (expression))(NN (myc))(NN (oncogene))(NN (protein))(JJ (Sprague-Dawley))(NN (rat))))) |ET|  |BS| 43:F01.145.544 584:D12.776.624.664 769:B01.050.150.900.649.865.635.505.700.750 770:D02.455.326.271.665.202.495.818.500  |ES| 4:1 19:1 24:1 115:1 412:1 849:1 900:1 1275:1 2703:1 2704:1 2705:1 2706:1 2707:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Liver))(NN (cell))(NN (proliferation)))(VP (VBD (increased))(ADVP (RB (significantly)))(NP (NP (NN (liver))(NN (tumor))(JJ (tamoxifen-treated))(NN (rat)))(NP (ADJP (CD (12))(NN (month)))(NN (treatment))(NN (recovery))(NN (period)))))) |ET|  |BS| 52:E02 183:G04.299.233.750 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 515:C04.588.274.623 640:D02.455.426.559.389.150.700.900 775:E02.760.058 776:G01.910.645  |ES| 7:1 19:1 47:1 94:1 124:1 299:1 546:1 836:1 849:1 1120:1 2721:1 2722:1 2723:1 2724:1 2725:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (DNA))(NN (methylation))(NN (alteration)))(VP (VBD (detected))(SBAR (S (NP (NN (zebrafish))(NN (liver))(NN (tumor)))(VP (VBD (induced))(NP (NP (JJ (environmental))(NN (carcinogen))(CD (7)))(, (,))(NP (JJ (12-dimethylbenz))(-LRB- (-LRB-))(-RRB- (-RRB-))(NN (anthracene))))))))) |ET|  |BS| 366:G02.111.087.029.538.161 515:C04.588.274.623 572:B01.050.150.900.493.200.244.828 977:D27.888.569.100.125  |ES| 2:1 7:1 10:1 14:1 19:1 81:1 412:1 666:1 836:1 951:1 988:1 1007:1 2017:1 2125:1 3446:1 3447:1 3448:1  |EV| 
4.5068990627598779497020586859435  |BT| (FRAG (PP (IN (After))(NP (NP (JJ (3-month))(NN (recovery))(NN (period))(JJ (tamoxifen-treated))(NN (rat))(JJ (large))(NN (liver))(NN (tumor)))(PRN (-LRB- (-LRB-))(NP (NN (diameter))(CD (3))(NN (cm)))(-RRB- (-RRB-)))))) |ET|  |BS| 8:C04 52:E02 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 515:C04.588.274.623 640:D02.455.426.559.389.150.700.900 776:G01.910.645 1151:C06.552.416  |ES| 7:1 10:1 14:1 19:1 836:1 849:1 862:1 1408:1 1409:1 2722:1 2724:1 2725:1 3265:1 4072:1 4073:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (ADVP (RB (Moreover)))(, (,))(NP (NN (mechanism))(NNS (fibrates)))(VP (VBP (induce))(NP (NN (hepatocyte))(NN (proliferation))(NN (cholestasis)))(ADVP (RB (still)))(VP (ADVP (RB (fully)))(VBN (understood))))) |ET|  |BS| 239:F02.463.188.357 262:A11.436.348 879:C06.130.120.135 1188:D02.241.081.114.968.500  |ES| 2:1 19:1 162:1 243:1 299:1 622:1 776:1 889:1 979:1 1909:1 4130:1 4131:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Metformin)))(VP (VBZ (inhibits))(NP (JJ (early))(NN (stage))(JJ (diethylnitrosamineinduced))(NN (hepatocarcinogenesis))(NN (rat))))) |ET|  |BS| 122:C14.280.383 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 784:D02.078.370.141.450  |ES| 19:1 615:1 849:1 900:1 1128:1 1129:1 2746:1 2747:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(S (NP (PRP$ (Our))(NNS (data)))(VP (VBP (suggest))(S (NP (VBN (truncated))(NN (PPARalpha))(NN (splice))(JJ (variant))(NN (function)))(NP (NP (JJ (endogenous))(NN (inhibitor))(JJ (proliferative))(JJ (pro-inflammatory))(NN (gene)))(SBAR (S (NP (JJ (human))(NN (cell))(NN (absence))(NN (mouse)))(VP (MD (may))(VP (VB (explain))(NP (JJ (species-specific))(NN (difference))(JJ (fibrate-induced))(NN (hepatocarcinogenesis)))))))))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 41:A11 55:B01.050.150.900.649.801.400.112.400.400 536:D12.776.826.239.500 1185:D12.125.072.401.623 1186:G16.824  |ES| 9:1 19:1 33:1 36:1 52:1 94:1 104:1 239:1 380:1 491:1 658:1 793:1 796:1 900:1 990:1 1534:1 1674:1 3870:1 4114:1 4115:1 4116:1 4117:1 4118:1 4119:1 4120:1 4121:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NNS (CONCLUSIONS))(: (:)))(PP (IN (In))(NP (NNS (hepatocytes))))(, (,))(NP (NN (JNK1))(NN (JNK2)))(VP (VP (VBP (appear))(NP (NP (JJ (combined))(NN (effect)))(VP (VBG (protecting))(NP (NN (mouse))(NN (CCl4))))))(: (-))(NP (JJ (acetaminophen-induced))(NN (liver))(NN (injury))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 242:A03.620 262:A11.436.348 661:D02.065.199.092.040  |ES| 2:1 19:1 52:1 75:1 104:1 164:1 239:1 244:1 836:1 894:1 2251:1 2357:1 2416:1 4110:1 4111:1 4112:1 4113:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Tongue))(NN (cancer))(NN (prevention))(NN (study)))(VP (VBD (conducted))(NP (NP (JJ (zinc-deficient))(NN (rat)))(NP (ADJP (RB (previously))(VBN (exposed)))(NN (tongue))(NN (carcinogen))(NN (celecoxib))(NN (treatment))))(VP (PP (IN (without))(NP (NN (zinc))(NN (replenishment))))(, (,))(NP (NP (NN (zinc))(NN (replenishment)))(ADVP (RB (alone))))))) |ET|  |BS| 38:Z01.058.290.120.180 40:Z01.542.248.700 52:E02 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 279:D27.888.569.100 684:D02.065.884.247 874:D01.268.556.940 875:A03.556.500.885 876:F01.145  |ES| 2:1 18:1 19:1 131:1 241:1 546:1 849:1 1195:1 1474:1 1527:1 2125:1 2807:1 3099:1 3100:1 3101:1 3102:1 3103:1 3104:1 3105:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (S (NP (NN (Cell))(NN (proliferation))(NN (hepatocarcinogenesis))(NN (rat)))(VP (VBD (initiated))(SBAR (S (NP (NN (diethylnitrosamine)))(VP (VBD (promoted))(NP (NN (phenobarbital))))))))(: (:))(NP (NP (JJ (potential))(NN (role))(JJ (early))(NN (DNA))(NN (damage))(NN (liver))(NN (metallothionein))(NN (expression))))) |ET|  |BS| 15:F01.829.316.616 183:G04.299.233.750 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 526:G05.355.180 554:D02.654.442.200 756:D03.383.742.698.253.650 777:D12.776.556.670  |ES| 19:1 31:1 104:1 115:1 299:1 666:1 827:1 836:1 849:1 900:1 1128:1 1848:1 1900:1 1912:1 1952:1 2685:1 2731:1 4094:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (JJ (Protective))(NN (effect))(NN (dioscin))(JJ (alcohol-induced))(NN (liver))(NN (injury)))) |ET|  |BS| 242:A03.620 751:D02.033.375 822:D02.033  |ES| 19:1 75:1 836:1 2416:1 2672:1 2909:1 2910:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (ADVP (RB (Finally)))(, (,))(NP (NN (Apo-FHL2))(NN (mouse)))(VP (VBD (developed))(SBAR (S (NP (NP (NN (tumor)))(, (,))(NP (NN (FHL2))(NN (transgene))))(VP (VBD (enhanced))(SBAR (S (NP (NN (hepatocarcinogenesis)))(VP (VBD (induced))(NP (JJ (liver-specific))(NN (deletion))(NP (NP (JJ (adenomatous))(NN (polyposis))(NN (coli))(NN (gene))(JJ (aberrant))(NN (Wnt/beta-catenin))(NN (signaling))(NN (Apc)))(PRN (-LRB- (-LRB-))(NP (NN (lox/lox)))(-RRB- (-RRB-))))(NN (animal))))))))))) |ET|  |BS| 3:C04.557.470.035.215.100 8:C04 11:B01.050.150.900.649.865.635.505.500 19:B01.050 21:G05.360.340.024.340.375.249.050 105:G02.149.115.800.925 242:A03.620 547:G05.360.340.024.340.825 548:D08.811.682.664.500.848 549:G05.355.600.800.320  |ES| 2:1 7:1 9:1 10:1 14:1 19:1 46:1 52:1 57:1 58:1 59:1 195:1 280:1 302:1 385:1 412:1 900:1 1059:1 1165:1 1725:1 1799:1 1929:1 1930:1 1931:1 1932:1 1933:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (S (NP (NP (NN (Ethanol)))(VBD (diminished))(JJ (hepatic))(NN (function)))(VP (VBD (increased))(NP (NN (liver))(NN (damage)))))(, (,))(S (NP (NP (NN (ethanol)))(ADVP (RB (alone))))(VP (VBP (induce))(NP (JJ (hepatic))(NN (foci/HCC))(NN (formation)))))) |ET|  |BS| 20:G03.495 104:C04.557.470.200.025.255 242:A03.620 751:D02.033.375  |ES| 2:1 19:1 33:1 43:1 47:1 241:1 243:1 836:1 838:1 1848:1 3178:1 3440:1 4156:1 4157:1  |EV| 
-4.5068990627598779497020586859435  |BT| (PP (DT (These))(S (VP (VBG (finding))(S (VP (VBP (suggest))(SBAR (S (NP (NN (sulindac)))(VP (MD (may))(NP (NP (JJ (effective))(NN (agent))(NN (colon))(NN (cancer))(NN (prevention)))(NP (JJ (human))(JJ (low))(NN (15-PGDH)))))))))(, (,))(S (NP (NN (use)))(MD (may))(ADVP (RB (also)))(VP (VBN (associated))(NP (JJ (inflammatory))(NN (lesion))(NN (colon)))))))) |ET|  |BS| 46:A03.556.124.526.356 55:B01.050.150.900.649.801.400.112.400.400 251:D02.455.426.559.847.486.875  |ES| 2:1 5:1 18:1 19:1 36:1 113:1 133:1 169:1 491:1 531:1 728:1 792:1 796:1 869:1 927:1 1131:1 1474:1 1639:1 1659:1 2430:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (NN (Injection))(NN (carcinogen)))(, (,))(NP (NN (diethylnitrosamine)))(, (,)))(VP (VBD (induced))(SBAR (S (NP (ADJP (RB (significantly))(JJR (larger)))(NN (liver))(NN (tumor))(NN (HCV))(JJ (transgenic))(NN (mouse)))(VP (VBP (overexpress))(NP (NP (NN (PP2Ac)))(VBN (compared))(NN (control))(NN (mouse)))))))) |ET|  |BS| 8:C04 11:B01.050.150.900.649.865.635.505.500 99:B01.050.050.136.500 226:E02.319.267.530 279:D27.888.569.100 550:B04.450.410 554:D02.654.442.200 1151:C06.552.416  |ES| 2:1 7:1 19:1 50:1 52:1 124:1 285:1 289:1 412:1 836:1 1938:1 1952:1 2125:1 2513:1 4079:1 4262:1 4263:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NN (CONCLUSION))(: (:)))(S (ADVP (RB (Collectively)))(, (,))(VP (VBP (result))(VP (VBP (suggest))(SBAR (S (NP (NN (curcumin)))(VP (VBZ (potentiates))(NP (NP (JJ (antitumor))(NN (effect))(NN (radiation))(NN (therapy)))(JJ (colorectal))(NN (cancer))(VBG (suppressing))(NP (NN (NF-kappaB))(JJ (NF-kappaB-regulated))(NN (gene))(NN (product))))(, (,))(NP (VBG (leading))(NN (inhibition))(NN (proliferation))(NN (angiogenesis)))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 7:D12.776 43:F01.145.544 52:E02 86:D01.268.556.435 142:I01.880.604 210:D12.776.260.600 692:D02.455.326.146.485.222.222 693:G01.750.745  |ES| 2:1 9:1 17:1 18:1 19:1 75:1 101:1 103:1 104:1 130:1 299:1 639:1 675:1 714:1 796:1 1872:1 1882:1 2244:1 2250:1 2498:1 2499:1 2500:1 2501:1 2502:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (ADVP (RB (Additionally)))(, (,))(VP (VBD (reported))(SBAR (S (NP (NN (tamoxifen)))(VP (MD (may))(VP (VB (cause))(NP (NP (NP (JJ (non-alcoholic))(NN (fatty))(NN (liver))(NN (disease)))(PRN (-LRB- (-LRB-))(NP (NN (NAFLD)))(-RRB- (-RRB-))))(NP (JJ (human))(JJ (experimental))(NN (animal)))))))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 577:C06.552.241.519 640:D02.455.426.559.389.150.700.900 1175:B01.050.050.199  |ES| 2:1 10:1 14:1 19:1 36:1 46:1 263:1 491:1 836:1 993:1 998:1 1779:1 2069:1 2070:1 2371:1 2609:1 4068:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Metformin)))(VP (VBZ (inhibits))(NP (JJ (early))(NN (stage))(JJ (diethylnitrosamineinduced))(NN (hepatocarcinogenesis))(NN (rat))))) |ET|  |BS| 122:C14.280.383 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 784:D02.078.370.141.450  |ES| 19:1 615:1 849:1 900:1 1128:1 1129:1 2746:1 2747:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (NN (Ras))(NN (pathway))(NN (activation))(JJ (hepatocellular))(NN (carcinoma))(JJ (anti-tumoral))(NN (effect)))(NP (VBN (combined))(JJ (sorafenib))(NN (rapamycin))(FW (vivo))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 8:C04 104:C04.557.470.200.025.255 827:D02.540.505.760  |ES| 19:1 75:1 164:1 225:1 303:1 304:1 378:1 383:1 1775:1 2063:1 2921:1 2922:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (JJ (Anticancer))(NN (effect))(NN (wogonin))(NN (estrogen))(JJ (receptor-positive)))(: (-))(NP (JJ (negative))(JJ (human))(NN (breast))(NN (cancer))(NN (cell))(NN (line))(NN (vitro))(JJ (nude))(NN (mouse))(NN (xenograft))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 88:B01.050.150.900.649.865.635.505.500.550.500 92:E04.936.764 93:A01.941.875 94:A11.251.210 936:D12.776.826.750.350  |ES| 18:1 19:1 23:1 36:1 52:1 75:1 94:1 216:1 264:1 265:1 266:1 2444:1 2446:1 3168:1 3285:1 3286:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Colitis)))(VP (VBD (induced))(NP (NP (NN (knockout)))(, (,))(NP (NP (NP (JJ (transgenic))(, (,))(NN (control)))(PRN (-LRB- (-LRB-))(NP (NN (C57BL/B6)))(-RRB- (-RRB-))))(NP (NP (NN (mouse))(NN (administration))(NN (dextran))(NN (sulfate))(NN (sodium)))(PRN (-LRB- (-LRB-))(NP (NN (DSS)))(-RRB- (-RRB-)))))(, (,))(NP (NP (NN (mouse)))(VP (VBN (given))(NP (NN (azoxymethane))))))(VP (VBP (induce))(NP (JJ (colorectal))(NN (carcinogenesis)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 33:C04.697.098 53:C06.405.205.265 131:D09.698.365.272.300 132:D02.172.080 352:B01.050.050.136 593:B01.050.050.199.520.520.420  |ES| 2:1 10:1 14:1 17:1 19:1 29:1 52:1 71:1 207:1 243:1 285:1 289:1 406:1 407:1 412:1 1993:1 2575:1 3300:1 3306:1 4108:1 4109:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NNS (METHODS))(: (:)))(S (NP (CD (Twenty-four))(JJ (Sprague-Dawley))(NN (rat))(VBN (treated))(NN (diethylnitrosamine))(NN (phenobarbital)))(VP (VBP (induce))(NP (JJ (hepatocellular))(NN (carcinoma)))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 52:E02 104:C04.557.470.200.025.255 168:E05.581 554:D02.654.442.200 756:D03.383.742.698.253.650 769:B01.050.150.900.649.865.635.505.700.750  |ES| 19:1 104:1 243:1 303:1 304:1 565:1 849:1 1099:1 1952:1 2685:1 2707:1 4310:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (DT (These)))(VP (VBP (result))(VP (VBP (indicate))(SBAR (S (NNP (Valerian))(VP (VBP (exhibit))(S (NP (JJ (inhibitory))(NN (effect))(NN (rat))(NN (hepatocarcinogenesis)))(VP (VBG (inhibiting))(NP (JJ (oxidative))(NN (DNA))(NN (damage)))))(, (,))(S (VP (VBG (suppressing))(NP (NP (NN (cell))(NN (proliferation)))(VP (VBG (inducing))(NP (NP (NP (NN (apoptosis))(NN (GST-P)))(PRN (-LRB- (-LRB-))(CC (+))(-RRB- (-RRB-))))(NN (focus))(VBG (activating))(NN (GABA))(-LRB- (-LRB-))(NN (A))(-RRB- (-RRB-))(JJ (R-mediated))(NN (signaling))))))))))))) |ET|  |BS| 39:G04.299.139.160 69:G02.111.087.800 122:C14.280.383 175:J01.897.280.500.269 183:G04.299.233.750 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 526:G05.355.180 599:M01.526.799.500 857:B01.650.940.800.575.100.955.888 858:B01.650.940.800.575.100.955.888 859:D02.241.081.114.500.350  |ES| 2:1 10:1 14:1 19:1 69:1 75:1 89:1 94:1 101:1 195:1 299:1 587:1 666:1 792:1 849:1 880:1 900:1 1431:1 1479:1 1848:1 1864:1 1958:1 2250:1 2429:1 2583:1 3057:1 3058:1 3059:1 3060:1 3061:1  |EV| 
-1.2421430180880070892612820898648  |BT| (S (NP (DT (The))(JJ (oncogenic))(NN (kinase))(NN (inhibitor))(NN (sorafenib)))(ADVP (RB (significantly)))(VP (VB (prolong))(SBAR (S (NP (JJ (median))(NN (survival))(NN (patient)))(VP (VBD (advanced))(NP (NP (JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(, (,))(SBAR (IN (although))(S (NP (NN (response))(JJ (disease-stabilizing))(JJ (cytostatic)))(NP (QP (RB (rather))(CD (one)))(NN (tumor))(NN (regression)))))))))) |ET|  |BS| 8:C04 50:M01.643 96:I03.784 104:C04.557.470.200.025.255 279:D27.888.569.100 288:C23.550.288 469:D08.811.913.696 845:D27.888.569.199 846:F01.393.784  |ES| 2:1 7:1 10:1 14:1 19:1 120:1 124:1 274:1 303:1 304:1 380:1 441:1 470:1 494:1 691:1 953:1 997:1 1010:1 1170:1 1592:1 2063:1 2998:1 2999:1 3000:1 3001:1 3002:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (VBN (injected))(NN (diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(VP (VBP (induce))(NP (JJ (hepatocellular))(NN (carcinoma))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 104:C04.557.470.200.025.255 554:D02.654.442.200  |ES| 10:1 14:1 19:1 243:1 303:1 304:1 1875:1 1952:1 3586:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NN (Evolution))(JJ (genomic))(NN (instability))(JJ (diethylnitrosamine-induced))(NN (hepatocarcinogenesis))(NN (mouse)))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 554:D02.654.442.200 1191:C23.550.362 1192:G05.355.044  |ES| 19:1 52:1 900:1 910:1 1299:1 2732:1 4158:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (JJ (Epigenetic))(NN (identification))(NN (ubiquitin))(JJ (carboxyl-terminal))(NN (hydrolase))(NN (L1))(JJ (functional))(NN (tumor))(NN (suppressor))(NN (biomarker))(JJ (hepatocellular))(NN (carcinoma))(JJ (digestive))(NN (tumor)))) |ET|  |BS| 104:C04.557.470.200.025.255 158:D23.101 206:G05.360.340.024.340.375.249 244:C04.588.274.476 374:F01.393.446 985:D08.811.277.352.897.850 986:C04.588.274  |ES| 7:1 19:1 303:1 304:1 415:1 700:1 885:1 1201:1 3469:1 3470:1 3471:1 3472:1 3473:1 3474:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (JJ (Overall))(NN (finding)))(VP (VBP (substantiate))(SBAR (S (NP (NN (artesunate)))(VP (VBZ (promotes))(SBAR (S (NP (JJ (anti-tumour))(, (,))(JJ (anti-proliferation))(NN (apoptosis))(NN (nitrosodiethylamine)))(VP (VBD (mediated))(NP (JJ (hepatocellular))(NN (carcinoma))))))))))) |ET|  |BS| 8:C04 39:G04.299.139.160 104:C04.557.470.200.025.255 554:D02.654.442.200 696:V02.270.500  |ES| 2:1 19:1 89:1 298:1 303:1 304:1 437:1 927:1 2434:1 2858:1 2859:1 2860:1 2861:1 2862:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (DT (The))(NN (aim))(NN (study)))(VP (VBP (investigate))(NP (NP (NP (NP (JJ (molecular))(NN (mechanism))(JJ (chemopreventive))(NN (effect)))(JJ (folic))(NN (acid))(NN (tributyrin)))(ADVP (RB (alone))))(NN (combination))(NN (rat))(NN (hepatocarcinogenesis))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 624:D27.505.696.706.018 839:D03.438.733.631.400  |ES| 19:1 75:1 131:1 161:1 162:1 241:1 459:1 530:1 691:1 849:1 900:1 1275:1 1567:1 1946:1 2985:1 2986:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NNP (Prevention))(NN (rat))(NN (liver))(NN (fibrosis))(NN (carcinogenesis))(NN (coffee))(NN (caffeine)))) |ET|  |BS| 33:C04.697.098 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 652:D20.215.784.249 676:C06.552.630 819:D03.132.960.175  |ES| 19:1 207:1 836:1 849:1 949:1 2386:1 2898:1 2899:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (DT (A))(JJ (diethylnitrosamine-induced))(NN (liver))(NN (cancer))(NN (model)))(VP (VBD (used))(VP (VB (evaluate))(NP (NN (role))(NN (Myc))(NN (hepatocarcinogenesis)))))) |ET|  |BS| 15:F01.829.316.616 30:Z01.058.290.190.800 31:D08.811.520.224.800 225:E05.337 554:D02.654.442.200  |ES| 18:1 19:1 31:1 69:1 72:1 476:1 836:1 890:1 900:1 1786:1 2732:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (DT (A))(JJ (novel))(NN (inhibitor))(JJ (fatty))(NN (acid))(NN (synthase))(NN (show))(NN (activity))(NN (HER2)))(CC (+))(NP (NN (breast))(NN (cancer))(NN (xenograft))(JJ (active))(JJ (anti-HER2))(JJ (drug-resistant))(NN (cell))(NN (line))))) |ET|  |BS| 63:G05.360.340.024.340.375.500.791.295.305 65:D08.811.913.696.620.682.725.400.009.400 67:D26 92:E04.936.764 93:A01.941.875 94:A11.251.210 259:D12.776.395.240.150.500 921:D08.811.682.664.500.772 922:D10.251  |ES| 18:1 19:1 23:1 66:1 69:1 94:1 197:1 264:1 265:1 380:1 399:1 429:1 891:1 1275:1 2070:1 3245:1 3246:1 3247:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (JJ (Cellular))(JJ (FLICE-inhibitory))(NN (protein))(NN (down-regulation)))(VP (VBZ (contributes))(NP (JJ (celecoxib-induced))(NN (apoptosis))(JJ (human))(NN (lung))(NN (cancer))(NN (cell))))) |ET|  |BS| 39:G04.299.139.160 41:A11 55:B01.050.150.900.649.801.400.112.400.400 85:G02.111.087.225 684:D02.065.884.247 948:D12.644.360.024.296.024  |ES| 4:1 18:1 19:1 36:1 89:1 94:1 257:1 328:1 845:1 3319:1 3320:1 3321:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (PRP$ (Our))(VBP (result)))(VP (VBP (indicate))(SBAR (S (NP (NNP (Lrat))(NNP (KO))(NN (mouse)))(NP (DT (le))(JJ (susceptible))(JJ (DEN-induced))(NN (hepatocarcinogenesis)))(ADVP (RB (due)))(VP (VBD (increased))(NP (ADJP (NP (NN (retinoid))(NN (signaling)))(JJR (higher)))(NN (expression))(NN (p21)))(, (,))(SBAR (S (NP (NP (VBN (accompanied))(JJ (altered))(JJ (hepatic))(NN (level)))(JJ (DEN-activating))(NN (enzyme))(NNP (MGMT))(NNP (Lrat))(NNP (KO))(NN (mouse)))(ADVP (RB (also)))(VP (VBP (contribute))(SBAR (S (NP (VBN (decreased))(NN (cancer))(NN (initiation)))(VP (VBD (suppressed))(NP (NN (liver))(NN (tumor))(NN (development)))))))))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 69:G02.111.087.800 515:C04.588.274.623 649:E01.370.225.124.200 711:D02.455.326.271.665.202.495 807:D08.811.913.555.500.800.650  |ES| 2:1 5:1 7:1 18:1 19:1 35:1 47:1 52:1 101:1 115:1 170:1 195:1 202:1 249:1 307:1 450:1 637:1 658:1 693:1 836:1 838:1 899:1 900:1 1135:1 1479:1 2388:1 2573:1 2735:1 2801:1 2848:1 2849:1 2850:1 2851:1 2852:1 2853:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (NN (addition))))(, (,))(NP (NN (mouse))(NNP (Diethylnitrosamine))(NN (model))(NN (hepatocarcinogenesis)))(VP (VBN (observed))(NP (JJ (strong))(NN (induction))(NN (CXCR7))(NN (CXCL11))(NN (transcript)))(, (,))(S (VP (VBG (confirming))(NP (NN (CXCR7/CXCL11))(NN (up-regulation))(VBN (conserved))(JJ (human))(NN (mouse))(NN (liver))(NN (cancer))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 55:B01.050.150.900.649.801.400.112.400.400 142:I01.880.604 554:D02.654.442.200  |ES| 2:1 18:1 19:1 36:1 52:1 72:1 244:1 261:1 468:1 736:1 836:1 896:1 900:1 937:1 3578:1 4151:1 4215:1 4216:1 4217:1 4218:1 4219:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NP (JJ (Mechanistic))(NN (Investigation))(NNP (Toxaphene)))(NP (VBN (Induced))(NN (Mouse))(NN (Liver))(NNS (Tumors))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 225:E05.337 515:C04.588.274.623 1149:D02.455.526.439.913  |ES| 19:1 53:1 2127:1 2721:1 4297:1 4298:1 4299:1 4300:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NNP (Resveratrol)))(VP (VBZ (interferes))(NP (NP (JJ (N-nitrosodiethylamine-induced))(JJ (hepatocellular))(NN (carcinoma)))(JJ (early))(JJ (advanced))(NN (stage))(JJ (male))(JJ (Wistar))(NN (rat))))) |ET|  |BS| 104:C04.557.470.200.025.255 554:D02.654.442.200 723:B01.050.150.900.649.865.635.505.700.900  |ES| 19:1 303:1 304:1 849:1 997:1 1128:1 1129:1 1402:1 2603:1 2946:1 2947:1 2948:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (NN (study))))(, (,))(NP (VBN (characterized))(NN (cell))(NN (signaling))(NN (event)))(VP (VBD (evoked))(NP (NN (decorin))(NN (deficiency))(CD (two))(JJ (experimental))(NN (model))(NN (hepatocarcinogenesis)))(S (VP (VBG (using))(NP (NN (thioacetamide))(NN (diethyl))(NN (nitrosamine))(NN (carcinogen))))))) |ET|  |BS| 69:G02.111.087.800 87:C18.654.521 95:E05.599 279:D27.888.569.100 296:D02.065.064.786 554:D02.654.442.200 708:D12.776.395.650.750.625  |ES| 2:1 19:1 72:1 94:1 131:1 195:1 205:1 244:1 253:1 263:1 350:1 900:1 933:1 985:1 1514:1 2125:1 2901:1 4190:1 4248:1 4249:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (JJ (Diethylnitrosamine-induced))(NN (hepatocarcinogenesis)))(VP (VBD (suppressed))(NP (NP (JJ (heterozygous))(JJ (NRDC-deficient))(NN (mouse)))(VP (VBN (compared))(NP (JJ (wild-type))(NNS (littermates))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 157:G05.380.383 554:D02.654.442.200  |ES| 8:1 19:1 50:1 52:1 307:1 786:1 900:1 1355:1 2569:1 4154:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (JJ (Decorin-mediated))(NN (inhibition))(JJ (colorectal))(NN (cancer))(NN (growth))(NN (migration)))(NP (VBN (associated))(NN (E-cadherin))(NN (vitro))(NN (mouse))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 11:B01.050.150.900.649.865.635.505.500 43:F01.145.544 45:G07.700.320.249 613:D12.776.395.550.200.200 708:D12.776.395.650.750.625  |ES| 17:1 18:1 19:1 52:1 102:1 103:1 169:1 216:1 514:1 2267:1 2557:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (ADVP (RB (Importantly)))(, (,))(NP (NN (GEN-27)))(VP (VBD (protected))(FRAG (NP (NP (NN (mouse))(NN (azoxymethane)))(PRN (-LRB- (-LRB-))(NP (NN (AOM)))(-RRB- (-RRB-))))(: (/))(FRAG (NP (NP (NN (dextran))(NN (sodium))(NN (sulfate)))(PRN (-LRB- (-LRB-))(NP (NN (DSS)))(-RRB- (-RRB-))))(: (-))(NP (NP (VBN (induced))(NN (colon))(NN (carcinogenesis)))(, (,))(NP (VBD (reduced))(NN (mortality)))(, (,))(NP (NN (tumor))(NN (number))(NN (tumor))(NN (volume)))))))) |ET|  |BS| 8:C04 11:B01.050.150.900.649.865.635.505.500 33:C04.697.098 46:A03.556.124.526.356 131:D09.698.365.272.300 132:D02.172.080 695:E05.318.308.985.550 1203:E05.041.124.892  |ES| 2:1 7:1 10:1 14:1 19:1 52:1 113:1 207:1 406:1 407:1 409:1 452:1 646:1 1993:1 1994:1 2413:1 2511:1 2651:1 3305:1 3306:1 3589:1 4214:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NNP (Administration))(NNP (SP600125))(NN (acetaminophen)))(VP (VBD (protected))(NP (NP (NP (NN (Jnk)))(PRN (-LRB- (-LRB-))(NP (NN (Deltahepa)))(-RRB- (-RRB-))))(NN (control))(NN (mouse))(NN (liver))(NN (injury))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 242:A03.620 661:D02.065.199.092.040  |ES| 10:1 14:1 19:1 52:1 289:1 836:1 2346:1 2411:1 2412:1 2413:1 2414:1 2415:1 2416:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (DT (The))(NN (theme))(NN (study)))(VP (VBP (evaluate))(SBAR (S (NP (JJ (therapeutic))(NN (efficacy)))(VP (VBD (nanoencapsulated))(FRAG (NP (JJ (flavonoidal))(NN (quercetin)))(-LRB- (-LRB-))(NP (NP (NP (CD (3,5,7,3))('' ('))(NN (,4)))('' ('))(PRN (: (-))(NP (NP (NN (pentahydroxy))(NN (flavone)))(, (,))(NP (NN (QC))))(-RRB- (-RRB-))))(S (VP (VBG (combating))(NP (JJ (DEN-induced))(NN (hepatocarcinogenesis))(NN (rat)))))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 52:E02 225:E05.337 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 533:D03.383.663.283.266.450.284.777 850:D03.383.663.283.266.450.260 851:J01.897.608  |ES| 2:1 10:1 14:1 19:1 131:1 541:1 691:1 849:1 890:1 900:1 1884:1 2304:1 2735:1 3027:1 3028:1 3029:1 3030:1 3031:1 3032:1 3033:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (JJ (Garlic))(NN (oil)))(VP (VBD (attenuated))(NP (NP (JJ (nitrosodiethylamine-induced))(NN (hepatocarcinogenesis)))(VP (VBG (modulating))(NP (JJ (metabolic))(NN (activation))(NN (detoxification))(NN (enzyme))))))) |ET|  |BS| 554:D02.654.442.200 728:G03.495.244.224 729:G03.495.244.450 730:D08.811  |ES| 19:1 225:1 808:1 900:1 2006:1 2388:1 2435:1 2613:1 2614:1 2615:1 2616:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NP (NP (NN (Expression))(NN (analysis))(NN (group))(NN (IIA))(JJ (secretory))(NN (phospholipase))(NN (A)))(PRN (-LRB- (-LRB-))(NP (CD (2)))(-RRB- (-RRB-))))(NN (mouse))(JJ (differential))(NN (susceptibility))(JJ (azoxymethane-induced))(NN (colon))(NN (tumorigenesis)))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 32:C04.697.098.500 33:C04.697.098 46:A03.556.124.526.356 132:D02.172.080 192:D08.811.277.352.100.680.750.937.750 401:C23.550.291.687 829:M01.686  |ES| 10:1 14:1 19:1 52:1 69:1 78:1 113:1 148:1 316:1 643:1 644:1 661:1 1353:1 1677:1 2222:1 2300:1 2533:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Expression))(NN (protein))(NN (kinase))(NN (C)))(VP (NNS (isoenzymes))(NP (JJ (colorectal))(NN (cancer))(NN (tissue))(JJ (differential))(NN (activation))(JJ (different))(NN (bile))(NN (acid))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 98:A10 992:D08.811.913.696.620.682.700.725 993:D08.811.348 994:D04.808.105  |ES| 4:1 17:1 18:1 19:1 225:1 272:1 316:1 414:1 470:1 1275:1 1621:1 1677:1 1955:1 3486:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (JJ (Overall))(NN (finding)))(VP (VBP (substantiate))(SBAR (S (NP (NN (artesunate)))(VP (VBZ (promotes))(SBAR (S (NP (JJ (anti-tumour))(, (,))(JJ (anti-proliferation))(NN (apoptosis))(NN (nitrosodiethylamine)))(VP (VBD (mediated))(NP (JJ (hepatocellular))(NN (carcinoma))))))))))) |ET|  |BS| 8:C04 39:G04.299.139.160 104:C04.557.470.200.025.255 554:D02.654.442.200 696:V02.270.500  |ES| 2:1 19:1 89:1 298:1 303:1 304:1 437:1 927:1 2434:1 2858:1 2859:1 2860:1 2861:1 2862:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (NP (NNP (Administration))(NN (acetaminophen))(NN (Jnk)))(PRN (-LRB- (-LRB-))(NP (NN (Deltahepa)))(-RRB- (-RRB-))))(NN (mouse)))(VP (VBD (produced))(NP (NP (JJR (greater))(NN (level))(NN (liver))(NN (injury)))(VBN (observed))(NP (NP (NN (Jnk1)))(PRN (-LRB- (-LRB-))(NP (NN (Deltahepa)))(-RRB- (-RRB-))))(NN (control))(NN (mouse)))(, (,))(NP (VBN (based))(NN (level))(NN (serum))(NN (marker))(JJ (microscopic))(JJ (histologic))(NN (analysis))(NN (liver))(NN (tissue))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 98:A10 242:A03.620 333:D01.045 426:E01.370.350.515 661:D02.065.199.092.040 1176:D23.101  |ES| 2:1 10:1 14:1 19:1 52:1 134:1 249:1 261:1 272:1 289:1 534:1 661:1 836:1 1992:1 2204:1 2346:1 2412:1 2414:1 2415:1 2416:1 2741:1 4069:1 4070:1 4071:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Sulindac))(NNS (NSAIDs)))(VP (ADVP (RB (widely)))(NP (VBN (studied))(NP (JJ (potential))(JJ (chemopreventive))(NN (agent))(NN (colon))(NN (cancer)))))) |ET|  |BS| 251:D02.455.426.559.847.486.875 796:D27.505.696.663.850.014.040.500 833:D27.505.696.706.018  |ES| 18:1 19:1 113:1 401:1 728:1 827:1 1946:1 2369:1 2965:1 2966:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Decrease))(JJ (hepatic))(JJ (stellate))(NN (cell))(NN (rat)))(VP (VBD (enhanced))(NP (NN (sensitivity))(JJ (clofibrate-induced))(NN (hepatocarcinogenesis))))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 677:A11.561 910:D02.241.081.114.968.500.500.195  |ES| 19:1 94:1 385:1 607:1 838:1 849:1 900:1 2461:1 3433:1 3434:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (ADVP (RB (Herein)))(NP (ADJP (NN (report))(JJ (concurrent)))(NP (NN (increase))(NN (liver))(NN (progenitor))(NN (cell)))(PRN (-LRB- (-LRB-))(NP (NNS (LPCs)))(-RRB- (-RRB-))))(NP (NP (VBG (transforming))(NN (growth))(NN (factor-beta)))(PRN (-LRB- (-LRB-))(NP (NN (TGF-beta)))(-RRB- (-RRB-))))(VP (NN (diethylnitrosamine))(S (-LRB- (-LRB-))(NP (NN (DEN))(-RRB- (-RRB-))(: (-)))(VP (VBN (induced))(NP (NN (rat))(NN (hepatocarcinogenesis))(JJ (cirrhotic))(NN (liver))(NN (HCC))(NN (patient))))))) |ET|  |BS| 50:M01.643 104:C04.557.470.200.025.255 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 262:A11.436.348 503:D12.644.276.374.687 554:D02.654.442.200  |ES| 10:1 14:1 19:1 40:1 94:1 102:1 120:1 409:1 417:1 428:1 441:1 836:1 849:1 900:1 1772:1 1773:1 1774:1 1875:1 1952:1 2968:1 4206:1 4207:1 4208:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (NP (DT (The))(JJ (tumour-promoting))(NN (effect))(NN (beta-naphthoflavone)))(PRN (-LRB- (-LRB-))(NP (NN (BNF)))(-RRB- (-RRB-))))(, (,))(NP (NP (NP (JJ (novel))(NN (aryl))(NN (hydrocarbon))(NN (receptor)))(PRN (-LRB- (-LRB-))(NP (NN (AhR)))(-RRB- (-RRB-))))(NN (agonist)))(, (,)))(VP (VBN (investigated))(S (VP (VBG (using))(NP (JJ (medium-term))(NN (hepatocarcinogenesis))(NN (model))(NN (rat))))))) |ET|  |BS| 8:C04 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 259:D12.776.395.240.150.500 849:G08.686.785.760.769.490.500 914:L01.178 969:D12.776.260.643.715 983:D03.383.663.283.266.450.175.100  |ES| 2:1 10:1 14:1 19:1 72:1 75:1 186:1 350:1 403:1 691:1 849:1 891:1 900:1 3215:1 3228:1 3417:1 3418:1 3468:1 4036:1 4037:1 4038:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (JJ (Chronic))(NN (ethanol))(NN (feeding)))(VP (VBZ (accelerates))(NP (JJ (hepatocellular))(NN (carcinoma))(NN (progression))(JJ (sex-dependent))(NN (manner)))(NP (NN (mouse))(NN (model))(NN (hepatocarcinogenesis))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 16:C23.550.291.656 104:C04.557.470.200.025.255 751:D02.033.375 1178:F01.145.802.188 1179:F01.393.446.250 1180:F01.145.802 1181:G08.686.810  |ES| 19:1 48:1 52:1 72:1 303:1 304:1 529:1 900:1 1668:1 2942:1 3440:1 3967:1 4105:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (NN (study))))(, (,))(VP (VBD (investigated))(SBAR (S (NP (NP (NP (JJ (chemopreventive))(NN (efficacy))(NN (PEITC))(NN (DBM))(NN (azoxymethane)))(PRN (-LRB- (-LRB-))(NP (NN (AOM)))(-RRB- (-RRB-))))(PRN (: (-))(VP (VBN (initiated))(NP (NP (NN (dextran))(NN (sodium))(NN (sulfate)))(PRN (-LRB- (-LRB-))(NP (NN (DSS)))(-RRB- (-RRB-)))))(: (-))))(VP (VBD (promoted))(SBAR (S (NP (NN (colon))(NN (cancer))(NN (mouse))(NN (model)))(VP (VBP (compare))(NP (NP (JJ (potential))(FW (vivo))(NN (mechanism)))(VP (VBG (leading))(NP (NN (chemoprevention))))))))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 86:D01.268.556.435 131:D09.698.365.272.300 132:D02.172.080 253:E02.319.162  |ES| 2:1 10:1 14:1 18:1 19:1 52:1 72:1 113:1 131:1 162:1 244:1 378:1 403:1 406:1 407:1 639:1 827:1 870:1 1946:1 1993:1 1994:1 2304:1 3300:1 3306:1 4024:1 4029:1 4245:1 4246:1 4247:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (JJ (Hepatocarcinogenic))(NN (susceptibility))(NN (fenofibrate))(JJ (possible))(NN (mechanism))(NN (carcinogenicity))(JJ (two-stage))(NN (hepatocarcinogenesis))(NN (model))(NN (rasH2))(NN (mouse)))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 279:D27.888.569.100 401:C23.550.291.687 916:D02.241.081.114.968.500.625  |ES| 19:1 52:1 72:1 162:1 900:1 1353:1 1359:1 2971:1 3225:1 3583:1 4186:1 4187:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NNP (Garcinol)))(VP (VBZ (suppresses))(NP (JJ (inflammation-associated))(NN (colon))(NN (carcinogenesis))(NN (mouse))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 33:C04.697.098 53:C06.405.205.265  |ES| 19:1 52:1 113:1 207:1 686:1 1849:1 2612:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(S (NP (DT (The))(NN (absence))(JJ (retinoid-containing))(NN (HSC))(NN (lipid))(NN (droplet)))(VP (VBP (promote))(SBAR (S (NP (NN (HSC))(NN (activation)))(VP (VBZ (reduces))(NP (NN (hepatocarcinogenesis))))))))) |ET|  |BS| 711:D02.455.326.271.665.202.495 962:A11.148.378 963:A11.284.430.214.190.875.393  |ES| 19:1 104:1 142:1 225:1 239:1 679:1 691:1 900:1 1534:1 2401:1 3381:1 3382:1 3383:1  |EV| 
-4.5068990627598779497020586859435  |BT| (FRAG (NP (NP (NN (ErbB2))(NN (ErbB3))(NN (receptor))(NN (tyrosine))(NN (kinase)))(NP (VBN (associated))(NN (development))(JJ (human))(NN (colon))(NN (cancer)))(, (,))(NP (NN (expression))(NN (receptor))(JJ (high))(NN (HT-29))(NN (cell))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 792:A11.251.210.190.475 987:D08.811.913.696.620.682.725.400  |ES| 2:1 18:1 19:1 35:1 36:1 94:1 113:1 115:1 169:1 178:1 186:1 470:1 1705:1 2341:1 2782:1 3475:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (DT (The))(JJ (present))(NN (study)))(VP (VBN (designed))(VP (VB (determine))(SBAR (IN (whether))(S (NP (NN (alteration))(NN (expression))(NN (RXRalpha))(NN (retinoid))(NN (receptor))(NN (RARalpha))(NN (RARbeta)))(VP (VBN (involved))(NP (NP (NN (hepatocarcinogenesis)))(VP (VBG (using))(NP (NP (NP (CD (3))('' ('))(: (-))(NN (methyl-4-dimethylaminoazobenzene))(-LRB- (-LRB-))(CD (3))('' ('))(: (-)))(NP (NN (MeDAB))(-RRB- (-RRB-))(: (-))))(VP (VBN (induced))(NP (NN (rat))(NN (liver))(NN (carcinogenesis))(NN (model))))))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 33:C04.697.098 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 1163:D02.092.146.325.500 1164:D12.776.826.701  |ES| 10:1 14:1 19:1 72:1 74:1 115:1 131:1 186:1 207:1 221:1 350:1 409:1 691:1 774:1 836:1 849:1 900:1 951:1 1307:1 1683:1 2573:1 4017:1 4018:1 4019:1 4020:1 4021:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (JJ (Concurrent))(NN (administration))(JJ (ascorbic))(NN (acid)))(VP (VBZ (enhances))(NP (NP (NN (liver))(JJ (tumor-promoting))(NN (activity)))(JJ (kojic))(NN (acid))(NN (rat))))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 515:C04.588.274.623 1187:D02.241.081.844.107  |ES| 19:1 399:1 836:1 849:1 1275:1 1356:1 2575:1 3776:1 4122:1 4123:1 4124:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NP (NP (NN (Treatment))(NN (mouse))(NN (EGFR-inhibitor)))(PRN (-LRB- (-LRB-))(NP (NN (EGFRi)))(-RRB- (-RRB-))))(, (,))(NP (NN (Canertinib)))(, (,)))(VP (VBP (1h))(ADJP (JJ (post-APAP)))(VP (VBD (resulted))(NP (NP (JJ (robust))(NN (inhibition))(NN (EGFR-activation))(JJ (striking))(NN (reduction)))(JJ (APAP-induced))(NN (liver))(NN (injury)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 43:F01.145.544 52:E02 242:A03.620 661:D02.065.199.092.040 877:N03.540.571.608  |ES| 2:1 10:1 14:1 19:1 52:1 103:1 370:1 594:1 836:1 2416:1 3106:1 3107:1 3108:1 3109:1 3110:1 3111:1 3112:1 3113:1 3114:1 3115:1  |EV| 
-4.0441430486271201516501605510712  |BT| (NP (NP (NN (CONCLUSION)))(: (:))(S (NP (NP (DT (The))(JJ (present))(NN (work)))(VP (VBZ (provides))(NP (NP (JJ (novel))(NNS (data)))(PP (VBG (concerning))(NP (JJ (preventive))(NN (action))(NN (glycerol))(NN (development))(NN (liver))(NN (cancer)))))))(VP (VBZ (represents))(NP (ADJP (RB (economically))(JJ (feasible)))(NN (intervention))(NN (treat))(JJ (high-risk))(NN (individual)))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 52:E02 61:E05.318.740.600.800 259:D12.776.395.240.150.500 445:I03.946 493:M01 697:D02.033.800.421 698:I01.261  |ES| 18:1 19:1 35:1 104:1 106:1 691:1 793:1 815:1 836:1 891:1 1090:1 1307:1 1546:1 1645:1 1882:1 1883:1 2013:1 2512:1 2514:1 2515:1 2516:1 2517:1 2518:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (NN (Cyclooxygenase))(CD (2))(NN (play))(JJ (critical))(NN (role))(NN (development))(JJ (gastrointestinal))(NN (cancer)))(NP (JJ (human))(NN (animal))(NN (model))))) |ET|  |BS| 15:F01.829.316.616 24:D08.811.600.720.750 55:B01.050.150.900.649.801.400.112.400.400 79:I03.450.642.693 285:E05.598  |ES| 18:1 19:1 31:1 35:1 36:1 46:1 72:1 148:1 183:1 238:1 825:1 3432:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (JJ (Hepatocellular))(NN (carcinoma)))(VP (VBD (found))(NP (CD (four))(CD (five))(NN (rat))(CD (12))(NN (month))(NN (tamoxifen))(NN (treatment))))) |ET|  |BS| 52:E02 104:C04.557.470.200.025.255 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 640:D02.455.426.559.389.150.700.900  |ES| 19:1 37:1 304:1 546:1 770:1 849:1 1120:1 2151:1 2371:1 2723:1 4188:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (JJ (Nonalcoholic))(NN (steatohepatitis)))(VP (VBD (induced))(SBAR (S (NP (JJ (high-fat))(NN (diet)))(VP (VBZ (promotes))(NP (JJ (diethylnitrosamine-initiated))(JJ (early))(NN (hepatocarcinogenesis))(NN (rat)))))))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 509:C06.552.241.519 554:D02.654.442.200 694:G07.203.650.240.267  |ES| 19:1 298:1 412:1 849:1 900:1 1128:1 1791:1 2191:1 2507:1 4092:1 4319:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NNP (Saffron)))(: (:))(NP (JJ (potential))(NN (candidate))(JJ (novel))(JJ (anticancer))(NN (drug))(JJ (hepatocellular))(NN (carcinoma)))) |ET|  |BS| 67:D26 104:C04.557.470.200.025.255 259:D12.776.395.240.150.500 701:B01.650.940.800.575.100.549.500  |ES| 19:1 104:1 191:1 303:1 304:1 827:1 891:1 1243:1 1880:1 2951:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Inhibition))(JJ (retinoic))(NN (acid))(NN (hepatocarcinogenesis)))(VP (VBD (induced))(NP (NN (N-nitrosomorpholine))(NN (expression))(NN (myc))(NN (oncogene))(NN (protein))(JJ (Sprague-Dawley))(NN (rat))))) |ET|  |BS| 43:F01.145.544 584:D12.776.624.664 769:B01.050.150.900.649.865.635.505.700.750 770:D02.455.326.271.665.202.495.818.500  |ES| 4:1 19:1 24:1 115:1 412:1 849:1 900:1 1275:1 2703:1 2704:1 2705:1 2706:1 2707:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (S (ADVP (RB (Here)))(, (,))(VP (VBD (identified))(SBAR (S (NP (JJ (novel))(NN (mechanism))(NN (alcohol)))(VP (VBZ (accelerates))(NP (NN (liver))(NN (fibrosis))))))))(: (:))(NP (NP (NN (inhibition))(JJ (antifibrotic))(NN (effect)))(SBAR (S (NP (NP (JJ (natural))(NN (killer)))(PRN (-LRB- (-LRB-))(NP (NN (NK)))(-RRB- (-RRB-))))(VP (NN (cell))(NP (NP (NN (interferon-gamma)))(PRN (-LRB- (-LRB-))(NP (NN (IFN-gamma)))(-RRB- (-RRB-))))))))) |ET|  |BS| 43:F01.145.544 259:D12.776.395.240.150.500 676:C06.552.630 751:D02.033.375 822:D02.033 1033:D12.644.276.374.440.893 1202:A11.118.637.555.567.537  |ES| 2:1 10:1 14:1 19:1 75:1 94:1 103:1 104:1 162:1 400:1 529:1 623:1 836:1 891:1 949:1 2333:1 2885:1 3710:1 4199:1 4200:1 4201:1 4202:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NN (Characterization))(JJ (nuclear))(JJ (receptor-mediated))(JJ (murine))(NN (hepatocarcinogenesis))(NN (herbicide))(NN (pronamide))(JJ (human))(NN (relevance)))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 55:B01.050.150.900.649.801.400.112.400.400 949:D27.720.031.700.366 950:D12.776.826  |ES| 19:1 36:1 627:1 900:1 1064:1 1256:1 3123:1 3322:1 3323:1 3324:1  |EV| 
-4.5068990627598779497020586859435  |BT| (FRAG (NP (NP (JJ (Anti-tumor))(NN (effect)))(VBN (pegylated))(NN (interferon))(NN (rat))(NN (hepatocarcinogenesis))(NN (model)))) |ET|  |BS| 8:C04 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 617:D12.644.276.374.440  |ES| 19:1 72:1 75:1 849:1 900:1 2305:1 2442:1 2443:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NNP (Mode))(NN (action))(NN (analysis))(JJ (synthetic))(NN (pyrethroid))(JJ (metofluthrin-induced))(NN (rat))(NN (liver))(NN (tumor)))(: (:))(NP (NN (evidence))(JJ (hepatic))(NN (CYP2B))(NN (induction))(NN (hepatocyte))(NN (proliferation)))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 262:A11.436.348 515:C04.588.274.623 1231:D02.455.849.575.812  |ES| 7:1 19:1 38:1 104:1 299:1 661:1 736:1 836:1 838:1 849:1 1909:1 2013:1 3218:1 4314:1 4315:1 4316:1 4317:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NP (NN (Glutathione))(NN (S-transferase))(JJ (placental))(-LRB- (-LRB-))(NN (GST-P))(-RRB- (-RRB-)))(: (-))(NP (NP (JJ (negative))(JJ (hepatocellular))(JJ (altered))(NN (focus)))(PRN (-LRB- (-LRB-))(NP (NN (HAF)))(-RRB- (-RRB-))))(, (,))(NP (NP (JJ (hepatocellular))(NN (adenoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCA)))(-RRB- (-RRB-))))(, (,))(NP (NP (JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(VP (VBD (generated))(NP (NP (NP (NP (CD (two))(JJ (initiation-promotion))(NN (model))(NN (N-nitrosodiethylamine)))(PRN (-LRB- (-LRB-))(NP (NN (NDEN)))(-RRB- (-RRB-))))(NP (NN (peroxisome))(NNS (proliferators))))(, (,))(NP (NN (Wy-14,643))(NN (clofibrate))))))) |ET|  |BS| 104:C04.557.470.200.025.255 554:D02.654.442.200 780:D08.811.913.225.500 783:A16.710 910:D02.241.081.114.968.500.500.195 912:D27.888.569.100.675 1194:C04.557.470.035.120  |ES| 2:1 10:1 14:1 19:1 42:1 72:1 73:1 303:1 304:1 441:1 693:1 933:1 1431:1 1887:1 2446:1 2602:1 2743:1 2745:1 3058:1 3200:1 4167:1 4168:1 4169:1 4170:1 4171:1 4172:1 4173:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Hepatocarcinogenesis)))(VP (VBD (induced))(NP (NP (JJ (male))(NP (NP (JJ (Sprague-Dawley))(NN (rat))(JJ (chronic))(NN (feeding))(NN (2-acetylaminofluorene)))(PRN (-LRB- (-LRB-))(NP (NN (2-AAF)))(-RRB- (-RRB-))))(NN (dose))(ADJP (CD (0.05))(NN (%)))(JJ (basal))(NN (diet)))(NP (JJ (daily))(CD (5))(NN (day))(NN (week)))))) |ET|  |BS| 38:Z01.058.290.120.180 40:Z01.542.248.700 595:G07.203.650.240 596:E02.642.249 767:D02.065.064.150 769:B01.050.150.900.649.865.635.505.700.750 881:D02.065.064.150  |ES| 10:1 14:1 19:1 369:1 412:1 578:1 783:1 849:1 1402:1 1790:1 1959:1 2191:1 2301:1 2696:1 2707:1 2942:1 3271:1 3849:1 4078:1 4184:1 4185:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NP (JJ (Partial))(JJ (hepatectomized))(NN (rat)))(PRN (-LRB- (-LRB-))(S (NP (NN (n)))(VP (JJ (=))(NP (QP (CD (11))(CD (12))))))(-RRB- (-RRB-))))(VP (VBN (fed))(NP (NN (diet))(VP (VBG (containing))(S (CD (0))(, (,))(NP (CD (0.03))(, (,))(CD (0.06))(, (,))(CD (0.125))(ADJP (CD (0.25))(NN (%)))(NN (BNF)))(NP (NP (CD (6))(NN (week))(JJ (intraperitoneal))(NN (injection))(NN (N-diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(VP (VBP (initiate))(NP (NN (hepatocarcinogenesis))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 554:D02.654.442.200 595:G07.203.650.240 663:C16.320.565.398.500.330.500 917:E02.319.267.530.490  |ES| 2:1 10:1 14:1 19:1 286:1 369:1 580:1 581:1 783:1 785:1 849:1 900:1 1057:1 1120:1 1875:1 2191:1 2426:1 3230:1 3231:1 3529:1 3595:1 4037:1 4093:1 4163:1 4326:1 4327:1 4328:1 4329:1 4330:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (JJ (Diet-induced))(NN (obesity))(NN (ethanol)))(VP (VBP (impair))(NP (NN (progression))(JJ (hepatocellular))(NN (carcinoma))(NN (mouse))(JJ (mesenteric))(NN (vein))(NN (injection))(NN (model))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 16:C23.550.291.656 104:C04.557.470.200.025.255 226:E02.319.267.530 564:C18.654.726.500 595:G07.203.650.240 596:E02.642.249 751:D02.033.375 976:A07.231.908.670.385  |ES| 19:1 48:1 52:1 72:1 303:1 304:1 785:1 2010:1 3439:1 3440:1 3441:1 3442:1 3443:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (ADVP (RB (Herein)))(, (,))(VP (VBD (investigated))(NP (NP (NP (NN (MMP10))(NN (expression))(NN (function)))(JJ (human))(JJ (hepatocellular))(NN (carcinoma))(-LRB- (-LRB-))(NN (HCC))(-RRB- (-RRB-))(NN (diethylnitrosamine))(-LRB- (-LRB-))(NN (DEN))(-RRB- (-RRB-))(: (-)))(VBN (induced))(NN (mouse))(NN (hepatocarcinogenesis))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 55:B01.050.150.900.649.801.400.112.400.400 104:C04.557.470.200.025.255 554:D02.654.442.200  |ES| 2:1 10:1 14:1 19:1 33:1 36:1 52:1 115:1 303:1 304:1 403:1 409:1 428:1 441:1 900:1 1875:1 1952:1 4210:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (NNP (UNLABELLED)))(: (:))(NP (NP (NP (JJ (Antidiabetic))(NNS (thiazolidinediones)))(PRN (-LRB- (-LRB-))(NP (NN (TZD)))(-RRB- (-RRB-))))(PP (FW (vitro))(NP (NP (JJ (antiproliferative))(NN (effect))(JJ (epithelial))(NN (cancer)))(, (,))(PP (VBG (including))(NP (NP (JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-)))))))))) |ET|  |BS| 104:C04.557.470.200.025.255 862:D02.886.675.933 878:D27.505.696.422  |ES| 2:1 10:1 14:1 18:1 19:1 75:1 104:1 127:1 216:1 303:1 304:1 441:1 561:1 2266:1 3117:1 3118:1 3119:1 3120:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (JJ (Nitric))(JJ (oxide-releasing))(NN (aspirin))(NN (indomethacin))(JJ (potent))(NN (inhibitor))(NN (colon))(NN (cancer))(JJ (azoxymethane-treated))(NN (rat)))(: (:))(NP (NN (effect))(JJ (molecular))(NN (target))))) |ET|  |BS| 52:E02 132:D02.172.080 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 795:D03.438.473.420  |ES| 18:1 19:1 22:1 75:1 104:1 113:1 160:1 161:1 380:1 849:1 2487:1 2790:1 2791:1 2792:1 2793:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NN (Modulation))(NN (energy))(JJ (metabolic))(NN (enzyme))(NN (expression))(JJ (N-nitrosodiethylamine-mediated))(NN (hepatocarcinogenesis))(JJ (Chinese))(NN (herb)))(, (,))(NP (NNP (Huqi))(NNP (San)))) |ET|  |BS| 554:D02.654.442.200 730:D08.811 788:H01.158.273.118.598.500  |ES| 2:1 19:1 115:1 900:1 2006:1 2388:1 2760:1 2761:1 2762:1 2763:1 2764:1 2765:1 2766:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Liver))(NN (tumor)))(VP (VBG (promoting))(NP (NP (NN (effect))(NN (orphenadrine))(NN (rat))(JJ (possible))(NN (mechanism))(NN (action)))(PP (VBG (including))(NP (NN (CAR))(NN (activation))(JJ (oxidative))(NN (stress))))))) |ET|  |BS| 139:J01.937.500.100 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 515:C04.588.274.623 716:G03.495.710 742:G03.787 1159:D02.092.471.600  |ES| 7:1 19:1 75:1 162:1 225:1 421:1 561:1 849:1 881:1 1359:1 2013:1 2522:1 2583:1 2721:1 4005:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (NN (Dextran))(NN (sodium))(NN (sulfate)))(PRN (-LRB- (-LRB-))(NP (NN (DSS)))(-RRB- (-RRB-))))(VP (VBN (given))(S (VP (VBP (induce))(NP (NP (NP (NN (colitis))(NN (C57/BL6)))(PRN (-LRB- (-LRB-))(NP (NN (control)))(-RRB- (-RRB-))))(NN (mouse)))))(, (,))(NP (ADVP (RB (well)))(NP (NP (NN (mouse))(NN (disruption))(NN (hydroxyprostaglandin))(NN (dehydrogenase))(CD (15))(NN (gene)))(PRN (-LRB- (-LRB-))(NP (JJ (15-PGDH-knockout))(NN (mouse)))(-RRB- (-RRB-))))(, (,))(NP (NP (NN (Yap1))(NN (gene)))(PRN (-LRB- (-LRB-))(NP (JJ (YAP-knockout))(NN (mouse)))(-RRB- (-RRB-))))(, (,))(NP (JJ (double-knockout))(NN (mouse)))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 29:B01.050.050.136.500.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 53:C06.405.205.265 131:D09.698.365.272.300  |ES| 2:1 9:1 10:1 14:1 19:1 29:1 52:1 143:1 243:1 289:1 406:1 407:1 787:1 1602:1 3085:1 3306:1 4143:1 4144:1 4145:1 4146:1 4147:1 4148:1 4149:1 4150:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NNS (Effects))(JJ (S-adenosylmethionine))(NN (methylthioadenosine))(JJ (inflammation-induced))(NN (colon))(NN (cancer))(NN (mouse)))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 53:C06.405.205.265 232:D02.886.030.676.180 525:C23.550.470  |ES| 18:1 19:1 52:1 113:1 1793:1 3461:1 3462:1 3463:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (ADVP (RB (Herein)))(, (,))(JJ (first))(NN (time)))(, (,))(VP (VBP (investigate))(NP (FW (vivo))(NN (efficacy))(NN (silibinin))(JJ (azoxymethane-induced))(NN (colon))(NN (tumorigenesis))(NN (A/J))(NN (mouse))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 32:C04.697.098.500 33:C04.697.098 46:A03.556.124.526.356 132:D02.172.080 322:G01.910  |ES| 2:1 19:1 52:1 78:1 113:1 378:1 428:1 459:1 816:1 1081:1 2304:1 2533:1 2534:1 2635:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (ADVP (RB (Hence)))(, (,))(NP (NN (chloroform)))(VP (VBD (prevented))(SBAR (S (NP (NN (hypomethylation)))(VP (VBD (increased))(NP (NP (NN (mRNA)))(NN (expression))(NN (c-myc))(NN (gene))(NN (promotion))(NN (liver))(NN (tumor))(NN (DCA)))(, (,))(S (VP (VBG (enhancing))(NP (JJ (DCA-promotion))(NN (kidney))(NN (tumor)))))))))) |ET|  |BS| 111:D13.444.735.544 155:G05.355.310 274:C04.588.945.947.535 515:C04.588.274.623 1196:D02.455.526.439.224  |ES| 2:1 7:1 9:1 19:1 47:1 115:1 325:1 455:1 836:1 1717:1 1943:1 1944:1 2337:1 2527:1 4107:1 4179:1 4180:1 4181:1  |EV| 
-4.5068990627598779497020586859435  |BT| (FRAG (ADVP (RB (Collectively)))(, (,))(NP (NP (NNS (data)))(SBAR (IN (along))(S (NP (JJ (negative))(NN (genotoxicity)))(VP (VBP (demonstrate))(SBAR (S (NP (NP (NN (oxyfluorfen)))(PRN (-LRB- (-LRB-))(NP (ADJP (QP (JJR (>))(CD (98)))(NN (%)))(NN (purity)))(-RRB- (-RRB-))))(ADJP (JJ (potential)))(VP (VBP (induce))(S (NP (NN (mouse))(NN (liver))(NN (tumor)))(ADJP (JJ (nongenotoxic)))))))(, (,))(NP (NP (JJ (mitogenic))(NNP (MOA))(JJ (clear))(NN (threshold)))(VP (VBD (predicted))(NP (JJ (carcinogenic))(JJ (human))(JJ (relevant))(NN (exposure))(NN (level)))))))))) |ET|  |BS| 8:C04 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 55:B01.050.150.900.649.801.400.112.400.400 279:D27.888.569.100 515:C04.588.274.623 575:V02.050 953:D27.505.519.593.624  |ES| 2:1 7:1 10:1 14:1 19:1 36:1 52:1 243:1 249:1 369:1 449:1 502:1 793:1 827:1 836:1 865:1 1466:1 1872:1 1953:1 2666:1 3336:1 3337:1 3338:1 3339:1 3340:1 3341:1 3342:1 3343:1 3344:1 3345:1 3346:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (VP (TO (To))(VP (VB (clarify))(NP (NP (JJ (possible))(NN (mechanism))(JJ (non-genotoxic))(NN (hepatocarcinogenesis)))(VP (VBD (induced))(NP (NP (NP (NN (piperonyl))(NN (butoxide)))(PRN (-LRB- (-LRB-))(NP (NN (PBO)))(-RRB- (-RRB-))))(, (,))(NP (NP (JJ (male))(NN (F344))(NN (rat)))(VP (VBN (administered))(S (NP (NN (i.p)))))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 590:B01.050.050.199.520.760.200 967:D01.248.497.158.490 1077:D03.383.246.118.600  |ES| 2:1 10:1 14:1 19:1 162:1 412:1 828:1 849:1 900:1 1359:1 1402:1 2336:1 3185:1 3193:1 3777:1 3778:1 4049:1 4050:1 4051:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NN (JNK))(NN (protein)))(VP (VBN (activated))(PP (IN (via))(NP (NN (phosphorylation))(NN (response))(NN (acetaminophen)))))(FRAG (: (-))(NP (NP (NN (carbon))(NN (tetrachloride)))(PRN (-LRB- (-LRB-))(NP (NN (CCl4)))(-RRB- (-RRB-))))(: (-))(NP (NP (VBN (induced))(NN (liver))(NN (damage)))(: (;))(S (NP (NN (level))(NN (activation)))(VP (VBP (correlate))(NP (NN (degree))(NN (injury)))))))) |ET|  |BS| 7:D12.776 242:A03.620 661:D02.065.199.092.040 972:G02.111.087.677 1220:D02.455.526.439.150  |ES| 4:1 10:1 14:1 19:1 163:1 217:1 225:1 249:1 409:1 494:1 596:1 836:1 1848:1 2416:1 2806:1 3426:1 4276:1 4277:1 4278:1 4279:1 4280:1 4281:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (JJ (Dietary))(NN (lycopene))(NN (tomato))(NN (extract))(NN (supplementation)))(VP (VBP (inhibit))(NP (JJ (nonalcoholic))(JJ (steatohepatitis-promoted))(NN (hepatocarcinogenesis))(NN (rat))))) |ET|  |BS| 122:C14.280.383 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 323:B01.650.940.800.575.100.905.322 324:B01.650.940.800.575.100.905.322 509:C06.552.241.519 595:G07.203.650.240  |ES| 19:1 849:1 900:1 1097:1 1370:1 1796:1 2496:1 2562:1 2566:1 2567:1 2568:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(NP (NN (Silibinin))(NN (target))(NN (beta-catenin))(NN (IGF-1Rbeta))(NN (pathway))(JJ (chemopreventive))(NN (efficacy))(JJ (azoxymethane-induced))(NN (colon))(NN (carcinogenesis))(NN (A/J))(NN (mouse)))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 23:D12.776.091.249 33:C04.697.098 46:A03.556.124.526.356 132:D02.172.080 581:D12.644.276.937  |ES| 19:1 52:1 60:1 104:1 113:1 160:1 207:1 239:1 383:1 1946:1 2304:1 2531:1 2532:1 2533:1 2534:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (JJ (2-Nitrobenzo))(-LRB- (-LSB-))(-RRB- (-RSB-))(NN (pyrene))(NN (6-nitrochrysene)))(VP (VBD (induced))(NP (NP (JJ (high))(NN (incidence))(NN (liver))(NN (tumor)))(PRN (-LRB- (-LRB-))(NP (CD (91-100))(NN (%)))(-RRB- (-RRB-))))(, (,))(PP (VBG (remaining))(NP (NN (test))(NN (compound))))))(VP (VBP (induce))(NP (NN (tumor))(NN (rate)))(NP (RB (significantly))(JJR (higher))(JJ (solvent))(NN (control))))) |ET|  |BS| 8:C04 434:E05.318.308.985.525.375 515:C04.588.274.623 1173:D02.455.426.559.847.799 1174:D27.720.844  |ES| 2:1 7:1 10:1 14:1 19:1 41:1 124:1 170:1 178:1 243:1 289:1 369:1 412:1 836:1 1373:1 1378:1 1418:1 1511:1 2433:1 4062:1 4063:1 4064:1 4065:1 4066:1 4067:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (ADVP (RB (Thus)))(, (,))(NP (NN (study)))(VP (VBP (show))(NP (JJ (myrtenal))(NN (ability))(VBP (suppress))(JJ (hepatocellular))(NN (carcinoma))(NN (rat))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 104:C04.557.470.200.025.255 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 385:F02.784.629.131  |ES| 2:1 19:1 131:1 303:1 304:1 429:1 849:1 1300:1 1691:1 2441:1 2682:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NN (CONCLUSION))(: (:)))(NP (DT (These))(VBP (result))(NP (VBN (suggested))(NN (TFA))(VBD (protected))(ADJP (NN (mouse))(JJ (CCl4-induced))(ADJP (NN (liver))(NN (injury))(JJ (antioxidant)))(NN (stress))(JJ (antiinflammatory)))(NN (effect))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 242:A03.620 686:D27.505.954.158 699:D02.241.081.018.285.500 700:D27.505.519.217  |ES| 19:1 52:1 75:1 101:1 104:1 792:1 836:1 925:1 1882:1 2413:1 2416:1 2477:1 2519:1 2520:1 2521:1 2522:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NP (NN (GP73)))(PRN (-LRB- (-LRB-))(PRN (: (-))(: (/))(: (-)))(-RRB- (-RRB-))))(, (,))(NP (NN (GP73))(PRN (-LRB- (-LRB-))(CC (+))(: (/))(: (-)))(-RRB- (-RRB-))(, (,))(NP (NP (NN (GP73))(PRN (-LRB- (-LRB-))(CC (+))(: (/))(CC (+))(-RRB- (-RRB-)))(NN (mouse)))(VP (VBN (given))(NP (NN (injection))(NN (diethylnitrosamine))))))(S (VP (VBP (induce))(NP (NN (liver))(NN (injury)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 226:E02.319.267.530 242:A03.620 554:D02.654.442.200  |ES| 2:1 10:1 14:1 19:1 29:1 44:1 45:1 51:1 52:1 243:1 785:1 836:1 1952:1 2416:1 4174:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (VBN (Enhanced))(NN (liver))(NN (tumor))(NN (promotion))(NN (liver))(NN (initiation))(NN (activity)))(NP (NN (rat))(VBN (subjected))(JJ (combined))(NN (administration))(NN (omeprazole))(NN (beta-naphthoflavone))))) |ET|  |BS| 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 515:C04.588.274.623 618:E02.186 983:D03.383.663.283.266.450.175.100 984:D02.886.640.074.500  |ES| 7:1 19:1 164:1 399:1 637:1 836:1 849:1 2337:1 2575:1 3267:1 3466:1 3467:1 3468:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (JJ (Inhibitory))(NN (effect))(NN (silibinin))(JJ (azoxymethane-induced))(NN (colon))(NN (tumorigenesis))(NN (A/J))(NN (mouse)))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 32:C04.697.098.500 33:C04.697.098 46:A03.556.124.526.356 132:D02.172.080  |ES| 19:1 52:1 75:1 78:1 113:1 2533:1 2534:1 2635:1 2713:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NNS (Effects)))(VP (VBD (baked))(S (NP (NP (NP (NN (PP)))(PRN (-LRB- (-LRB-))(NP (ADJP (CD (20))(NN (%)))(NN (wt/wt)))(-RRB- (-RRB-))))(NN (colon))(NNS (CSCs)))(ADVP (RB (also)))(VP (VBN (tested))(NP (FW (vivo))(NN (mouse))(JJ (azoxymethane-induced))(NN (colon))(NN (tumorigenesis))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 32:C04.697.098.500 33:C04.697.098 46:A03.556.124.526.356 132:D02.172.080 556:C11.768.175 1126:Z01.639.760.590.715  |ES| 5:1 10:1 14:1 19:1 52:1 78:1 113:1 369:1 378:1 1870:1 1966:1 2533:1 2988:1 3461:1 3941:1 3942:1 4155:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (NP (JJ (experimental))(NN (mouse))(NN (model))(NN (hepatocarcinogenesis)))(PRN (-LRB- (-LRB-))(NP (JJ (diethylnitrosamine-induced)))(-RRB- (-RRB-)))))(, (,))(NP (NN (tumor)))(VP (VBD (showed))(NP (NP (VBN (increased))(NN (activation))(NN (TGF-beta))(NN (pathway)))(VBD (enhanced))(NN (CXCR4))(NN (level))))) |ET|  |BS| 8:C04 11:B01.050.150.900.649.865.635.505.500 95:E05.599 503:D12.644.276.374.687 554:D02.654.442.200 1204:D12.776.543.750.100.160.500.400  |ES| 2:1 7:1 10:1 14:1 19:1 47:1 52:1 72:1 132:1 225:1 244:1 249:1 263:1 383:1 385:1 900:1 1774:1 2732:1 4220:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (JJ (current))(NN (study))))(, (,))(VP (VBD (investigated))(SBAR (IN (whether))(S (NP (NP (JJ (ursodeoxycholic))(NN (acid)))(PRN (-LRB- (-LRB-))(NP (NN (UDCA)))(-RRB- (-RRB-))))(VP (VBP (inhibit))(NP (NP (JJ (colitis-related))(NN (mouse))(NN (colon))(NN (carcinogenesis)))(VBN (compared))(NN (effect))(NN (sulfasalazine)))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 33:C04.697.098 46:A03.556.124.526.356 53:C06.405.205.265 122:C14.280.383 737:D04.808.105.225.272.962 755:D02.065.884.730  |ES| 2:1 10:1 14:1 19:1 50:1 52:1 75:1 113:1 131:1 175:1 207:1 221:1 244:1 403:1 1275:1 1370:1 2630:1 2631:1 2680:1 2681:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (NN (Connexin))(CD (32))(NN (luteolin))(NN (play))(JJ (protective))(NN (role)))(JJ (non-alcoholic))(NN (steatohepatitis))(NN (development))(JJ (related))(NN (hepatocarcinogenesis))(NN (rat)))) |ET|  |BS| 15:F01.829.316.616 79:I03.450.642.693 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 509:C06.552.241.519 704:D03.383.663.283.266.450.260.555  |ES| 19:1 31:1 35:1 238:1 419:1 493:1 849:1 900:1 1791:1 2069:1 2545:1 2546:1 2547:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (NP (NN (BACKGROUND))(: (:)))(NP (NP (JJ (Chemopreventive))(NN (effect))(JJ (selective))(NN (cyclooxygenase-2)))(PRN (-LRB- (-LRB-))(NP (NN (COX-2)))(-RRB- (-RRB-))))(NN (inhibitor))(NN (JTE-522))(NN (diethylnitrosamine))(-LRB- (-LRB-))(NN (DEN))(-RRB- (-RRB-))(: (-)))(VBN (induced))(NN (hepatocarcinogenesis)))(VP (VBD (evaluated))(NP (NNP (Wistar))(NN (rat))))) |ET|  |BS| 225:E05.337 349:D27.505.519.389.310.500 554:D02.654.442.200 624:D27.505.696.706.018 723:B01.050.150.900.649.865.635.505.700.900  |ES| 10:1 14:1 19:1 61:1 75:1 76:1 104:1 380:1 409:1 780:1 849:1 900:1 1046:1 1749:1 1875:1 1952:1 2603:1 3972:1 3973:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Hepatocyte))(JJ (nuclear))(NN (factor))(CD (4))(NN (alpha))(NN (deletion)))(VP (VBZ (promotes))(S (NP (JJ (diethylnitrosamine-induced))(JJ (hepatocellular))(NN (carcinoma)))(ADJP (JJ (rodent)))))) |ET|  |BS| 104:C04.557.470.200.025.255 306:G05.355.600.800 514:B01.050.150.900.649.865 554:D02.654.442.200 1197:D12.776.260.262.968  |ES| 19:1 185:1 298:1 303:1 304:1 319:1 1059:1 1256:1 1836:1 2173:1 2349:1 2732:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (ADVP (RB (However)))(PRN (, (,))(NP (JJ (Ptk6-null))(NN (mouse)))(ADVP (RB (also)))(NP (JJ (resistant))(JJ (azoxymethane-induced))(NN (colon))(NN (tumorigenesis)))))) |ET|  |BS| 29:B01.050.050.136.500.500 32:C04.697.098.500 33:C04.697.098 46:A03.556.124.526.356 132:D02.172.080  |ES| 2:1 5:1 19:1 52:1 78:1 113:1 427:1 433:1 2533:1 4212:1  |EV| 
-4.5068990627598779497020586859435  |BT| (FRAG (NP (NNP (Boswellia))(NNP (serrata))(NN (resin))(NN (extract)))(VBZ (alleviates))(NP (NP (NN (azoxymethane)))(PRN (-LRB- (-LRB-))(NP (NN (AOM)))(-RRB- (-RRB-))))(: (/))(NP (NP (NN (dextran))(NN (sodium))(NN (sulfate)))(PRN (-LRB- (-LRB-))(NP (NN (DSS)))(-RRB- (-RRB-))))(: (-))(NP (VBN (induced))(NN (colon))(NN (tumorigenesis)))) |ET|  |BS| 32:C04.697.098.500 33:C04.697.098 46:A03.556.124.526.356 131:D09.698.365.272.300 132:D02.172.080 942:D05.750.078.840.490  |ES| 10:1 14:1 19:1 78:1 113:1 406:1 407:1 409:1 1993:1 1994:1 2496:1 3301:1 3302:1 3303:1 3304:1 3305:1 3306:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (ADVP (RB (Here)))(, (,))(NP (NN (report))(NN (level))(NN (MT-1))(NN (MT-2A)))(ADVP (RB (drastically)))(VP (VBD (reduced))(NP (JJ (primary))(NP (NP (JJ (human))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NNS (HCCs)))(-RRB- (-RRB-))))(JJ (diethylnitrosamine-induced))(NN (liver))(NN (tumor))(NN (mouse)))(, (,))(NP (ADVP (RB (primarily)))(JJ (due))(NP (JJ (transcriptional))(NN (repression)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 55:B01.050.150.900.649.801.400.112.400.400 104:C04.557.470.200.025.255 208:F01.393.821 209:G02.111.087.847 515:C04.588.274.623 554:D02.654.442.200  |ES| 2:1 7:1 10:1 14:1 19:1 36:1 52:1 249:1 303:1 304:1 344:1 400:1 417:1 452:1 559:1 706:1 836:1 1132:1 1970:1 2732:1 2851:1 4203:1 4204:1 4205:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (NN (Evaluation))(JJ (chemopreventive))(NN (effect)))(NP (NNP (Fumaria))(NN (indica))(NN (N-nitrosodiethylamine))(JJ (CCl4-induced))(JJ (hepatocellular))(NN (carcinoma))(NNP (Wistar))(NN (rat))))) |ET|  |BS| 104:C04.557.470.200.025.255 225:E05.337 554:D02.654.442.200 624:D27.505.696.706.018 723:B01.050.150.900.649.865.635.505.700.900 724:B01.650.940.800.575.100.443.750  |ES| 19:1 75:1 303:1 304:1 849:1 1208:1 1946:1 2520:1 2600:1 2601:1 2602:1 2603:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NN (Disruption))(NN (Ptk6))(NN (decrease))(JJ (azoxymethane-induced))(NN (colon))(NN (tumorigenesis))(NN (mouse)))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 32:C04.697.098.500 33:C04.697.098 46:A03.556.124.526.356 132:D02.172.080  |ES| 19:1 52:1 78:1 113:1 295:1 2533:1 3444:1 3445:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Loss))(NN (metallothionein)))(VP (VBZ (predisposes))(NP (NN (mouse))(JJ (diethylnitrosamine-induced))(NN (hepatocarcinogenesis))(VBG (activating))(NN (NF-kappaB))(NN (target))(NN (gene))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 210:D12.776.260.600 554:D02.654.442.200 777:D12.776.556.670  |ES| 9:1 19:1 52:1 160:1 714:1 900:1 1788:1 1948:1 1958:1 2731:1 2732:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (PRP (We)))(VP (VBD (investigated))(SBAR (S (NP (NN (effect))(NN (liver))(NN (damage)))(VP (VBD (induced))(NP (NN (flutamide))(JJ (primary))(NN (rat))(NNS (hepatocytes)))(S (VP (VBG (using))(NP (NP (NN (liver)))(NP (JJ (microfluidic))(NN (biochip))))))))))) |ET|  |BS| 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 262:A11.436.348 1171:E05.830.666 1172:D02.065.199.420  |ES| 19:1 75:1 344:1 350:1 403:1 412:1 836:1 843:1 849:1 894:1 1848:1 4057:1 4058:1 4059:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (NN (Overdose))(NN (acetaminophen)))(PRN (-LRB- (-LRB-))(NP (NN (APAP)))(-RRB- (-RRB-))))(VP (VBP (cause))(NP (NN (liver))(NN (injury))(JJ (human))(NN (animal))))) |ET|  |BS| 19:B01.050 55:B01.050.150.900.649.801.400.112.400.400 73:N05.715.350.200 242:A03.620 661:D02.065.199.092.040 1233:C25.775.383  |ES| 10:1 14:1 19:1 36:1 46:1 836:1 1779:1 2412:1 2416:1 4193:1 4325:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (JJ (present))(NN (study))))(, (,))(NP (VBN (examined))(NN (effect))(NN (pitavastatin))(: (-))(NN (drug)))(VP (VBD (used))(S (NP (NN (treatment))(NN (hyperlipidemia)))(: (-))(NP (NP (NN (development))(NN (diethylnitrosamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(: (-))(VP (VBN (induced))(S (NP (NP (NN (liver))(JJ (preneoplastic))(NN (lesion))(NN (C57BL/KsJ-db/db)))(PRN (-LRB- (-LRB-))(NP (NN (db/db)))(-RRB- (-RRB-))))(NP (JJ (obese))(NN (mouse)))))))) |ET|  |BS| 52:E02 67:D26 242:A03.620 554:D02.654.442.200 593:B01.050.050.199.520.520.420 765:B01.050.150.900.649.865.635.505.500.550.530 766:C18.452.584.500.500  |ES| 2:1 10:1 14:1 19:1 35:1 52:1 75:1 131:1 191:1 244:1 324:1 409:1 476:1 546:1 836:1 1131:1 1307:1 1438:1 1875:1 1952:1 2468:1 2690:1 2691:1 2692:1 2693:1 2694:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NNP (Aliskiren)))(VP (VBZ (attenuates))(NP (NN (steatohepatitis))(NN (increase))(NN (turnover))(JJ (hepatic))(JJ (fat))(NN (mouse))(NN (fed))(NN (methionine))(NN (choline))(JJ (deficient))(NN (diet))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 508:C06.552.241 594:D02.033.100.291.211 595:G07.203.650.240 596:E02.642.249 663:C16.320.565.398.500.330.500 664:D02.886.030.676 665:N04.452.677.680  |ES| 19:1 40:1 52:1 838:1 1504:1 1791:1 2050:1 2191:1 2422:1 2423:1 2424:1 2425:1 2426:1 2427:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (PRP (It)))(VP (VBD (suggested))(SBAR (S (NP (NN (CYP2E1)))(ADVP (RB (completely)))(VP (VBZ (participates))(NP (JJ (diethylnitrosamine-induced))(NN (hepatocarcinogenesis)))(, (,))(SBAR (S (NP (JJ (high))(NP (NN (frequency)))(NN (tumor))(JJ (wild-type))(NN (mouse)))(VP (MD (could))(VP (VBN (associated))(NP (VBN (increased))(NN (apoptosis)))))))))))) |ET|  |BS| 8:C04 11:B01.050.150.900.649.865.635.505.500 39:G04.299.139.160 554:D02.654.442.200 1218:D08.244.453.300  |ES| 2:1 7:1 8:1 19:1 47:1 52:1 89:1 169:1 178:1 900:1 908:1 925:1 1247:1 1327:1 2732:1 4270:1 4271:1 4272:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (JJ (Inhibitory))(NN (effect))(NN (silibinin))(JJ (azoxymethane-induced))(NN (colon))(NN (tumorigenesis))(NN (A/J))(NN (mouse)))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 32:C04.697.098.500 33:C04.697.098 46:A03.556.124.526.356 132:D02.172.080  |ES| 19:1 52:1 75:1 78:1 113:1 2533:1 2534:1 2635:1 2713:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NP (NNP (Zerumbone)))(, (,))(NP (JJ (tropical))(NN (ginger))(NN (sesquiterpene)))(, (,)))(VP (VBZ (inhibits))(NP (NN (colon))(NN (lung))(NN (carcinogenesis))(NN (mouse))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 33:C04.697.098 46:A03.556.124.526.356 122:C14.280.383 182:A04.411 762:D02.455.849.765 890:B01.650.940.800.575.100.975.900.444  |ES| 2:1 19:1 52:1 113:1 207:1 328:1 615:1 2687:1 3150:1 3151:1 3152:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NP (NP (NN (Balb/c))(NN (mouse))(VBN (treated))(NN (azoxymethane)))(PRN (-LRB- (-LRB-))(NP (NN (AOM)))(-RRB- (-RRB-))))(NN (dextran))(NN (sulfate))(NN (sodium)))(VP (VBP (induce))(NP (NN (colon))(NN (cancer))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 52:E02 131:D09.698.365.272.300 132:D02.172.080 940:B01.050.050.199.520.520.338  |ES| 10:1 14:1 18:1 19:1 52:1 113:1 243:1 406:1 407:1 1099:1 1993:1 1994:1 3299:1 3300:1  |EV| 
4.5068990627598779497020586859435  |BT| (FRAG (PP (IN (In))(NP (NN (mouse))(NN (fed))(NN (bezafibrate))(CD (1))(NN (year))))(, (,))(NP (NP (JJ (preneoplastic))(NN (focus)))(, (,))(NP (NP (NP (NN (adenoma))(JJ (hepatocellular))(NN (carcinoma)))(VP (VBN (found))))(PRN (-LRB- (-LRB-))(CC (+))(: (/))(CC (+))(-RRB- (-RRB-))))(NP (NN (mouse)))(, (,))(NP (NP (JJ (single))(JJ (microscopic))(NN (adenoma)))(VP (VBD (found))(S (NP (NP (CD (one)))(PRN (-LRB- (-LRB-))(: (-))(: (/))(: (-))(-RRB- (-RRB-))))(NP (NN (mouse)))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 17:C04.557.470.035 104:C04.557.470.200.025.255 426:E01.370.350.515 663:C16.320.565.398.500.330.500 805:F01.829.263.315.500.725 806:F01.829.263.315.500.725 909:D02.065.277.067  |ES| 2:1 10:1 14:1 19:1 37:1 42:1 45:1 51:1 52:1 98:1 244:1 303:1 304:1 1010:1 1431:1 1438:1 1452:1 2426:1 2846:1 3201:1 4071:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NP (NN (Mouse))(JJ (nongenotoxic))(NNS (hepatocarcinogens)))(SBAR (S (NP (JJ (phenobarbital))(PRN (-LRB- (-LRB-))(NP (NN (PB)))(-RRB- (-RRB-)))(NN (chlordane)))(VP (VBP (induce))(ADVP (RB (hepatomegaly)))(VP (VBN (characterized))(NP (NN (hypertrophy))(NN (hyperplasia))))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 510:C23.550.444 756:D03.383.742.698.253.650 1150:D02.455.526.439.180 1151:C06.552.416 1152:C23.300.775  |ES| 10:1 14:1 19:1 243:1 985:1 1795:1 2127:1 2685:1 3340:1 3496:1 3989:1 3990:1 3991:1 3992:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NN (CONCLUSION))(: (:)))(NP (DT (These))(VBP (result))(NP (VBN (suggested))(NN (TFA))(VBD (protected))(ADJP (NN (mouse))(JJ (CCl4-induced))(ADJP (NN (liver))(NN (injury))(JJ (antioxidant)))(NN (stress))(JJ (antiinflammatory)))(NN (effect))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 242:A03.620 686:D27.505.954.158 699:D02.241.081.018.285.500 700:D27.505.519.217  |ES| 19:1 52:1 75:1 101:1 104:1 792:1 836:1 925:1 1882:1 2413:1 2416:1 2477:1 2519:1 2520:1 2521:1 2522:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NP (NNP (UNLABELLED)))(: (:))(NP (NP (NP (JJ (Antidiabetic))(NNS (thiazolidinediones)))(PRN (-LRB- (-LRB-))(NP (NN (TZD)))(-RRB- (-RRB-))))(PP (FW (vitro))(NP (NP (JJ (antiproliferative))(NN (effect))(JJ (epithelial))(NN (cancer)))(, (,))(PP (VBG (including))(NP (NP (JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-)))))))))) |ET|  |BS| 104:C04.557.470.200.025.255 862:D02.886.675.933 878:D27.505.696.422  |ES| 2:1 10:1 14:1 18:1 19:1 75:1 104:1 127:1 216:1 303:1 304:1 441:1 561:1 2266:1 3117:1 3118:1 3119:1 3120:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NP (NN (Evaluation))(JJ (chemopreventive))(NN (effect)))(NP (NNP (Fumaria))(NN (indica))(NN (N-nitrosodiethylamine))(JJ (CCl4-induced))(JJ (hepatocellular))(NN (carcinoma))(NNP (Wistar))(NN (rat))))) |ET|  |BS| 104:C04.557.470.200.025.255 225:E05.337 554:D02.654.442.200 624:D27.505.696.706.018 723:B01.050.150.900.649.865.635.505.700.900 724:B01.650.940.800.575.100.443.750  |ES| 19:1 75:1 303:1 304:1 849:1 1208:1 1946:1 2520:1 2600:1 2601:1 2602:1 2603:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (DT (This))(NN (research)))(VP (VBZ (provides))(NP (NN (evidence))(NN (tea)))(, (,))(NP (ADVP (RB (particularly)))(NP (VBN (administered))(NN (combination))(NN (sulindac)))(, (,))(NP (PP (ADJP (RB (highly))(JJ (effective)))(S (VP (VBG (inhibiting))(NP (NP (NP (JJ (intestinal))(NN (neoplasia))(NN (male))(NN (Apc)))(PRN (-LRB- (-LRB-))(NP (NN (min)))(-RRB- (-RRB-))))(NN (mouse)))(PP (IN (via))(NP (JJ (direct))(JJ (indirect))(NN (effect))(NN (beta-catenin/APC))(NN (pathway))))))))))) |ET|  |BS| 3:C04.557.470.035.215.100 11:B01.050.150.900.649.865.635.505.500 23:D12.776.091.249 102:C04.588.274.476.411 122:C14.280.383 251:D02.455.426.559.847.486.875 644:H01.770.644 645:H01.770.644  |ES| 2:1 10:1 14:1 19:1 38:1 52:1 75:1 109:1 280:1 383:1 530:1 596:1 626:1 640:1 807:1 815:1 869:1 880:1 1402:1 1639:1 1891:1 2336:1 2378:1 2379:1 2380:1 2381:1 2382:1 2383:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (PRP (We)))(VP (VBD (observed))(NP (NP (NP (JJ (significant))(NN (reduction))(NN (number))(NN (size))(JJ (small))(JJ (intestinal))(NN (polyp))(NN (APC)))(PRN (-LRB- (-LRB-))(NP (NP (NN (min)))(CC (+))(: (/))(: (-)))(-RRB- (-RRB-))))(NN (mouse))(VBN (treated))(CC (either))(NP (NP (NP (NP (NN (celecoxib)))(PRN (-LRB- (-LRB-))(NP (JJ (selective))(NN (COX-2))(NN (inhibitor)))(-RRB- (-RRB-))))(NN (erlotinib)))(PRN (-LRB- (-LRB-))(NP (NP (NN (Tarceva)))(, (,))(NP (NN (EGFR))(NN (inhibitor))))(-RRB- (-RRB-))))))) |ET|  |BS| 3:C04.557.470.035.215.100 11:B01.050.150.900.649.865.635.505.500 52:E02 193:C23.300.825.411 349:D27.505.519.389.310.500 684:D02.065.884.247 888:D03.438.786.375  |ES| 2:1 10:1 11:1 14:1 19:1 39:1 52:1 76:1 109:1 135:1 187:1 261:1 370:1 380:1 646:1 647:1 750:1 843:1 1099:1 1749:1 2142:1 2342:1 2807:1 3143:1 3144:1  |EV| 
-4.5068990627598779497020586859435  |BT| (NP (NP (NNP (Sesamin)))(, (,))(NP (JJ (lipid-soluble))(NN (lignan)))(, (,))(S (NP (CD (one))(NN (agent)))(VP (VBZ (belongs))(NP (SBAR (S (NP (NP (NN (class))(NNS (phytoestrogens)))(, (,))(NP (NP (VBN (isolated))(NN (sesame)))(PRN (-LRB- (-LRB-))(NP (NN (Sesamum))(NN (indicum)))(-RRB- (-RRB-))))(, (,)))(VP (VBN (linked))(NP (NN (prevention))(NN (hyperlipidemia))))))(, (,))(NP (NP (NN (hypertension)))(, (,))(NP (NN (carcinogenesis))(JJ (unknown))(NN (mechanism)))))))) |ET|  |BS| 33:C04.697.098 621:D02.455.426.559.389.140.450 659:D10 766:C18.452.584.500.500 830:B01.650.940.800.575.100.583.690.750 831:D27.505.696.399.472.277.540.500 832:C14.907.489  |ES| 2:1 10:1 14:1 19:1 162:1 207:1 728:1 1010:1 1363:1 1474:1 1653:1 2182:1 2313:1 2692:1 2814:1 2952:1 2953:1 2954:1 2955:1 2956:1 2957:1 2958:1 2959:1  |EV| 
-4.5068990627598779497020586859435  |BT| (FRAG (SBAR (IN (Although))(S (VP (ADVP (RB (spontaneously)))(VB (develop))(NP (NP (NN (liver))(NN (tumor)))(, (,))(NP (NN (IL-22TG))(NN (mouse))(JJ (susceptible))(JJ (diethylnitrosamine-induced))(NN (liver))(NN (cancer)))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 515:C04.588.274.623 554:D02.654.442.200 897:Z01.252.245.500.375 931:Z01.107.567.875.350.350 932:D12.644.276.374.465  |ES| 2:1 7:1 18:1 19:1 52:1 107:1 648:1 836:1 899:1 1506:1 2732:1 3279:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NNP (Melatonin)))(VP (VBZ (Activates))(NP (NP (JJ (Endoplasmic))(NN (Reticulum))(NN (Stress))(NN (Apoptosis))(NNS (Rats)))(NP (JJ (Diethylnitrosamine-Induced))(NN (Hepatocarcinogenesis)))))) |ET|  |BS| 39:G04.299.139.160 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 554:D02.654.442.200 707:D03.438.473.914.481 1071:G04.434  |ES| 19:1 1959:1 2738:1 3291:1 3664:1 4301:1 4302:1 4303:1 4304:1 4305:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(NP (NN (Silibinin))(NN (target))(NN (beta-catenin))(NN (IGF-1Rbeta))(NN (pathway))(JJ (chemopreventive))(NN (efficacy))(JJ (azoxymethane-induced))(NN (colon))(NN (carcinogenesis))(NN (A/J))(NN (mouse)))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 23:D12.776.091.249 33:C04.697.098 46:A03.556.124.526.356 132:D02.172.080 581:D12.644.276.937  |ES| 19:1 52:1 60:1 104:1 113:1 160:1 207:1 239:1 383:1 1946:1 2304:1 2531:1 2532:1 2533:1 2534:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NN (Cell))(NN (expression))(NN (pattern))(NN (CD147))(JJ (N-diethylnitrosamine/phenobarbital-induced))(NN (mouse))(JJ (hepatocellular))(NN (carcinoma)))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 41:A11 104:C04.557.470.200.025.255 554:D02.654.442.200 756:D03.383.742.698.253.650  |ES| 19:1 52:1 115:1 260:1 303:1 304:1 4094:1 4095:1 4096:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (NN (conclusion))))(, (,))(NP (NN (simvastatin)))(VP (VBD (inhibited))(NP (NP (NN (colon))(NN (cancer))(NN (development))(NN (induction)))(NN (apoptosis))(NN (suppression))(NN (angiogenesis))))) |ET|  |BS| 39:G04.299.139.160 122:C14.280.383 754:D02.455.426.559.847.638.400.900  |ES| 2:1 18:1 19:1 35:1 89:1 113:1 244:1 365:1 736:1 1284:1 2453:1 2502:1 2679:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (S (NP (JJ (Previous))(NN (work)))(VP (VBD (showed))(NP (NN (loss))(NN (TIP30)))))(, (,))(ADVP (RB (also)))(VP (VBN (called))(S (NP (NN (CC3))))(, (,))(NP (NP (JJ (putative))(NN (tumor))(NN (suppressor)))(, (,))(NP (VBD (increased))(NN (incidence))(JJ (hepatocellular))(NN (carcinoma))(NN (mouse)))(, (,))(NP (JJ (clinical))(NN (sample))(JJ (human))(NN (HCC))(NN (tissue))(JJ (aberrant))(NN (expression))(NN (TIP30)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 55:B01.050.150.900.649.801.400.112.400.400 98:A10 104:C04.557.470.200.025.255 206:G05.360.340.024.340.375.249 434:E05.318.308.985.525.375 445:I03.946  |ES| 2:1 5:1 7:1 19:1 32:1 36:1 47:1 52:1 84:1 115:1 132:1 272:1 303:1 304:1 441:1 700:1 835:1 918:1 1511:1 1546:1 1547:1 1725:1 2900:1 2904:1 2905:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NNP (Chemoprevention))(NNP (Diethylnitrosamine-Initiated))(NNP (Phenobarbital-Promoted))(NNP (Hepatocarcinogenesis))(NNP (Rats))(NNP (Sulfated))(NNP (Polysaccharides))(NNP (Aqueous))(NN (Extract))(NNP (Ulva))(NN (lactuca)))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 253:E02.319.162 554:D02.654.442.200 756:D03.383.742.698.253.650 803:D01.248.497.158.845 804:D09.698 1184:B01.650.940.150.900  |ES| 19:1 1959:1 2842:1 3664:1 4097:1 4098:1 4099:1 4100:1 4101:1 4102:1 4103:1 4104:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (JJ (present))(NN (study))))(, (,))(VP (VBN (shown))(NP (NP (JJ (myrtenal))(, (,))(JJ (natural))(NN (monoterpene)))(, (,))(NP (VP (VBP (act))(SBAR (S (NP (JJ (antineoplastic))(NN (agent))(NN (diethylnitrosamine)))(VP (VBD (induced))(NP (JJ (phenobarbital))(VBN (promoted))(NP (JJ (experimental))(JJ (hepatocellular))(NN (carcinoma)))))))))))) |ET|  |BS| 81:E02.095.465.425.400.330.050.400 554:D02.654.442.200 660:D27.505.954.248 756:D03.383.742.698.253.650 757:C04.588.274.623.460 758:D02.455.849.575  |ES| 2:1 19:1 131:1 237:1 244:1 246:1 263:1 303:1 304:1 412:1 728:1 1307:1 1912:1 1952:1 2333:1 2682:1 2683:1 2684:1 2685:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (PRP (It)))(ADVP (RB (also)))(VP (VBD (nominated))(NP (NP (JJ (dichloroacetic))(NN (acid)))(VP (VBN (studied))(NP (NP (JJ (representative))(NN (class))(JJ (haloacetic))(NN (acid)))(NP (VBN (shown))(NN (cause))(NN (liver))(NN (tumor))(NN (rat))(NN (mouse)))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 515:C04.588.274.623 1062:D01.029 1219:D02.241.081.018.214.500  |ES| 5:1 7:1 19:1 52:1 237:1 401:1 836:1 849:1 1017:1 1275:1 1327:1 1779:1 2814:1 4273:1 4274:1 4275:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (JJ (Conditional))(NN (beta-catenin))(NN (loss))(NN (mouse)))(VP (VBZ (promotes))(NP (NP (NN (chemical))(NN (hepatocarcinogenesis)))(: (:))(NP (NN (role))(NP (ADJP (JJ (oxidative))(NN (stress))(JJ (platelet-derived)))(NN (growth))(NN (factor))(NN (receptor))(NN (alpha/phosphoinositide))(NN (3-kinase)))(NN (signaling)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 15:F01.829.316.616 23:D12.776.091.249 69:G02.111.087.800 578:D08.811.913.696.620.550 716:G03.495.710 965:D08.811.913.696.620.682.725.400.900  |ES| 19:1 31:1 32:1 52:1 60:1 102:1 104:1 185:1 186:1 195:1 298:1 900:1 2124:1 2522:1 2583:1 3391:1 3392:1 3393:1 3394:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NP (NNS (OBJECTIVES)))(: (:))(NP (NP (NP (NP (DT (The))(JJ (chemopreventive))(JJ (potential))(NN (Tephrosia))(NN (purpurea))(NN (extract)))(PRN (-LRB- (-LRB-))(NP (NN (TPE)))(-RRB- (-RRB-))))(NN (N-nitrosodiethylamine))(-LRB- (-LRB-))(NN (NDEA))(-RRB- (-RRB-))(: (-)))(VP (VBN (induced))(NP (NP (NP (JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(SBAR (S (NP (JJ (Wistar))(NN (rat)))(VP (VBN (assessed)))))))))) |ET|  |BS| 104:C04.557.470.200.025.255 415:F01.658.500 554:D02.654.442.200 723:B01.050.150.900.649.865.635.505.700.900 1153:B01.650.940.800.575.100.401.890  |ES| 10:1 14:1 19:1 104:1 303:1 304:1 409:1 441:1 691:1 827:1 849:1 1946:1 2496:1 2602:1 2603:1 3823:1 3993:1 3994:1 3995:1 3996:1 3997:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Beta-ionone)))(VP (VP (VBZ (inhibits))(NP (JJ (colonic))(JJ (aberrant))(NN (crypt))(NN (focus))(NN (formation))(NN (rat))))(, (,))(VP (VBZ (suppresses))(NP (NN (cell))(NN (growth))))(, (,))(VP (VBZ (induces))(NP (NN (retinoid))(NN (X))(NN (receptor-alpha))(JJ (human))(NN (colon))(NN (cancer))(NN (cell)))))) |ET|  |BS| 20:G03.495 41:A11 45:G07.700.320.249 46:A03.556.124.526.356 55:B01.050.150.900.649.801.400.112.400.400 122:C14.280.383 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 824:C04.834.020 941:D12.776.826.701.500.500  |ES| 2:1 18:1 19:1 36:1 43:1 94:1 102:1 113:1 214:1 615:1 677:1 686:1 849:1 929:1 1431:1 1725:1 1889:1 2454:1 2573:1 2913:1  |EV| 
-1.4557148748517647618427872657776  |BT| (S (S (NP (NN (Rimonabant)))(VP (VBZ (inhibits))(NP (JJ (human))(NN (colon))(NN (cancer))(NN (cell))(NN (growth)))))(VP (VBZ (reduces))(NP (NN (formation))(JJ (precancerous))(NN (lesion))(NN (mouse))(NN (colon))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 20:G03.495 41:A11 45:G07.700.320.249 46:A03.556.124.526.356 55:B01.050.150.900.649.801.400.112.400.400 122:C14.280.383 341:C04.834  |ES| 18:1 19:1 36:1 43:1 52:1 94:1 102:1 113:1 142:1 615:1 1130:1 1131:1 2949:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (DT (All))(NN (result)))(VP (VBP (suggest))(SBAR (S (NP (JJ (low))(NN (concentration))(NN (acrylamide)))(VP (MD (may))(VP (VB (contribute))(NP (NP (NN (progression))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-)))))))))) |ET|  |BS| 16:C23.550.291.656 104:C04.557.470.200.025.255 905:F02.830.104.214 930:D02.065.122.015  |ES| 10:1 14:1 19:1 48:1 101:1 303:1 304:1 441:1 450:1 491:1 531:1 796:1 965:1 3189:1 3278:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (N-acetyl-L-cysteine)))(VP (VBD (blocked))(SBAR (S (NP (NN (EGFR))(NN (activation)))(VP (VBD (reduced))(NP (JJ (N-nitrosodiethylamine-initiated))(NN (hepatocarcinogenesis))(NN (level))(NNP (Cre-Ctrl))(NN (mouse)))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 122:C14.280.383 554:D02.654.442.200 791:D02.886.030.230.259  |ES| 19:1 52:1 187:1 225:1 249:1 452:1 900:1 2776:1 2777:1 2778:1 2779:1  |EV| 
-3.3020936123234605474863201379776  |BT| (NP (NP (NP (JJ (Glycyrrhizic))(NN (Acid)))(NP (VBN (used))(NN (treat))(JJ (chronic))(NN (hepatitis))))(, (,))(S (VP (VBG (inhibiting))(NP (NN (penetration))(NN (hepatitis))(NN (A))(NN (virus))(NNS (hepatocytes)))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 52:E02 122:C14.280.383 262:A11.436.348 734:D02.455.849.919.530.466 735:B04.450.420.410 736:C06.552.380.350  |ES| 2:1 19:1 69:1 476:1 880:1 894:1 1090:1 1422:1 1790:1 2048:1 2625:1 2626:1 2627:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (PRP$ (Our))(NN (result)))(VP (VBD (showed))(NP (NN (cimetidine))(VBG (inhibiting))(NN (effect))(NN (hepatocarcinogenesis))))) |ET|  |BS| 12:Z01.542.049 122:C14.280.383 808:D02.078.370.200  |ES| 19:1 75:1 101:1 132:1 658:1 880:1 900:1 2857:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (DT (These)))(VP (VBP (result))(VP (VP (VBP (indicate))(SBAR (S (NP (NP (NN (chitin)))(, (,))(NP (NN (chitosan))(JJ (related))(NN (compound))))(VP (VBP (exert))(NP (NP (JJ (unequivocal))(JJ (chemopreventive))(NN (effect)))(NP (JJ (heterocyclic))(JJ (amine-induced))(NN (hepatocarcinogenesis))))))))(, (,))(SBAR (S (NP (NN (effect))(NN (organ)))(VP (MD (may))(SBAR (S (NP (NN (tissue))(JJ (specific))(JJ (possible))(JJ (inhibitory))(NN (action))(JJ (mammary))(NN (gland)))(VP (VBD (offset))(NP (NN (promotion))(NN (colon))(NN (lesion))(NN (development)))))))))))) |ET|  |BS| 46:A03.556.124.526.356 98:A10 609:A01.236.249 624:D27.505.696.706.018 854:D05.750.078.139.500 855:D05.750.078.139 856:D02.092  |ES| 2:1 19:1 35:1 75:1 101:1 113:1 272:1 419:1 491:1 540:1 592:1 792:1 900:1 1131:1 1359:1 1382:1 1479:1 1946:1 2013:1 2248:1 2337:1 2429:1 2433:1 2843:1 3051:1 3052:1 3053:1 3054:1 3055:1 3056:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Valerian)))(VP (VBZ (inhibits))(NP (NP (NP (NN (rat))(NN (hepatocarcinogenesis))(VBG (activating))(NN (GABA)))(PRN (-LRB- (-LRB-))(NP (NN (A)))(-RRB- (-RRB-))))(NP (JJ (receptor-mediated))(NN (signaling)))))) |ET|  |BS| 69:G02.111.087.800 122:C14.280.383 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 857:B01.650.940.800.575.100.955.888 858:B01.650.940.800.575.100.955.888 880:D12.776.157.530.400.175.562  |ES| 10:1 14:1 19:1 69:1 195:1 615:1 849:1 900:1 1958:1 3057:1 3060:1 3123:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NNS (Glucans))(JJ (edible))(NN (mushroom))(NN (Pleurotus))(NN (pulmonarius)))(VP (VBP (inhibit))(NP (JJ (colitis-associated))(NN (colon))(NN (carcinogenesis))(NN (mouse))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 33:C04.697.098 46:A03.556.124.526.356 53:C06.405.205.265 122:C14.280.383 731:B01.300.179.100.650 732:D05.750.078.562 733:B01.300.179.100  |ES| 19:1 52:1 113:1 207:1 410:1 1370:1 2620:1 2621:1 2622:1 2623:1 2624:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (DT (The))(JJ (preventive))(NN (effect)))(VP (VP (VBN (processed))(NP (NP (NP (NP (NNP (Aloe))(NN (vera))(NN (gel)))(PRN (-LRB- (-LRB-))(NP (NN (PAG)))(-RRB- (-RRB-))))(NN (colon))(NN (carcinogenesis)))(VP (VBN (examined))(S (VP (VBG (using))(NP (NP (NN (azoxymethane)))(PRN (-LRB- (-LRB-))(NP (NN (AOM)))(-RRB- (-RRB-)))))))))(: (-))(VP (VBN (initiated))(NP (NP (NN (dextran))(NN (sodium))(NN (sulfate)))(PRN (-LRB- (-LRB-))(NP (NN (DSS)))(-RRB- (-RRB-)))))))(: (-))(VP (VBD (promoted))(NP (NN (mouse))(NN (colon))(NN (carcinogenesis))(NN (model))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 33:C04.697.098 46:A03.556.124.526.356 131:D09.698.365.272.300 132:D02.172.080  |ES| 10:1 14:1 19:1 52:1 72:1 75:1 113:1 207:1 324:1 350:1 406:1 407:1 674:1 691:1 1883:1 1993:1 1994:1 3300:1 3306:1 4024:1 4025:1 4026:1 4027:1 4028:1 4029:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NN (DESIGN))(: (:)))(NP (NP (NP (JJ (Spontaneous))(JJ (experimental))(NN (fibrogenesis)))(SBAR (S (NP (ADJP (RB (well))(JJ (diethylnitrosamine-induced)))(NN (hepatocarcinogenesis)))(VP (VBD (investigated))(NP (NP (JJ (lecithin-retinol))(NN (acyltransferase)))(PRN (-LRB- (-LRB-))(NP (NN (LRAT)))(-RRB- (-RRB-))))))))(: (-))(NP (JJ (deficient))(NN (mouse))(NN (lack))(JJ (retinoid-containing))(NN (lipid))(NN (droplet))(NNS (HSCs))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 554:D02.654.442.200 711:D02.455.326.271.665.202.495 962:A11.148.378 963:A11.284.430.214.190.875.393  |ES| 10:1 14:1 19:1 52:1 104:1 263:1 403:1 690:1 787:1 900:1 2401:1 2732:1 3381:1 3383:1 3937:1 4136:1 4137:1 4138:1 4139:1 4140:1 4141:1 4142:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (DT (The))(JJ (selective))(NN (EGFR))(NN (inhibitor))(NN (Gefitinib)))(VP (VBD (found))(S (VP (VBP (prevent))(NP (NN (hepatocarcinogenesis))(NN (rat))(JJ (cirrhotic))(NN (liver))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 242:A03.620 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700  |ES| 19:1 37:1 187:1 380:1 691:1 733:1 836:1 849:1 900:1 1749:1 2968:1 3024:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (DT (The))(NN (purpose))(NN (study)))(VP (VBP (evaluate))(NP (NP (NP (JJ (anticancer))(NN (potency))(NN (mechanism))(JJ (novel))(NN (difluorodiarylidenyl))(NN (piperidone)))(PRN (-LRB- (-LRB-))(NP (NN (H-4073)))(-RRB- (-RRB-))))(S (NP (NP (NN (N-hydroxypyrroline))(NN (modification)))(PRN (-LRB- (-LRB-))(NP (NN (HO-3867)))(-RRB- (-RRB-))))(NP (JJ (human))(JJ (ovarian))(NN (cancer))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 55:B01.050.150.900.649.801.400.112.400.400 179:D01.248.497.300.459.700 225:E05.337 259:D12.776.395.240.150.500 848:D03.383.621.808  |ES| 10:1 14:1 18:1 19:1 36:1 131:1 162:1 691:1 890:1 891:1 1763:1 1880:1 2374:1 2796:1 3011:1 3012:1 3013:1 3014:1 3015:1 3016:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (DT (The))(JJ (present))(NN (study)))(VP (VBN (undertaken))))(VBP (investigate))(NP (NP (NN (effect))(JJ (dietary))(NN (supplementation))(NN (nimesulide))(NN (eugenol))(NN (N-nitrosodiethylamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(: (-))(VP (VBN (initiated))(NP (JJ (early))(NN (hepatocarcinogenesis))(NN (F344))(JJ (male))(NN (rat))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 554:D02.654.442.200 590:B01.050.050.199.520.760.200 595:G07.203.650.240 1165:D02.241.223.200.054.500  |ES| 10:1 14:1 19:1 75:1 131:1 459:1 691:1 849:1 900:1 1128:1 1307:1 1402:1 1875:1 2567:1 2594:1 2602:1 3185:1 3186:1 4022:1 4023:1 4024:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (JJ (Mechanistic))(NN (study))(NN (liver))(NN (tumor)))(VP (VBG (promoting))(NP (NN (effect))(NN (flutamide))(NN (rat))))) |ET|  |BS| 8:C04 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 1172:D02.065.199.420 1226:E01.370.372.460  |ES| 7:1 19:1 75:1 131:1 836:1 849:1 881:1 4057:1 4297:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (VBN (Enhanced))(NP (NN (liver)))(NN (tumor))(NN (promotion))(NN (activity))(NN (rat)))(VP (VBN (subjected))(NP (JJ (combined))(NN (administration))(JJ (phenobarbital))(NN (orphenadrine))))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 515:C04.588.274.623 618:E02.186 756:D03.383.742.698.253.650 1159:D02.092.471.600  |ES| 7:1 19:1 164:1 399:1 836:1 849:1 2337:1 2575:1 2685:1 3267:1 3466:1 4005:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (VBN (Accelerated))(NN (liver))(NN (regeneration))(NN (hepatocarcinogenesis))(NN (mouse)))(VP (VBG (overexpressing))(NP (NN (serine-45))(JJ (mutant))(NN (beta-catenin))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 23:D12.776.091.249 925:G10.261.326.520 926:D12.125.154.800  |ES| 19:1 52:1 60:1 811:1 836:1 900:1 3259:1 3260:1 3261:1 3262:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NNS (Thiazolidinediones)))(VP (VBP (inhibit))(NP (NN (hepatocarcinogenesis))(NN (hepatitis))(NN (B))(JJ (virus-transgenic))(NN (mouse))(NN (peroxisome))(JJ (proliferator-activated))(NN (receptor))(JJ (gamma-independent))(NN (regulation))(NN (nucleophosmin))))) |ET|  |BS| 38:Z01.058.290.120.180 40:Z01.542.248.700 99:B01.050.050.136.500 122:C14.280.383 142:I01.880.604 719:D12.776.826.239.588 862:D02.886.675.933 863:B04.280.375.650.425  |ES| 19:1 52:1 186:1 438:1 763:1 900:1 1370:1 1801:1 1887:1 2048:1 3069:1 3070:1 3071:1 3072:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (ADJP (RB (Orally))(VBN (administered)))(NN (lycopene)))(VP (VBZ (attenuates))(NP (NP (JJ (diethylnitrosamine-induced))(NN (hepatocarcinogenesis))(NN (rat)))(VP (VBG (modulating))(NP (NP (NN (Nrf-2)))(: (/))(NP (NN (HO-1))(NN (Akt/mTOR))(NN (pathway)))))))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 378:D08.811.913.696.620.682.700.755 554:D02.654.442.200 799:D12.776.260.615.249 800:Z01.107.169.534  |ES| 19:1 383:1 849:1 900:1 2336:1 2423:1 2435:1 2566:1 2732:1 2817:1 2818:1 2819:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NNP (Diosmin)))(VP (VBZ (abrogates))(VP (ADVP (RB (chemically)))(VBN (induced))(NN (hepatocarcinogenesis))(PP (IN (via))(NP (NP (NN (alleviation))(JJ (oxidative))(NN (stress)))(, (,))(NP (JJ (hyperproliferative))(JJ (inflammatory))(NN (marker))(JJ (murine))(NN (model)))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 158:D23.101 715:D03.383.663.283.266.450.260.222 716:G03.495.710  |ES| 2:1 19:1 72:1 412:1 534:1 596:1 627:1 900:1 2430:1 2522:1 2579:1 2580:1 2581:1 2582:1 2583:1 2584:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NP (NP (JJ (Polyinosinic-polycytidylic))(NN (acid)))(PRN (-LRB- (-LRB-))(NP (NN (Poly))(NN (I))(: (:))(NN (C)))(-RRB- (-RRB-))))(NN (IFN-gamma))(NN (treatment)))(VP (VBD (inhibited))(NP (NN (liver))(NN (fibrosis))(JJ (pair-fed))(JJ (ethanol-fed))(NN (mouse))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 52:E02 122:C14.280.383 663:C16.320.565.398.500.330.500 676:C06.552.630 751:D02.033.375 815:D13.695.578.550.560.600 816:G01.358.500.505.300  |ES| 10:1 14:1 19:1 52:1 104:1 365:1 546:1 836:1 949:1 1275:1 1955:1 2350:1 2883:1 2884:1 2885:1 2886:1 2887:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (beta-Naphthoflavone)))(VP (VBZ (enhances))(NP (NP (JJ (oxidative))(NN (stress))(NN (response)))(NN (induction))(JJ (preneoplastic))(NN (lesion))(JJ (diethylnitrosamine-initiated))(NN (hepatocarcinogenesis))(NN (model)))(ADVP (RB (partially)))(VP (VBD (hepatectomized))(NP (NN (rat)))))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 554:D02.654.442.200 716:G03.495.710 983:D03.383.663.283.266.450.175.100  |ES| 19:1 72:1 494:1 736:1 849:1 900:1 1131:1 1351:1 1356:1 1438:1 2522:1 2583:1 4091:1 4092:1 4093:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (S (NP (NN (Expression))(NN (retinoid))(NN (X))(NN (receptor))(NN (alpha)))(VP (VBD (decreased))(NP (CD (3))('' (')))))(: (-))(FRAG (NP (JJ (methyl-4-dimethylaminoazobenzene-induced))(JJ (hepatocellular))(NN (carcinoma))(NN (rat))))) |ET|  |BS| 104:C04.557.470.200.025.255 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 941:D12.776.826.701.500.500 1193:D02.092.146.325  |ES| 19:1 186:1 202:1 303:1 304:1 316:1 849:1 929:1 1836:1 2573:1 4159:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Simvastatin)))(VP (VP (VBZ (induces))(NP (NN (apoptosis))(JJ (human))(NN (colon))(NN (cancer))(NN (cell))(NN (tumor))(NN (xenograft))))(, (,))(VP (VBZ (attenuates))(NP (JJ (colitis-associated))(NN (colon))(NN (cancer))(NN (mouse)))))) |ET|  |BS| 8:C04 11:B01.050.150.900.649.865.635.505.500 39:G04.299.139.160 41:A11 53:C06.405.205.265 55:B01.050.150.900.649.801.400.112.400.400 92:E04.936.764 93:A01.941.875 754:D02.455.426.559.847.638.400.900  |ES| 2:1 7:1 18:1 19:1 36:1 52:1 89:1 94:1 113:1 214:1 265:1 410:1 2423:1 2961:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (DT (The))(JJ (sulfated))(NN (polysaccharide))(NNP (U.))(NN (lactuca)))(VP (MD (may))(SBAR (S (NP (JJ (unique))(NN (property))(VBG (providing))(NN (protection))(JJ (DENA-induced))(JJ (oxidative))(NN (stress)))(VP (MD (could))(VP (VB (contribute))(NP (NN (chemoprevention))(JJ (experimental))(NN (hepatocarcinogenesis))))))))) |ET|  |BS| 253:E02.319.162 554:D02.654.442.200 716:G03.495.710 803:D01.248.497.158.845 804:D09.698  |ES| 19:1 263:1 450:1 491:1 691:1 841:1 870:1 900:1 908:1 1469:1 2522:1 2583:1 2734:1 2839:1 2840:1 2841:1 2842:1 3025:1 3026:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (ADVP (RB (Herein)))(, (,))(JJ (first))(NN (time)))(, (,))(VP (VBP (investigate))(NP (FW (vivo))(NN (efficacy))(NN (silibinin))(JJ (azoxymethane-induced))(NN (colon))(NN (tumorigenesis))(NN (A/J))(NN (mouse))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 32:C04.697.098.500 33:C04.697.098 46:A03.556.124.526.356 132:D02.172.080 322:G01.910  |ES| 2:1 19:1 52:1 78:1 113:1 378:1 428:1 459:1 816:1 1081:1 2304:1 2533:1 2534:1 2635:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NP (NN (Inhibition))(JJ (azoxymethane-induced))(JJ (colorectal))(NN (cancer))(NN (CP-31398)))(, (,))(NP (NN (TP53))(NN (modulator)))(, (,))(ADVP (RB (alone)))(NP (NN (combination))(JJ (low))(NNS (dos))))(VP (VBP (celecoxib))(NP (JJ (male))(NN (F344))(NN (rat))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 43:F01.145.544 132:D02.172.080 590:B01.050.050.199.520.760.200 684:D02.065.884.247  |ES| 2:1 17:1 18:1 19:1 241:1 530:1 531:1 849:1 1018:1 1402:1 1607:1 2533:1 2653:1 2703:1 2807:1 3047:1 3185:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (S (VP (TO (To))(VP (VB (investigate))(NP (NP (NP (JJ (protective))(NN (effect))(NN (bilberry))(NN (extract)))(PRN (-LRB- (-LRB-))(NP (NN (BBE)))(-RRB- (-RRB-))))(NP (NP (NP (ADJP (RB (enzymatically))(VBN (modified)))(NN (isoquercitrin)))(PRN (-LRB- (-LRB-))(NP (NN (EMIQ)))(-RRB- (-RRB-))))(NP (NP (JJ (hepatocarcinogenic))(NN (process)))(VP (VBG (involving))(NP (NP (JJ (oxidative))(NN (stress))(NN (response)))(, (,))(VP (VBN (used))(S (NP (NP (JJ (two-stage))(NN (hepatocarcinogenesis))(NN (model))(JJ (N-diethylnitrosamine-initiated))(NN (piperonyl))(NN (butoxide)))(PRN (-LRB- (-LRB-))(NP (NN (PBO)))(-RRB- (-RRB-))))))))))))))(: (-))(VP (VBD (promoted))(NP (NN (rat))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 554:D02.654.442.200 716:G03.495.710 1077:D03.383.246.118.600  |ES| 2:1 10:1 14:1 19:1 72:1 75:1 459:1 476:1 493:1 494:1 638:1 828:1 849:1 900:1 2335:1 2372:1 2496:1 2522:1 2583:1 2971:1 3773:1 3774:1 3777:1 3778:1 4029:1 4050:1 4052:1 4053:1 4054:1 4055:1 4056:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (PP (IN (In))(NP (JJ (present))(NN (study))))(, (,))(NP (VBN (shown))(NN (diosmin)))(VP (VBZ (attenuates))(SBAR (S (NP (NP (NN (2-AAF)))(VP (VBD (induced))(NP (NP (NP (JJ (hepatic))(NN (toxicity))(JJ (early))(NN (tumor))(NN (promotion))(NN (marker)))(PRN (-LRB- (-LRB-))(NP (NP (NN (ODC)))(, (,))(NP (NN (PCNA))(NN (Ki67))))(-RRB- (-RRB-))))(, (,))(NP (JJ (chemopreventive))(NN (efficacy))(NN (DEN))))))(VP (VBD (initiated))(NP (JJ (2-AAF))(VBN (promoted))(NN (hyper-proliferation))(NN (hepatocarcinogenesis))(NNP (Wistar))(NN (rat)))))))) |ET|  |BS| 376:D23.101.140 715:D03.383.663.283.266.450.260.222 723:B01.050.150.900.649.865.635.505.700.900 745:C10.597.350.350 767:D02.065.064.150 768:D12.776.660.740  |ES| 2:1 7:1 10:1 14:1 19:1 131:1 237:1 244:1 412:1 534:1 838:1 849:1 900:1 1128:1 1307:1 1875:1 1900:1 1912:1 1946:1 2304:1 2337:1 2406:1 2423:1 2603:1 2695:1 2696:1 2697:1 2698:1 2699:1 2700:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (DT (The))(JJ (present))(NN (study)))(VP (VBZ (allows))(SBAR (S (NP (NN (u)))(VP (VBP (conclude))(SBAR (S (NP (JJ (diosmin))(JJ (dietary))(NN (supplement)))(, (,))(VP (MD (could))(VP (VBN (used))(S (NP (JJ (chemopreventive))(NN (agent)))(VP (VBP (prevent))(NP (NN (hepatocarcinogenesis)))))))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 557:D02.241.081.069.600.150 715:D03.383.663.283.266.450.260.222 847:G07.203.300.456  |ES| 2:1 19:1 131:1 476:1 691:1 728:1 733:1 900:1 908:1 1307:1 1946:1 1968:1 2243:1 2594:1 2695:1 3003:1 3004:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Rat))(NN (liver))(NN (tumor)))(VP (VBD (initiated))(NP (NP (NP (NN (N-nitrosodiethylamine)))(PRN (-LRB- (-LRB-))(NP (NN (DEN)))(-RRB- (-RRB-))))(VP (VBD (followed))(S (NP (NP (NN (promotion))(NN (phenobarbital)))(PRN (-LRB- (-LRB-))(NP (NN (PB)))(-RRB- (-RRB-))))(NP (NP (NP (VBN (examined))(NN (expression))(VBG (transforming))(NN (growth))(NN (factor-beta)))(PRN (-LRB- (-LRB-))(NP (NN (TGF))(NN (beta)))(-RRB- (-RRB-))))(NP (NN (type))(CD (I))(, (,))(NP (QP (CD (II))(CD (III))))(NP (NN (receptor)))))))))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 515:C04.588.274.623 554:D02.654.442.200 756:D03.383.742.698.253.650 1161:D12.644.276.374.687.100  |ES| 2:1 7:1 10:1 14:1 19:1 102:1 115:1 186:1 324:1 543:1 836:1 1116:1 1772:1 1773:1 1875:1 1900:1 1972:1 2281:1 2337:1 2350:1 2602:1 2685:1 3130:1 3496:1 4008:1 4009:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (DT (These)))(VP (VBP (result))(ADVP (RB (also)))(VP (VBP (support))(NP (NN (role))(NNP (BMX))(JJ (potential))(NN (drug))(NN (candidate))(NN (use))(NN (combination))(NN (cisplatin))(NN (treatment))(JJ (human))(NN (lung))(NN (cancer)))))) |ET|  |BS| 15:F01.829.316.616 52:E02 55:B01.050.150.900.649.801.400.112.400.400 67:D26 375:Z01.639.100 498:D01.210.375  |ES| 5:1 18:1 19:1 31:1 36:1 101:1 191:1 328:1 530:1 546:1 792:1 827:1 1243:1 1364:1 1659:1 1761:1 3050:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NN (Diethylnitrosamine))(NN (initiation)))(VP (VBP (alter))(NP (ADJP (JJ (clofibric))(JJ (acid-induced)))(NN (hepatocarcinogenesis))(NN (rat))))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 554:D02.654.442.200 1190:D02.241.081.114.968.500.500  |ES| 19:1 637:1 849:1 900:1 2599:1 4151:1 4152:1 4153:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NNP (Chlorophyllin)))(VP (VP (VBN (shown))(ADVP (RB (significantly)))(VP (VB (reduce))(S (NP (JJ (genotoxic))(NN (AFB))(NNS (biomarkers)))(ADJP (JJ (human))))))(, (,))(ADVP (RB (therefore)))(VP (VBP (hold))(NP (NP (NN (promise))(JJ (practical))(NN (mean)))(VP (VBG (reducing))(NP (NN (incidence))(JJ (AFB-induced))(NN (liver))(NN (cancer)))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 55:B01.050.150.900.649.801.400.112.400.400 158:D23.101 434:E05.318.308.985.525.375  |ES| 2:1 18:1 19:1 36:1 124:1 218:1 237:1 836:1 1269:1 1511:1 2215:1 2361:1 2825:1 2827:1 3039:1 3328:1 3329:1 3330:1 3331:1 3332:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Cytochrome))(NN (P450))(NN (1A2)))(VP (VBZ (Metabolizes))(S (NP (NN (17beta-Estradiol)))(VP (VB (Suppress))(NP (JJ (Hepatocellular))(NN (Carcinoma))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 104:C04.557.470.200.025.255 705:D08.244.453.040.443 706:D04.808.365.415.248  |ES| 19:1 1241:1 2151:1 2548:1 2549:1 2550:1 2551:1 2552:1 2553:1  |EV| 
4.5068990627598779497020586859435  |BT| (NP (NP (NP (NNP (Phenobarbital)))(PRN (-LRB- (-LRB-))(NP (NN (PB)))(-RRB- (-RRB-))))(NP (NP (NP (NN (orphenadrine))(-LRB- (-LRB-))(NN (ORPH))(-RRB- (-RRB-))(NN (cytochrome))(NN (P450)))(PRN (-LRB- (-LRB-))(NP (NN (CYP)))(-RRB- (-RRB-))))(NP (NN (2B))(NN (inducer))(NN (liver))(JJ (tumor-promoting))(NN (effect))(NN (rat))))) |ET|  |BS| 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 515:C04.588.274.623 756:D03.383.742.698.253.650 1159:D02.092.471.600 1160:D27.505.389.249  |ES| 10:1 14:1 19:1 75:1 836:1 849:1 2549:1 3496:1 3776:1 3788:1 3789:1 3791:1 4004:1 4005:1 4006:1 4007:1  |EV| 
4.5068990627598779497020586859435  |BT| (S (NP (NNP (Cyclooxygenase))(CD (2))(NN (Prostaglandin))(NN (E2)))(VP (VBN (Involved))(NP (JJ (N-Nitrosodiethylamine-Initiated))(JJ (Early))(NN (Rat))(NN (Hepatocarcinogenesis))))) |ET|  |BS| 24:D08.811.600.720.750 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 554:D02.654.442.200 1118:D10.251.355.255.550.250.200  |ES| 19:1 148:1 1959:1 3432:1 3909:1 4008:1 4132:1 4133:1 4134:1 4135:1  |EV| 
-4.5068990627598779497020586859435  |BT| (FRAG (NP (NP (JJ (Immunohistochemical))(NN (analysis)))(JJ (late))(NN (stage))(NN (tumor))(NN (promotion))(NN (oxfendazole))(NN (rat))(NN (hepatocarcinogenesis))(NN (model)))) |ET|  |BS| 8:C04 38:Z01.058.290.120.180 40:Z01.542.248.700 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700  |ES| 7:1 19:1 72:1 661:1 849:1 900:1 1129:1 2337:1 2648:1 2649:1 2650:1  |EV| 
-4.5068990627598779497020586859435  |BT| (S (NP (NN (Methyl))(NN (antcinate))(NN (A))(NN (Antrodia))(NN (camphorata)))(VP (VBZ (induces))(NP (NP (NN (apoptosis))(JJ (human))(NN (liver))(NN (cancer))(NN (cell))(JJ (oxidant-mediated))(NN (cofilin)))(: (-))(NP (JJ (Bax-triggered))(JJ (mitochondrial))(NN (pathway)))))) |ET|  |BS| 39:G04.299.139.160 55:B01.050.150.900.649.801.400.112.400.400 104:C04.557.470.200.025.255 342:D12.644.360.075.718.400 565:A11.284.430.214.190.875.564 567:G05.360.340.024.340.365 573:N05.715.350.200.650 786:B01.300.179.120.174.070 787:D27.720.642  |ES| 18:1 19:1 36:1 69:1 89:1 94:1 214:1 383:1 836:1 2004:1 2753:1 2754:1 2755:1 2756:1 2757:1 2758:1 2759:1  |EV| 
-4.5068990627598779497020586859435  |BT| (FRAG (NP (NN (Deficiency))(NN (folate)))(, (,))(NP (S (VP (VBP (play))(NP (NN (role))(NN (synthesis))(NNP (SAM))(NN (lead)))))(NP (VBD (increased))(NN (risk))(NN (colon))(NN (cancer))))) |ET|  |BS| 15:F01.829.316.616 20:G03.495 61:E05.318.740.600.800 79:I03.450.642.693 86:D01.268.556.435 232:D02.886.030.676.180 974:C18.654.521.500.133.699.308  |ES| 2:1 18:1 19:1 31:1 47:1 113:1 171:1 238:1 254:1 778:1 3435:1 3436:1 3437:1  |EV| 
-2.4447956670679786839173175394535  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(S (NP (PRP$ (Our))(NN (result)))(VP (VBP (suggest))(SBAR (S (NP (NN (Raloxifene))(JJ (potent))(NN (IL-6))(: (/))(NN (GP130))(NN (inhibitor)))(VP (MD (may))(VP (VB (chemoprevention))(NP (NP (NN (agent))(NN (liver))(NN (cancer)))(VP (VBG (targeting))(NP (JJ (persistent))(NN (STAT3))(NN (signaling)))))))))))) |ET|  |BS| 69:G02.111.087.800 82:D12.644.360.024.342.300 201:D12.644.276.374.465.224 253:E02.319.162 964:D02.455.426.559.389.150.700.900.775  |ES| 18:1 19:1 22:1 101:1 104:1 195:1 239:1 251:1 380:1 491:1 616:1 658:1 728:1 796:1 836:1 870:1 3384:1 3385:1 3386:1  |EV| 
-0.20611126791095557564403861761093  |BT| (S (NP (PRP (We)))(VP (VP (VBP (propose))(SBAR (S (NP (JJ (estrogen-mediated))(NN (inhibition))(NN (IL-6))(NN (production))(NNS (KCs)))(VP (VBZ (reduces))(NP (NP (NN (liver))(NN (cancer))(NN (risk))(NN (female)))(, (,))(NP (NP (NN (finding)))(VP (MD (may))(VP (VBN (used))))))))))(VP (VBP (prevent))(NP (NN (HCC))(NN (male)))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 43:F01.145.544 61:E05.318.740.600.800 104:C04.557.470.200.025.255 201:D12.644.276.374.465.224 889:D27.505.696.399.472.277  |ES| 2:1 18:1 19:1 103:1 142:1 171:1 441:1 476:1 491:1 733:1 836:1 843:1 927:1 1402:1 1404:1 2677:1 3146:1 3147:1 3148:1 3149:1  |EV| 
-0.056586208847193120163865387439728  |BT| (NP (NP (NNS (METHODS))(: (:)))(NP (NP (JJ (UVB-induced))(NN (skin))(NN (carcinogenesis))(NN (model))(NN (SKH-1))(NN (mouse)))(VP (VBN (used))(S (VP (VBG (determining))(NP (JJ (preventive))(NN (effect))(NN (magnolol))(NN (skin))(NN (cancer))(NN (development)))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 33:C04.697.098 168:E05.581 785:A17.815  |ES| 18:1 19:1 35:1 52:1 72:1 75:1 104:1 207:1 476:1 565:1 1883:1 2319:1 2526:1 2750:1 2751:1 2752:1  |EV| 
